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Introduction 
Fortunately carcinoma at the confluence of the hepatic ducts 
is rare. A tumour of the extrahepatic bile duct is found in one 
out of every 1,000 autopsies (33, 88, 273, 321, 433, 485) and 
in one out of every 100 bile duct operations (41, 218, 273, 
348, 413, 440, 609). One percent of all malignant tumours orig-
inates from the extrahepatic bile ducts, peri-ampullary and 
gallbladder cancers excluded (60, 348, 458, 505), and half of 
them is localised in the confluence of the hepatic ducts (5, 9, 
19, 44, 178, 258, 273, 343, 477, 538, 564). Probably this re-
presents an underestimation of the true picture, now they have 
become so well known and notorious (Klatskin et al.(65)) and 
since the assessment of obstructive jaundice recently has been 
improved so much (79, 80, 208, 292, 371, 412, 484, 564). 
Tumours of the hepatic duct confluence have slight predominance 
in men over women. The average age of the patients is 60 to 65 
years but nearly all series contain a few patients between the 
age of 30 and 40. 
Aetiology 
Different pathogenic factors may play a role but the real 
cause of a bile duct cancer is not known. Chronic inflammation 
of the ducts with stasis of bile may finally lead to cancer 
(501), as in sclerosing cholangitis (123, 320), typhoid carrier 
state (603), chronic suppurative cholangitis with intrahepatic 
gallstones (513) and bile duct parasites (31, 45, 274, 553). 
Gallstones occur in patients with bile duct cancers as often as 
in those without and so are not causally related (88, 433, 437). 
Various substances can induce bile duct cancers in laboratory -
animals (190, 292, 501, 532, 553). Spontaneous bile duct can-
cers that may have been caused by carcinogens are reported in 
animals (153, 162). Labourers in the rubber industry are said 
to have an increased risk (316). 
Malignant degeneration of benign bile duct adenomas, papillo-
mas (280, 288) or bile duct cysts (301, 569) is well recorded. 
Concomitant colitis ulcerosa occurs in 0 to 14% of the patients 
(7, 44, 107, 223, 470, 548, 579) and a second primary tumour is 
present in 3 to 16% (38, 172, 223,235, 343). 
Symptoms, signs and course of the disease 
The symptoms of a bile duct tumour are non-specific and are 
almost entirely due to bile duct obstruction which results in 
a progressive jaundice (12, 33, 187, 286, 309, 596, 606). 
Non-specific prodromal complaints may be present about two 
months before the outset of the jaundice and consist of loss of 
appetite, emaciation, abdominal pains, itch or diarrhoea (13, 
43, 394, 542, 564). Jaundice usually comes into being only when 
the bile duct obstruction is virtually complete (55, 484). It 
may be intermittent at first (17, 88, 111, 113, 145, 321, 477), 
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especially when caused by a papillary tumour (372), and is 
often attended with pruritis and weight loss. Half of the pa-
tients have upper abdominal pain (88, 292, 477, 489). Portal 
hypertension (217), ascites (171, 321, 365) and gastrointes-
tinal disturbances are also reported. 
In half of the patients (29-78%) the diagnosis has not been 
made at a previous laparotomy (7, 13, 195, 208, 594, 606, 609). 
Fever and cholangitis rarely complicate the natural course of 
bile duct tumours (113, 321, 489) but infection is common after 
surgical intervention (285, 351). 
The average duration from the start of the jaundice to the 
surgical treatment amounts to four months (7, 171, 208, 258, 
273, 286, 409, 462, 485, 542, 581). 
Physical examination of a patient with a proximal bile duct 
cancer usually reveals jaundice and an enlarged liver. 
Laboratory examination of the blood just confirms the obstruc-
tive jaundice (17). A selectively raised alkaline phosphatase 
level, although non-specific (73) and not significant (579), 
may indicate a bile duct tumour in the pre-icteric stage (41, 
63, 77, 235, 252, 596, 606). The typical findings at surgical 
exploration are a large, firm, congested liver and a collapsed 
gallbladder and common bile duct. 
Without treatment the patient usually dies from hepatobil-
iary insufficiency within three months of the diagnosis being 
made (319), but a much longer survival is reported incidental-
ly (442) . The treated patient also dies usually from the con-
sequences of biliary obstruction and not from the malignant 
properties of the tumour. Cholangitis, septicaemia and liver 
abscesses as well as liver insufficiency or biliary cirrhosis 
are by far the most important causes of death (12, 13, 14, 60, 
174, 223, 277, 285, 286, 420, 477, 485, 507, 564, 581). At 
autopsy only a small, undisseminated tumour is found in nearly 
half of the patients (396) . 
Diagnosis of the cause of jaundice 
Since there is no reason for any diagnostic delay, a patient 
with obstructive jaundice should be prepared for surgery by 
the second week of being jaundiced (489). For a rapid, effi-
cient and appropriate diagnosis of jaundice, the many modern 
diagnostic tools have to be used selectively (35, 36, 54, 63, 
251, 272, 621). Anamnesis and physical and laboratory examina-
tions usually make it possible to differentiate between medi-
cal and surgical jaundice (554) . Ultrasound investigation de-
monstrates bile duct dilatation with 95% certainty (55, 63, 
388, 577) , provides information about the size of the liver 
lobes (583) and may indicate liver metastases (560). 
Dilated ducts necessitate an intervention (286). Cholangio-
graphie identification and, if possible, cytologic verifica-
tion of the tumour (177) form the final assessment of the 
diagnosis. 
Therapy 
Restoration of the bile flow to the bowel is the first aim of 
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the therapy since the bile duct obstruction determines both 
mortality and morbidity. A lasting bilio-enteric reconstruc-
tion is only rarely attained and consequently the mean post-
operative survival is only one to 1^ years. Resection of the 
tumour offers the best therapeutic possibilities and moreover 
has the potential to remove the malignancy, however tiny this 
chance seems to be in practice. Palliative internal bile drai-
nage either paratumoral or transtumoral is considered if re-
section is impossible or not pursued. 
In patients with high operative risks percutaneously or endo-
scopically inserted drains may offer the best solution. The 
benefit of adjuvant radiotherapy remains unclear but irradia-
tion may be administered. Finally it is important 'to distin-
guish between the need for operations that may prolong the act 
of dying and for those that may extend a tolerable but limited 
span of life' (5) . 
Aims and purposes of the thesis 
Renshaw (462) wrote in 1922:'The surgical treatment of malig-
nant conditions of the biliary tract has not advanced propor-
tionately with that of other parts of the upper abdomen. Alas, 
this still applies to the cancers of the hepatic duct conflu-
ence, as it does to gallbladder cancers, in spite of the fact 
that many of the confluence tumours are small, circumscript 
and not yet disseminated at the time they are discovered (309, 
396, 537a). 
The present understanding of a tumour of the hepatic duct 
confluence and of the many pathological factors which play a 
role in this disease is ill-defined and superficial. Progress 
of the knowledge of confluence tumours requires a thorough 
prospective investigation based on knowledge obtained in the 
past. The aims of this study are threefold: 
1_ to provide a comprehensive review of the data already known, 
from which a prospective study can be initiated; 
2 to record the present-day treatment methods and their suit-
ability for the individual patient; and 
3 last but not least, to investigate the causes of the common 
therapeutic failure and to develop a better treatment. 
For that purpose the anatomy of the liver hilus, the charac-
teristics of these tumours and the various types of treatment 
are reviewed. A retrospective survey of 51 patients with conflu-
ence tumours and a prospective study of 24 patients with con-
fluence tumours involving the portal vein are presented. Based 
on an analysis of the poor results the required extent of a 
radical resection is defined and discussed together with the 
practicability of such a resection. Subsequently a technically 
feasible operation is described as developed in an anatoriical 
study. The clinical applicability of such an operation seems 
reasonable as demonstrated in animal exneriments. 
3 
Part Λ C h a r a c t e r i s t i c s and current s u r g i c a l treatments 
1. Anatomy 
1.1. Anatomy of the liver 
The liver has a twofold segmental structure (27, 28, 142, 219, 
247, 267). One segmentation is governed by the structures which 
enter and leave at the porta hepatis i.e. the portal vein, he­
patic artery, hepatic ducts, lymphatic vessels and nerves. 
These portal or hilar structures and their intrahepatic bran­
ches stay together, the bile ducts usually in ventral and the 
arteries in dorsal position to the accompanyinq portal vein 
branches (466) . Also inside the liver thev are envelooed in a 
fibrous sheath which is the intrahepatic continuation of the 
perihepatic capsule of Glisson (142) . This capsule condenses 
in the porta hepatis to a fibrous hilar plate (plaque hilaire) 
and from there ramifies,following the intrahepatic divisions 
of the portal structures. Eight liver segments can be discern­
ed based on the intrahepatic division of these portal struc­
tures. The portal structures of these segments have no mutual 
communications other than by the segmental main branches, they 
are numbered from I to VIII according to Couinaud (142). The 
other segmentation is determined by the three suprahepatic 
veins which leave the liver posterocranially, each of them 
draining its own suprahepatic segment. 
The portal and suprahepatic structures are intertwined in 
such a way that the main branches of the suprahepatic veins run 
in the plains of separation (scissures) between the portal seg­
mental structures and vice versa (Fig. 1) . 
The portal segments II and III correspond with the left sup­
rahepatic segment and form the classic left liver lobe, situa­
ted at the left side of the umbilical fissure, ligamentum 
teres hepatis, ligamentum falciforme and sulcus Arantii. 
The segments IV up to and including VIII correspond with the 
middle and right suprahepatic segments and form the classic 
right liver lobe. The quadrate lobe consists of the anterior 
part of segment IV. The caudate lobe of Spigel, also indicated 
as portal segment I or dorsal liver segment, forms a separate 
segment and is situated at the cranio-dorsal side of the liver, 
straddling the left anterior side of the inferior cavai vein 
beside the right adrenal gland. 
The plane of separation between segment IV and segments V 
and VIII is called principal scissure and contains the middle 
suprahepatic vein. This scissure divides the liver according 
to its portal structures in two main parts (387), a right and 
a left hemi-liver. Along this principal scissure a right or 
left hemipatectomy is carried out. The plain of separation be-
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v. cava inferior 
suprahepafic veins 
left portal scissure 
portal structures 
right portal scissure I umbilical scissure 
principal portal scissure 
right hemi-liver left hemi-liver 
[right hemihepatectomy) ^ (left hemihepatectomy 1 ^  
right liver lobe (right lobectomy) left I iver lobe 
я
 |(|eft lobectojiy ) 
Fia.l. Segmental anatomy of the liver, 
tween segment IV and segments II and III is called umbilical 
scissure and corresponds with the left suprahepatic interseg­
mental plane. This scissure divides the liver in its classi­
cal right and left lobes and resections along this plane are 
therefore best called right and left lobectomy (49, 565). 
1.2. Anatomy of the hepatoduodenal ligament and hilus 
of the liver 
The hepatoduodenal ligament forms the free right margin of 
the lesser omentum and contains the structures which enter or 
leave the porta hepatis (Chapter 6.3. ; Fig. 10). 
5 
Vena portae 
The portal vein arises behind the pancreas and before the 
inferior cavai vein from the confluence of the splenic vein, 
which runs from cranial-left to caudal-right along the poste-
rior surface of the pancreas, and the superior mesenteric vein. 
The portal vein is 8 cm in length and runs along the left-
posterior side of the bile duct and right-posterior to the 
hepatic artery in the hepatoduodenal ligament to the porta 
hepatis. It receives the v. coronaria, v. pylorica, v. pan-
creaticoduodenalis superior and v. gastroepiploica dextra, 
enters the right corner of the porta hepatis and there widens 
and bifurcates posterior to and in contact with the left side 
of the hepatic duct confluence (268) . The right main branch 
measures 2-3 cm and divides into the right lateral and 
right paramedian branches. 
The left main branch is smaller than the right one but still 
as wide as the splenic vein. Considering the many variations 
of the hilar anatomy, the course of the left portal vein 
branch is remarkably constant. It always runs extrahepatically 
and transversally in the porta hepatis in cranial-left direc-
tion, measures 4-5 cm and gives off some side branches to the 
caudate and quadrate lobes. In the left edge of the porta 
hepatis the left portal vein branch bends anteriorly and 
widens to its umbilical part, also called the recessus of Rex. 
This recessus of Rex is situated in the posterior side of the 
umbilical fissure and runs in anterior direction. 
From its base the portal vein branch to segment II originates 
and further downstream the branches to segment III and to the 
left side of segment IV emerge. Finally the recessus of Rex 
terminates in the closed umbilical vein in the ligamentum 
teres (142, 157, 206, 346, 502) (Figs 2 and 3). 
Variations of the anatomy of the portal vein system are 
rare. Rests of valves are only found in small side branches 
of stomach and omentum veins of neonates. Thev atrophy 
and vanish quickly (157, 615), therefore the direction of the 
blood flow in the portal system is determined by the existing 
pressure gradient only (479). 
Arteria hepática 
The common hepatic artery arises from the truncus coeliacus, 
runs in right-anterior direction along the cranial border of 
the head of the pancreas, crosses the portal vein left-ante-
riorly, gives off the gastroduodenal artery and the right 
gastric artery and then runs as proper hepatic artery left-
anterior to the portal vein and along the left side of the 
bile duct to the porta hepatis. 
The gastroduodenal artery runs anterior to the portal vein 
in postero-caudal direction, at the left side of the common 
bile duct and posterior to the duodenum. There it divides in-
to the a. gastroepiploica dextra and the a. pancreaticoduo-
denalis superior which anastomose with the corresponding left 
and inferior arteries arising from the splenic and the supe-
rior mesenteric artery respectively (18, 401, 415, 519) . 
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quadrate lobe (segment IV) 
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between segments III and IV 
left liver lobe 
(segments II and III ) 
recessus of Rex 
caudate lobe (segment 11 
a. hepática 
v. portae 
d. hepaticus comm. 
Fig. 2. The left extrahepatic portal structures, 
(seen from ventrocaudal direction). 
The proper hepatic artery runs along the left side of the 
bile duct and left-anterior to the portal vein to the porta 
hepatis and splits somewhat earlier than the portal vein into 
a right and left branch. The right branch runs between the 
portal vein and the common hepatic duct to the right, launches 
the cystic artery, then runs right-anterior to the right por-
tal vein branch and divides into the right lateral and right 
paramedian branches. The left branch runs left-caudal to the 
left portal vein branch to the left liver lobe. It gives off 
a middle hepatic artery which runs on the right side of the 
umbilical fissure to the quadrate lobe. 
Deviations of this pattern exist in 45% of the people. The 
most important anomalies are a left hepatic artery orginating 
from the left gastric artery (22%) and a right hepatic artery 
sprouting from the superior mesenteric artery (12%) (397). 
Bile ducts 
The ductus hepatocholedochus runs in the anterior free margin 
of the hepatoduodenal ligament, right-anterior to the portal 
vein and right to the hepatic artery. Following the 8 cm long 
duct upstream from its entrance in the duodenum, at first the 
cystic duct and gallbladder are given off. At the right edge 
of the porta hepatis the 3 cm long common hepatic duct divides 
into the right and left hepatic ducts. 
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v.cava inferior 
v. suprahepatica sin. 
portal structures of segment I I 
lig.teres 
recessus of Rex 
left branch of a hepática 
d. hepaticus sin. 
left branch of v. portae 
Fig. 3. The left edge of the porta hepatis and the 
subhilus of the left liver lobe (seen from 
right-lateral direction after removal of the 
right lobe). The branching of the segment 
II structures has been drawn outside the 
parenchyma. 
This bifurcation, more correctly called 'confluence' with 
respect to the direction of the bile flow, is always situated 
extrahepatically, as is the left hepatic duct (58). The dis-
tance between the bile duct and the portal vein becomes even 
smaller as both structures approach the liver and in the porta 
hepatis they are in contact with each other. The hepatic duct 
confluence lies directly on the portal vein bifurcation or on 
the base of its right main branch (268) . The anterior side of 
the confluence and the beginning of the left hepatic duct are 
covered by the hilar plate (142, 254) . 
The right hepatic duct measures 1-2 cm, runs left-anterior 
to the right portal vein branch and splits intrahepatically 
into the right lateral and right paramedian ducts. The 4-5 cm 
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long left hepatic duct runs transversally in the porta hepatis 
to the left and gives off one to three side branches to segment 
IV. Some small branches to the caudate lobe originate from the 
posterior side of the left hepatic duct and sometimes from the 
hepatic duct confluence too. 
Following the left hepatic duct in upstream direction, the 
duct is at first in cranio-anterior position to the left portal 
vein branch but at the left edae of the porta hepatis it is 
cranial to the base of the Recessus Rex. 
There the left hepatic duct divides in general inside the left 
liver lobe into the duct to segment II and the duct to segment 
III. The segment III duct runs at the left antero-cranial side 
of the corresponding portal vein branch to segment III (121, 
142, 247) (Fig. 3). 
Variations of the extrahepatic biliary anatomy are frequently 
seen. Only 56-72% of the people have a hepatic duct confluence 
as described. In 28-44% one or more segmental ducts arise in an 
unusual way from a hepatic duct (142, 484) . The course of the 
left hepatic duct is fairly constant, although the second order 
confluence, in which the segmental ducts II and III come to-
gether, is located to the right of the umbilical fissure in 
22-42% of the people (scission horizontale) (142, 247) . 
The vascularization of the extrahepatic bile ducts consists 
of a peribiliary arterial and venous plexus. The arterial net-
work arises from branches of the proper hepatic and gastroduo-
denal arteries. The venous plexus, together with a similar 
plexus around the gallbladder, is reported to drain its blood 
partially to small venules which enter the adjacent liver 
parenchyma of the quadrate lobe and gallbladder bed. These 
venules would divide into capillaries, that finally re-unite 
in the suprahepatic venous system (3, 181, 405, 445). 
Lymphatic system 
Lymph vessels in the hepatoduodenal ligament are numerous. The 
lymph drainage of the liver hilus follows two main chains: 
one along the portal vein and the bile duct and the second 
along the hepatic artery. The periarterial chain mainly col-
lects lymph from the left liver lobe and carries it via one or 
two lymph nodes near the origin of the left hepatic artery 
branch and nodes along the proper or common hepatic artery to 
the coeliac and para-aortal nodes. 
The periportal and peribiliary chains drain the lymph of the 
extrahepatic biliary tract and the right liver lobe. There is 
only recently agreement about the presence of lymph nodes in 
the liver hilus as former reports were contradictory (181) . 
Obstructive jaundice caused by compression of the hepatic duct 
confluence by a tuberculous lymph node is described (377) and 
finally Hardy and coworkers (240) demonstrated that hilar 
lymph nodes do exist and are situated posterior to the portal 
vein bifurcation and the beginning of the left portal vein 
branch. These nodes receive lymph from adjacent regions and 
drain on the lymphatic network around the portal vein. This 
periportal chain is connected with the peribiliary lymphatic 
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system and with the periarterial chain by lymph vessels 
posteriorly in the hepatoduodenal ligament. 
The peribiliary lymph vessels run via the cystic node and 
the hiatal node to the superior pancreatoduodenal nodes be-
side the distal end of the common bile duct and beside the 
duodenum and pancreas. From there the lymph flow heads for the 
coeliac nodes and via the posterior pancreatoduodenal nodes 
for the nodes near the origin of the superior mesenteric arte-
ry (159, 181, 240, 415, 377, 466). 
Some peribiliary lymph vessels run straight to the pancrea-
toduodenal nodes (159, 415). During obstruction of the lymph 
drainage a retrograde flow of lymph is possible (181, 449) . 
Because of a biliolymphatic permeability part of the bile may 
be drained by the lymphatic system during biliary obstruction 
(159, 213). 
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2. Review of the literature on carcinoma of the 
hepatic duct confluence 
The main problem in reviewing the literature is the absolute 
lack of a systematic classification of the patients and their 
tumours. The reported frequencies of tumour characteristics 
and metastases depend strongly on the systematic thoroughness 
of the investigation and on the moment this is done. Detailed 
information on these factors is seldom provided. Often exact 
information about tumour properties and therapies is missing 
or concealed in a subjective personal classification. There-
fore the patients to be discussed in this Chapter form a very 
heterogeneous population and the mutual comparability of the 
various components leaves much to be desired. 
In many papers tumours of the hepatic duct confluence are 
discussed in conjunction with tumours of other parts of the 
bile duct without proper specification. The results of treat-
ment of confluence tumours are worse than those of more dis-
tally localised tumours (421, 489) . After resection the 
malignancy is histologically confirmed,but in patient studies on 
other types of treatment histological confirmation is unclear 
or only partially provided which makes the results of these 
treatments susceptible to criticism. Operative mortality usu-
ally is defined as death in the first month after the opera-
tion, but in some publications it means death in the first two 
months thus influencing the average postoperative survival. 
Some authors understand by duration of survival, the time of 
life from the outset of the jaundice but the major part starts 
to count as from the main operation. In most reports one part 
of the patients has died while the other part is alive. Conse-
quently the average survival is determined partly by the 
death of the patients and partly by the time of writing. This 
last imperfection is relative as it applies to all patients. 
The present review includes as much as possible only histo-"-
logically proven primary tumours of the hepatic duct conflu-
ence. In this context 'bile duct tumour' means only primary 
tumours of the left, right and common hepatic ducts and 
supraduodenal portion of the common bile duct and exclude 
tumours of the gallbladder and periampullary area. Duplication 
and overlap of series or updated reviews on the same patients 
I have tried to avoid. Operative mortality is defined as death 
within the first month after operation. The duration of sur-
vival is counted as from the day of the main operation. In 
this period of survival those patients are excluded who died 
in the first postoperative month, all other patients are in-
cluded in this study whether dead or alive at the time of 
writing. Liver resection along the principal scissure is call-
ed hemihepatectomy, and resection along the umbilical scissure 
lobectomy. Heterogeneous as it remains, no effort was made to 
apply statistics to this patient material. 
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2.1. Pathological anatomy of cancers of the hepatic duct 
confluence 
Macroscopic features 
The main macroscopic types of bile duct tumours can be dis-
cerned as nodular or annular and as papillary or villous 
types. The macroscopic type is mainly determined by the stroma 
reaction around the tumour (433) . The stroma of tumours situ-
ated at the liver hilus usually consists of strongly fibrotic 
connective tissue which produces a scirrhous nodular or annu-
lar mass (602) . A papillary type is found in 6% of patients 
with a bile duct tumour (77, 88, 309, 372, 384, 441, 484,564). 
A bile duct tumour is found to be multiple or diffusely 
spread for a long distance of the bile duct including the con-
fluence in 9% of the patients. In these cases the extrahepatic 
bile duct may become a rigid tube (linite biliare (112)r 
cancer en tuyau (433), Röhrenform (437)), while intrahepa-
tically the tumour may follow the biliary bile ducts fanwise 
(cancer en éventail (33, 433)) (Table I). 
Table I. Incidence of the multicentric or diffuse type of primary 
bile duct tumours. 
Authors bile duct tumours diffuse or multicentric tumours 
Adson and Farnell (5) 221 11 
Andersson et al. (17) 53 6 
Benhamou et al. (33) 17 θ 
Bertrand et al. (43) 16 4 
Bessot and Boissel (44) 36 2 
Brown et al. (88) 37 5 
Ham and Mackenzie (235) 32 2 
Hepp and Mercadier (255) 9 1 
LeNeel et al. (348) 20 2 
Mourgue-Molines et al. (409) 16 4 
Neibling et al. (413) 90 4 
Saubier et al. (491) 45 3 
Tompkins et al. (564) 96 7 
Warren et al. (596) 77 13 
Total no. of patients 765 72 (9.4%) 
In general the macroscopic and palpable size of a proximal 
bile duct tumour is small (309, 396). Sometimes the tumour 
forms a large, hard mass (480) in which the site of the pri­
mary lesion hardly can be traced. In these cases the place of 
the largest thickening or the centre of the bile duct obstruc­
tion may be regarded as origin of the tumour (171). 
The tumours may preferably arise from the left side of the 
confluence or the left hepatic duct (458, 596) although tu­
mours arising from the right side are also described. 
There is a possibility that right-sided tumours are more often 
missed or booked as intrahepatic tumours as they are more 
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difficult to reach than left-sided tumours (357). 
There are three possibilities for a bile duct obstruction in 
the hepatic duct confluence (43, 48): 1_ partial or complete 
obstruction of a duct; 2 unilateral or bilateral obstruction; 
and 3 obstruction confined to the main confluence or extended 
to secondary confluences. 
Microscopic features 
Virtually all primary bile duct tumours are adenocarcinomas. 
The mucin produced by tumour cells becomes blue-stained by 
Alcian blue, contrary to the mucin of benign cells (602).Other 
types of epithelial tumours are found occasionally, non-epi-
thelial tumours are extremely rare (171, 210). 
Well-differentiated tumours are predominant (13, 171, 172, 309, 
485, 54 2, 548, 564, 596) although in some series most tumours 
are poorly differentiated (343, 477). 
In proximal bile duct tumours the connective tissue around the 
tumour tissue is in general densely fibrotic, sclerotic and 
scirrhous (13, 77, 171, 210, 290, 413, 433, 484, 523, 548,602). 
The fibrotic reaction around the tumour may even be so abundant 
that hardly any tumour cells can be found (477). Virtually, it 
can be impossible to discern desmoplastic and proliferative 
changes of bile duct tissue from sclerosing carcinoma (602) . 
For these reasons a representative biopsy may be difficult to 
obtain for the surgeon and difficult to interpret for the 
pathologist. Moreover a periductal fibrosis may unjustly be 
considered as a carcinomatous expansion (602). These factors 
should be taken into account when judging the results of the 
various treatments. 
There is no clear relation between the histological type and 
the macroscopic aspect (433, 542). In general tumours at the 
confluence of the hepatic ducts are small, well differentiated, 
scirrhous, annular adenocarcinomata (309, 396, 515, 602, 606). 
Infiltration and local spread 
Submucosal spread in the wall of the bile duct is the most com-
mon way of local tumour expansion and may occur for a wide 
distance (77, 88, 145, 229, 292, 433, 480, 556, 572). Therefore 
a bile duct carcinoma has to be regarded as a regional rather 
than as a local lesion of the bile duct (433) . It is not clear 
as to how far involvement of the gallbladder, which may occur 
in up to 13% of the patients (321) is due to local spread, 
separate dissemination or multifocality of the primary tumour. 
The wall of the bile duct only consists of an epithelial layer 
and a thin layer of connective tissue with some smooth muscle 
fibres. The outside of the bile duct is supplied richly with 
nerves, lymph vessels and blood vessels. The epithelial layer 
forms glands bulging from the exterior of the duct. Hence pene-
trating malignant cells immediately reach the periductal tis-
sues (172, 229, 556, 561, 579, 619). Consequently spread of the 
tumour outside the bile duct is found in 70% of the patients 
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(171, 172, 216, 542, 579). 
Spread in and along the periductal tissues occurs by way of 
invasion of 
the perineural lymph clefts, reported in 39-64% of the 
patients (77, 88, 172, 210, 292, 413, 433)(Chapter 3;Fig.6); 
such spread can progress far from the origin of the tumour 
(594) ; 
the periductal venules and arterioles, reported in 18 of 22 
patients (82%) (433); 
the adjacent liver parenchyma of segments IV and I; 
the abundant lymphatic network; 
the portal vein and the hepatic artery. Penetration of a 
bile duct tumour into the portal vein (217, 442) may occur 
often and early (77, 268, 542, 556, 557), according to 
others only occasionally (60, 171) or even rarely (88, 172, 
216, 433). 
Since the confluence of the hepatic ducts is in direct contact 
with the right side of the underlying bifurcation of the portal 
vein, an early invasion seems plausible (268) . Involvement of 
the portal vein can be caused by the tumour itself as well as 
by fibrotic tissue that surrounds the tumour (424, 557). 
Regional dissemination 
Involvement of the lymphatic system occurs early (8, 409). A 
staged specification of the lymph nodes involved is not report-
ed in the literature. Likewise no suggestion could be found 
which nodes should be considered as the limit of regional 
lymph spread. In this context the area of regional lymph spread 
is defined to consist in the complete hepatoduodenal ligament 
up to and including the pancreatoduodenal nodes but excluding 
the mesenteric and coeliac nodes. 
Table II. Incidence of regional lymphatic metastases demonstrated in patients 
with primary bile duct tumours. 
Authors bile duct tumours regional lymph node metastases 
Benhamou et al. (33) 17 5 
Bessot and Boissel (44) 18 6 
Black et al. (60) 80 47 
Brown et al. (88) 62 32 
El Domeiri et al. (172) 24 13 
Glenn and Hays (211) 10 7 
Ham and Mackenrie (235) 32 9 
Kuwayti et al. (321) 63 21 
Ross et al. (477) 103 15 
Thorbjarnarson (557) 31 7 
Tompkins et al. (564) 96 14 
Warren et al. (596) 77 25 
Total no. of patients 613 201 (33%) 
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Regional lymphatic metastases so defined are described in 
33% (15-70%) of the patients with bile duct tumours (Table II). 
In patients with bile duct cancers localised in the hepatic 
duct confluence the reported incidence is 21% (0-44%) (Table 
III). Involved coeliac or para-aortal nodes are observed in 13S 
of the patients with a bile duct tumour (88, 321, 416, 596). 
Table III. Incidence of regional lymphatic metastases demonstrated in patients 
with primary tumours of the hepatic duct confluence. 
Authors confluence tumours regional lymph node metastases 
Altemeler et al. (13) 18 β 
Bertrand et al. (43) 16 1 
Edmondson (171) 11 4 
Ingis and Farmer (290) 14 0 
Klatskin (309) 13 1 
Launois et al. (330) 11 3 
Van der Velde and Leer (581) 8 2 
Total no. of patients 91 19 (21%) 
Liver metastases are reported in 30% (0-50%) of the patients 
with a bile duct tumour (Table IV). Localisation or extent of 
metastases is rarely mentioned (365) . Hepatic metastases may 
occur more often as the tumours are situated closer to the 
liver (421). Since small deposits will be easily missed, hepa­
tic metastases probably occur in about half of the patients 
with tumours of the hepatic duct confluence (8, 51). 
Lymphatic and hepatic metastases іпаУ occur simultaneously in 
one patient. In about half of the patients with a bile duct 
cancer one or both types of metastases are reported (Table V). 
As this incidence is probably too low rather than too high, it 
may be estimated that lymphatic or hepatic metastases exist at 
the time of treatment in about 1/2 to 2/3 of patients with bile 
duct tumours. Nevertheless, in many patients no metastases are 
found after previous operations or even after death, as is 
illustrated in 86 of 165 patients (52%) from six combined 
series in whom metastases were explicitly searched for during 
autopsy (60, 109, 236, 290, 396, 556). 
Dissemination at distance 
Metastases outside-the regional lymph nodes or the liver are 
seen in about 15% of the patients (0-30%) (33, 60, 88, 171,172, 
235, 273, 290, 309, 321, 409, 433, 564). In general they are 
located in the peritoneum of the lesser omentum, but other 
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Table IV. Incidence of hepatic metastases demonstrated in patients with 
primary bile duct tumours. 
Authors bile duct tumours hepatic metastases 
Benhamou et al. (ЭЭ) 17 
Bertrand et al. (43) 16 
Bessot and Boissel (44) 18 
Black et al. (60) 80 
Brown et al. (88) 54 
El Domeiri et al. (172) 54 
Ham and Mackenzie (235) 32 
Ingis and Farmer (290) 14 
Iwasaki et al. (294) 23 
Klatskin (309) 13 
Kuwayti et al. (321) 63 
Neibling et al. (413) 90 
Neugebauer et al. (416) 54 
Thorb]arnarson (557) 31 
Tompkins et al. (564) 96 
Van der Velde and Leer (581) β 
Total no. of patients 663 
7 
1 
9 
28 
21 
25 
7 
0 
8 
2 
21 
30 
15 
7 
17 
2 
200 (30») 
Table V. Incidence of regional lymphatic or hepatic metastases or both, 
demonstrated in patients with primary bile duct tumours 
Authors patients (percentage) 
Andersson et al. (17) 
Bismuth and Grebert (51) 
Black et al. (60) 
Braasch et al. (77) 
Goinard and Pëlissier (216) 
Kirshbaum and Kozoll (308) 
Krain (316) 
Kune (319) 
Lees et al. (343) 
Neibling et al. (413) 
Olivier (430) 
Rodgers et al. (471) 
Saegesser et al. (484) 
Stewart et al. (533) 
Van Heerden et al. (579) 
Van der Velde and Leer (581) 
Warren et al. (596) 
Whelton et al. (606) 
47 
40 
45 
33 
70 
77 
33 
33 to 66 
23 
63 
75 
46 
63 
46 
71 
52 
45 
55 
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peritoneal locations are also possible, as are incidental 
metastases in pancreas, ovaries, spleen and stomach. 
Dissemination outside the abdominal cavity is rare (although 
reported in 25% of one series (235)) and occurs mainly in the 
lungs. 
Rapidity of growth and mutual relation of tumoui properties 
The growth of a bile duct cancer in general and of a conflu-
ence cancer in particular is called fast by some authors (77, 
441) and slow by others (12, 13, 294, 309, 409, 562). There is 
no systematic investigation into the mutual relations of the 
various tumour characteristics. 
The poorer the differentiation of the tumour, the worse is 
the prognosis of the patient (30, 433) but according to other 
authors this makes no difference (556) . Patients without meta-
stases show a longer survival than patients with metastases 
(343, 471). The histological type of the tumour would not 
correlate with the occurrence of metastases (606) and a rela-
tion between infiltrative growth and the macroscopic type of 
the tumour is denied (542) . However,a papillary tumour would 
be less inclined to infiltrative growth (561) but more to a 
slow intraductal growth and hence should have a better prognosis 
than the usual sclerosing carcinoma (372, 523, 561, 563). When 
a scirrhous tumour has progressed so far that it blocks the 
lumen of the bile duct, the tumour cells have already invaded 
the surrounding tissues. Therefore tumour cells may remain in 
or between the many hilar structures after a supposedly com-
plete resection of the tumour (314, 561, 579). 
2.2. Pathophysiology and surgical considerations 
Bile duct obstruction 
Bile can pass through a very narrow lumen (55) . Only when the 
bile duct is almost completely blocked the upstream biliary 
system becomes dilated, caused by the raised biliary pressure. 
Many intrahepatic bile ducts may widen up to l^i or 2 cm in 
cross section (13, 344) . When the maximal hepatic secretion 
pressure of 30 cm water is reached the bile secretion stops 
(216, 513). The portal blood flow may be hampered by the 
strongly dilated ducts, as both ducts and vessels are enclosed 
by the stiff, fibrous Glissonian sheaths (22, 85, 390). The 
liver tissue of which the biliary drainage is blocked, at 
first becomes congested and swollen and then atrophies. If 
another part of the liver keeps its normal biliary drainage 
then in that part a compensatory hypertrophy develops simulta-
neously (78, 236, 245, 359, 390, 494, 495, 496). If the com-
plete biliary tree is blocked and the drainage of only a part 
is restored, then in that part a compensatory hypertrophy will 
occur, provided that the liver parenchyma is not seriously 
damaged by long-standing biliary obstruction (55, 69, 147, 
473) . 
Jaundice only occurs in case the biliary drainage of the 
entire liver is almost completely blocked (484). Dilatation 
and jaundice are absent as long as the hepatocholedochal duct 
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is partially obstructed (63) . A tumour of the hepatic duct 
confluence which has completely blocked one hepatic duct 
does not cause jaundice until the other hepatic duct is also 
seriously obstructed. Meanwhile the completely obstructed part 
of the liver has atrophied considerablv. Dilatation of the 
bile ducts precedes jaundice. Delay of the operation until the 
bile ducts are appropriately dilated is for that reason useless 
(484) . 
The intestinal flora is disturbed by the absence of bile 
(63) and in particular fats and fat-soluble vitamins are mal-
absorbed (285) . The resulting alimentary derangement is further 
deteriorated by anorexia. After two to three months of total 
biliary obstruction a secondary biliary cirrhosis develops with 
portal hypertension and impaired liver function, bringing about 
hypalbuminaemia and coagulation disorders (36, 63, 430) . Often 
these patients are operated on more than once with concomitant 
infections of the bile ducts and imminent renal insufficiency 
(11). 
The treatment of choice 
The kind of operation is determined by the palliation and 
potential cure to be expected, coupled to the lowest possible 
postoperative morbidity and mortality (243). In making this 
choice the condition of the patient and his tumour is just as 
determining as the attitude and skill of the attending surgeon 
(458). An operation in which no bile drainage is achieved may 
only speed up the fatal course of the disease. Without therapy 
the patient dies jaundiced from liver failure, but after in-
adequate restoration of the biliary drainage he dies jaundiced 
from cholangitis. Unless chosen as terminal palliation for 
patients with intractable pruritis, external bile drainage only 
adds a biliary fistula to the disease (430) . 
Surgical intervention mainly consists of resection, para-
tumoral bile drainage and transtumoral bile drainage. 
Resection - Both for duration and quality of survival a well-
functioning internal bile drainage forms the main goal of 
therapy. Resection of the tumour followed by the reconstruction 
of a proper bilio-enteric anastomosis offers the best and long-
est survival (8, 66, 178, 333, 471, 489)(Chapter 2.5; Fig. 4), 
and the only chance to cure the patient of his malignancy, how-
ever small this chance in practice may be. In most patients a 
recurrent tumour growth develops after resection, so that even 
excision of th'e tumour can be considered as some sort of palli-
ation (137, 223). No patient could be traced with a clearly 
demonstrated curative resection although at least nine patients 
with a five-years survival after resection have been reported 
(74, 80, 109, 146, 333, 517, 561). Sometimes, however, the 
tumours grow so slowly that even after palliative drainage 
procedures five years survivals have been described in patients 
with proven cancers of the hepatic duct confluence (13, 286, 
343). Even after an incomplete or palliative local resection 
with or without resection of the quadrate lobe, the quality of 
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the remaining life is better than after any other drainage 
procedure, because it provides the possibility of a good bi-
lateral bile drainage (8, 66, 259, 558). 
When comparing the various possibilities also the risks have 
to be considered (302, 472) . A higher risk to perform a resec-
tion seems justified when considering the generally shorter 
time and inferior quality of life after drainage procedures 
(487, 488). Moreover the operative mortality is not higher 
after resection than after drainage operations, although the 
comparability of the patients remains questionable. Radiother-
apy may theoretically eradicate the tumour but is in practice 
disappointing. 
In conclusion: If possible a resection of the tumour should 
be performed and from a palliative point of view even an in-
complete resection is better than non-resective drainage. 
Only if resection has been excluded para- or transtumoral 
drainage can be considered (66, 330, 458, 487, 488, 489, 492, 
601). Therefore the aim of the pre-operative examination is 
to trace or to eliminate the contra-indications for a resec-
tion and to determine precisely the biliary and vascular 
anatomy. 
Pre-operatively the patient has to be brought in an optimal 
condition for a possible liver resection. Therefore it may be 
beneficial to operate in two sessions as performed by Rohner 
(473) . In a first operation the internal biliary drainage of 
the liver segments,to be preserved after the actual resection, 
is restored by a paratumoral biliodigestive connection using a 
dilated intrahepatic duct for the crucial anastomosis. This 
enables the liver to recover and to subside which makes the 
hilus better accessible (48) . If the communication between the 
left and the right hemi-livers is blocked, this unilateral 
biliary drainage at the same time provokes a compensatory hy-
pertrophy of the liver part to be maintained. In a second 
session resection of the tumour and the adjacent part of the 
liver is carried out, leaving the hypertrophied liver part 
with the crucial biliodigestive anastomosis which has already 
been made (473). 
The disadvantages of a staged procedure are the inevitable 
formation of adhesions which impede a later resection and the 
meanwhile continuing tumour growth. Consequently if feasible, 
the complete operation should be performed in one session (484). 
A preceding biliary decompression without operation can be ob-
tained by percutaneous transhepatic drainage (392, 423) . 
Para- and transtumoral bile drainages - If resection is impos-
sible and palliation is considered to be the treatment of 
choice, the quality of the remaining life is even more impor-
tant than the duration. In that case postoperative treatment 
or control has to be avoided as much as possible (57) . A com-
parison between a paratumoral biliodigestive bypass and a 
transtumoral drainage encounters the doubtful matching of the 
treated patients. If a good biliary bypass can be constructed 
this may offer the best possible and reliable palliation in 
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one session. The construction of an intrahepatic bilio-enteric 
anastomosis is undeniably a more extensive, longer and more 
difficult operation than the insertion of a transtumoral tube. 
A paratumoral bypass has a higher operative mortality and the 
postoperative survival is about the same after both procedures. 
Therefore transtumoral intubation has strong advocates (128, 
547) as well as opponents (243, 339) . In transtumoral drainage 
the tumour is stretched and torn (516) but no reports could be 
found indicating an increased tumour growth or dissemination. 
Transtumoral drains may be blocked or may dislocate, external 
extensions of the drains may cause local and biliary infection 
as well as psychological problems (Chapter 2.4.3; Table XVIII). 
Application of either method where indicated is most appro-
priate (285, 286). A paratumoral bypass is especially indicat-
ed in a young patient in a good general condition with dilated 
intrahepatic ducts and a tumour too large to resect. 
Contra-indications against a formal intrahepatic bilio-enteric 
anastomosis are: undilated ducts, atrophy of the liver segments 
concerned, tumour involvement of the secondary confluences of 
the bile ducts concerned, portal hypertension, ascites, liver 
or other metastases and a poor general condition (50, 285, 
286). If transtumoral drainage is chosen, then a sunken drain 
(285) or a transhepatic drain with a subcutaneously placed end 
(65) are to be preferred from a palliative point of view. 
U-tubes which leave the abdomen may also give satisfactory 
palliation (545) . 
The aim of a palliative procedure is a good bile drainage 
of as much liver tissue as possible for as long as possible. 
An adequate bile drainage of 30% of the liver is enough to 
clear obstructive jaundice (55, 285, 315, 371, 436). If the 
communication between the left and right bile duct system is 
blocked by the tumour, then restoration of the bile drainage 
on one side is sufficient to make the jaundice disappear (48, 
147, 285, 309, 359, 371, 396, 457, 495, 500, 504, 545, 556, 
572). An end-to-side cholangiojejunostomy with a dilated bile 
duct of segment III as described by Soupault and Couinaud 
(521) is a suitable method (48, 258). 
Theoretically the right hemi-liver should be preferred for 
a unilateral drainage as the right hemi-liver is larger than 
the left one (16, 111Ì but a good right-sided cholangiojeju-
nostomy is much more difficult to construct than a left one 
(48, 50). In this respect transtumoral drainage is suitable, 
the more so since the right hepatic duct is approximately in 
line with the common hepatic duct. The right hepatic duct mea-
sures 1-2 cm and a tumour of the hepatic duct confluence may 
quickly reach the secondary confluence of the right lateral 
and right paramedian duct. Therefore unilateral right-sided 
drainage carries the risk of soon being confined to drainage 
of only half of the right lobe by progress of the tumour. 
The main disadvantage of unilateral drainage is the risk of 
infection and abscess formation in the undrained liver seg-
ments. Purulent cholangitis and liver abscesses are likely to 
develop in an obstructed bile duct system contaminated by 
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bacterias during surgical manipulation or percutaneous 
punction (124, 277, 359, 438, 573, 609). Unless it is expect-
ed that an adequate bile drainage can be achieved, it may be 
better for a completely blocked but not infected part of the 
liver to be left alone and to atrophy, provided a sufficient 
mass of the remaining liver is well drained and functions well 
(128, 277, 359). 
For these reasons many authors prefer a bilateral bilio-
enteric reconstruction (107, 124, 137, 285, 328, 330, 430,438, 
457, 460, 480, 484, 500, 503, 572). Exact information about 
the site and extent of the tumour and about the complete bili-
ary anatomy is required to be able to achieve an optimal bile 
drainage. 
If after dissection of a tumour, up to that moment thought 
to be completely resectable, it becomes obvious that only in-
complete resection is possible, this should be carried out and 
followed by a bilateral hepático jejunostomy (63) . If after ex-
ploration even incomplete resection appears impossible, a pa-
ratumoral bilio-enteric bypass is the best solution, if possi-
ble bilateral but otherwise in combination with a transtumoral 
drainage of the contralateral side (137, 489). If it is clear 
immediately after opening of the abdomen that resection is im-
possible or useless, one has to choose between paratumoral and 
transtumoral drainage in agreement with the local situation 
and the life expectancy of the patient (137, 286, 489). Only 
in case the possibility of a resection has been ruled out and 
the risk of a palliative operation is too high, a percutaneous 
percutaneous transhepatic transtumoral drainage is indicated 
as main treatment. It offers an elegant but usually brief pal-
liation. Combined with local radiotherapy by temporary inser-
tion of radioactive material a period of survival comparable 
to that of operative drainage procedures may even be achieved 
(135, 188). 
Intrahepatic bilio-enteric anastomosis 
The reconstruction of a good bilio-enteric biliary drainage is 
the crucial part of the operation and often also its most dif-
ficult part. A careful apposition of the bile duct mucosa and 
the intestinal mucosa is thought to be essential (39, 50, 63, 
106, 147, 243, 256, 258, 330, 353, 371, 457, 484, 498, 514, 
600). Use of a healthy, well-vascularised bile duct without 
any tension on the sutures and a scrupulous technique are im-
perative. At the enteral side a 60 cm long Roux-Y jejunal loop 
offers the best possibilities (8, 39, 52, 66, 256, 266, 328, 
330, 458, 514, 600, 606). Dissection has to be confined to the 
minimum in order to prevent an impaired vascularization of the 
bile duct wall (243, 303). The anastomosis should be as wide 
as possible and should preferably be contructed laterally on 
the bile duct (256, 486, 498). 
A carefully sutured anastomosis with interrupted stitches 
provides the best anastomosis. It is necessary to place all 
or part of the stitches at first and only then to tie them 
according to a strict schedule in order to keep a close view 
on the anastomosis during reconstruction (457, 498, 588). 
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If a regular anastomosis is impossible,the mucosal graft 
technique may offer a solution. In this technique a funnel 
of dissected jejunal mucosa from an area near the top of a 
jejunal loop, is tied to a transhepatic drain and blindly 
drawn into the bile duct together with the drain (150, 515). 
The fixation and the width of the resulting bilio-enteric 
connection are inferior to a sutured anastomosis and the in-
testinal mucosa drawn into the bile duct may block biliary 
side branches (57, 66). 
Although hepato-enterostomy does not produce intermucosal 
contact it may give good results as well, provided that it is 
performed on a level that has healthy and wide bile ducts.It is 
a relatively simple procedure and the desirable intermucosal 
contact still develops since the intestinal mucosa overgrows 
the cut surface of the liver and joins the biliary mucosa (124, 
207, 243, 303, 323, 325, 328, 385, 386, 438, 539, 572). 
In case the hepatic ducts are cut beyond their secondary 
confluences, several duct orifices stay behind to be dealt 
with. Mutual connection of these ducts may provide one or two 
large biliary channels suitable for a direct anastomosis with 
a jejunal loop (8). Theoretically, postoperative regeneration 
of parenchyma between the various ducts may push the ducts a-
side and disrupt the anastomoses. Therefore a hepato-entero-
stomy may be preferred if duct orifices are separated from 
each other by intervening liver tissue. 
2.3. Preparations for treatment 
Pre-operative assessment 
Percutaneous transhepatic cholangiography (PTC) is the favou-
rate investigation after an ultrasound examination has suggest-
ed a proximal biliary obstruction. PTC provides accurate in-
formation about place and upstream expansion of the tumour and 
about the biliary anatomy, the bile duct dilatation and atrophy 
or hypertrophy of liver segments. During investigation bile can 
be collected for cytological and bacterial examinations. If 
required, temporary or permanent external bile drainage can be 
added. A complete, good quality cholangiogram is essential as 
both choice and performance of the operation depend on it. 
In the differential diagnosis all other obstructing process-
es either inside or outside the bile duct have to be consider-
ed but all may need laparotomy for both diagnosis and treat-
ment. Caroli (111) stated that a primary total block of the 
hepatic duct confluence is always caused by a malignant tumour 
and that a partial block at the hilar level is nearly always 
caused by a malignant tumour. In four out of 75 consecutive 
patients operated by Blumgart (68) for a typical tumour of the 
hepatic duct confluence, no malignant cells could be found. 
Unless a resection is already abandoned, the pre-operative 
investigation at this stage is directed towards the assessment 
of the downstream and periductal expansion of the tumour and 
the existence of metastases. Endoscopic retrograde cholangio-
graphy (ERC) (62, 63), CT scan (76, 223, 289, 439) and angio-
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graphy (72, 260, 270, 463, 537, 616) are performed and lapa-
roscopy may provide additional information (8, 64). The vas­
cular anatomy of the liver and the hepatoduodenal ligament is 
defined and the presence of segmental atrophy or hypertrophy 
assessed. Since the portal vein bifurcation is situated close 
to the hepatic duct confluence, the possibility of tumour in­
volvement of the vein has to be examined carefully. The venous 
phase of a coeliac arteriogram can be sufficient, but a direct 
splenoportogram (616) or percutaneous transhepatic portogram 
(270, 537) may be necessary. Angiographicallv demonstrated in­
volvement of the portal vein by the tumour or by fibrotic reaction 
surrounding the tumour is always confirmed at operation (270, 
616), but a negative angiogram does not exclude vascular im­
pairment (270, 330) . 
If possible, tumour tissue should be obtained prior to oper­
ation. Operative dissection of the fibrotic hilus of the en­
larged, firm liver is difficult and risky (277, 473) . Biopsies 
often turn out to contain fibrotic tissue only (609) . Histo­
logical diagnosis from a biopsy can be notoriously difficult 
(13, ΘΘ, 208, 246, 277, 430, 477, 485, 553), especially if it 
has to be done by frozen section examination. Besides an open 
biopsy is undesirable from an oncological point of view. 
Aspiration of bile rarely yields tumour cells (609) but per­
cutaneous transhepatic brush-scraping is described to be 
successful in up to 42% of the patients (131, 173, 177, 178, 
393) . 
Pre-operative measures 
Every jaundiced patient requires immediate medical attention 
and the bad general condition of the patient after a long­
standing bile duct obstruction should be prevented. If the 
general condition and the liver function are poor - often be­
cause a previous operation failed - they must where possible 
be improved pre-operatively. This can be done during the pre­
operative investigations. The common postoperative problems 
that have to be anticipated are septicaemia, hypalbuminaemia, 
coagulation disorders and renal insufficiency. An operative 
field disturbed by previous operations and an age over 60 
years are unfavourable factors (38). 
Rehydration of the patient and correction of fluid and 
electrolyte balance are essential. Anaemia, hypalbuminaemia, 
coagulation and nutrition disorders have to be corrected, if 
necessary by parenteral nutrition (36, 64, 450). Antibiotics 
are necessary to treat septic bile ducts but success may only 
be expected in a well-drained biliary tree. 
Pre-operative percutaneous transhepatic biliary drainage (PTBD) 
may be required (42). Habitual use of pre-operative PTBD in 
patients with obstructive jaundice, however, seems unjusti­
fied (109, 423, 491). The benefits of pre-operative PTBD con­
sist of an improved condition of the patient and his liver, a 
gain of time for diagnostic assessment and a possibility of 
repeated brush biopsies. Disadvantages are the complications of 
drain insertion (bile leakage, haemorrhage, haemobilia, pneu­
mothorax, dislocation or breaking of the drain) in about 5 to 
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10% of the patients (156, 161, 169, 482, 575), the risk of 
conveyance of tumour cells (429), the shrinkage of the dilated 
bile ducts (55, 587, 597) and in particular the risk of conta-
mination of a blocked but previously sterile biliary system 
(61, 239, 277, 392, 574) . 
The operative mortality of extensive pancreatobiliary opera-
tions in icteric patients does not need to be high and addit-
ional pre-operative PTBD carries the considerable risk of the 
introduction of infection (427). Right hepatic lobectomy has 
been successfully performed in jaundiced patients (432, 573, 
574) and the operative mortality in hepatic surgery can be 
related to the septic complications of pre-operative PTBD (66). 
If the operative risk is increased by an already existing ob-
structive cholangitis or liver insufficiency, then pre-opera-
tive PTBD can be of value (61, 63, 161, 392, 450, 572). 
Peroperative assessment 
A good peroperative assessment,especially regarding the up-
stream expansion (5) and the vascular tumour involvement, is 
essential for the operation to be carried out. However, lymph-
atic and peritoneal metastases as well as small liver metasta-
ses elude pre-operative discovery;the invasion of the tumour 
into the caudate and quadrate lobes is also difficult to dem-
onstrate. Pre-operative assessment of resectability of liver 
tumours appears at laparotomy to be wrong in 25% of the cases 
(307). Therefore the definitive establishment of surgical oos-
sibilities and resectability is only possible by the combina-
tion of röntgenological information and surgical exploration 
(9, 60, 66, 243,330, 357, 394, 420, 430, 433, 484, 489). If 
during pre-operative examination no contra-indication has been 
demonstrated against resection, surgical exploration and dis-
section is indicated. The only possibility to determine the 
resectability is to go for the tumour with the intention to 
remove it (489). Even then it may turn out only at the end of 
the dissection when the rear side of the tumour has been reach-
ed, that a potentially curative resection is impossible (489) . 
In that case palliative resection still is the best solution 
and makes the dissection not futile. 
Unless the pre-operative cholangiogram provides all biliary 
information desired, a peroperative cholangiogram by trans-
hepatic punction is indicated (8, 39, 277, 286, 357, 394, 474, 
477). If a choledochoscope can be placed in the collapsed, 
narrow main bile duct the tumour can be inspected and biopsied 
(609). Multicentric occurrence of the tumour can be examined 
in the same way (548, 562, 563) . As long as a paratumoral by-
pass is one of the possibilities, the gallbladder should not 
be removed as it can serve this purpose (606) . 
An extensive mobilisation of the duodenum and head of the 
pancreas is required to assess the extension and possible dis-
semination of the tumour. This is followed by a careful in-
spection and palpation of the liver, hepatoduodenal ligament, 
gallbladder and duodenopancreatic area. Tumour involvement of 
the portal vein can be judged by opening the peritoneum of the 
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right free margin of the hepatoduodenal ligament and to dis-
sect the portal vein from the bile duct towards the liver (5). 
As the common bile duct does no longer function it can be di-
vided distally and dissected upwards from the underlying por-
tal vein towards the liver. This is a simpler procedure and 
provides a better exposure (66, 294, 330, 513). 
Histological confirmation of the tumour is necessarv. before 
proceeding to the actual resection (178) as in case of a benign 
bile duct obstruction a limited resection or adequate bilio-
enteric bypass is sufficient. If at that time no representati-
ve tumour tissue has been obtained this has to be done by a 
direct approach to the tumour. Puncture may yield appropriate 
tissue but often the only way for a proper biopsy is a local 
resection of the tumour (66). 
The hilus of the liver and the hepatic duct confluence can 
be explored by 1 lifting of the hilar plate, 2 liver split a-
long the principle scissure, and 3^  resection of the quadrate 
lobe. 
- Lifting of the hilar plate (Hepp and Couinaud, 1956 (254)) 
(décollement de la plaque hilaire (119, 121, 142, 144, 257)). 
The hilar plate is transversally incised at its transition to 
the capsule of the quadrate lobe and dissected in caudal direc-
tion from the hepatic duct confluence and left hepatic duct. 
This is the essential manoeuvre in the treatment of benign 
strictures of the confluence (257). The large, firm liver and 
the fibrosis around the tumour render this approach less suit-
able for a hilar bile duct cancer. 
- Liver split along the principal scissure (Champeau and 
Pineau, 1955 (117, 215, 544, 590). 
Transection of the liver along the portal avascular plane be-
tween the left and right hemi-liver which runs from the gall-
bladder fossa to the left side of the inferior cavai vein,pro-
vides a wide exposure of the right side of the hilus including 
the confluence of the hepatic ducts. Also the upstream exten-
sion of the tumour can be well assessed by this approach (39, 
63, 64, 100, 486, 488) . 
- Mobilisation or resection of the quadrate lobe (Champeau, 
1967 (120, 122)). 
The left corner of the hilus is exposed by transection of the 
bridge of liver tissue which connects the segments III and IV 
in front of the recessus of Rex (118) . Then the quadrate lobe 
is mobilised or resected by incising the liver in the umbili-
cal and principle scissures and to connect these two incisions 
by a transverse incision cranially through the parenchyma of 
segment IV. Now the complete hilus is completely exposed (8, 9, 
39, 49, 66, 330, 489) . After exposure of the tumour area both 
distally and proximally, the nature, extent and resectability 
of the tumour can be determined. 
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2.4. Therapy 
2.4.1. Resection 
Extent of the resection 
To achieve a curative resection of a tumour without demonstra-
ble metastases the areas of potential invasion and initial 
dissemination have to be removed en bloc with the tumour. The 
presence of the portal vein and the hepatic artery in the 
liver hilus so far rules out a radical block resection of a 
cancer of the hepatic duct confluence (5, 374, 599). Leaving 
these vessels out of consideration a resection which intends 
to be as curative as possible has to include the following 
areas of potential invasion: 1^ the biliary tract downstream 
of the tumour; 2 the biliary tract upstream of the tumour; 
3^  the adjacent liver tissue (segments IV and I) ;and 4_ the lym-
phatic tissue in the hepatoduodenal ligament. 
1_ the biliary tract downstream of the tumour 
Considering the characteristics of the tumour it is prefer-
able always to remove the gallbladder (39, 128, 330, 557) and 
to transect the common bile duct as distallv as possible at 
the margin of the duodenum (8, 39, 51, 66, 330, 538). Frozen 
section examination of the transected duct is essential (330) 
but not completely reliable because of its difficult inter-
pretation (572) . 
2 the biliary tract upstream of the tumour 
From a curative point of view it is preferable to keep away 
from the tumour as far as possible. This means that the bile 
ducts, especially on the right side, have to be transected be-
yond the secondary confluences (39, 243, 294, 489) . If the 
tumour extends far in one of the hepatic ducts or affects a 
secondary confluence, a hemihepatectomy at the side involved is 
necessary (9, 294, 572). Also a unilateral periductal invasion 
of one of the main branches of the portal vein or hepatic arte-
ry requires a resection of the hemi-liver concerned (330), as 
does a solitary metastasis (458). 
3 the adjacent liver tissue, consisting in the quadrate lobe 
(9, 39, 243, 330) and the caudate lobe (410). 
£ the lymphatic tissue in the hepatoduodenal ligament 
Removal as complete as possible of all the regional lympha-
tic nodes and vessels in the hepatoduodenal ligament and of 
the posterior duodenopancreatic nodes (480) has to be added to 
the resection, leaving only the bare portal vein and hepatic 
artery (curage du pédicule hépatique) (39, 58, 330, 480, 458, 
489) . 
To cope with these four requirements the resection theoreti-
cally has to be as extensive as possible. A wide resection of 
the bile ducts requires a concomitant partial hepatectomy and 
a hepatico-enterostomy for biliary reconstruction. The addi-
tion of a liver resection may increase the operative mortality 
of tumour resection (66, 168, 243, 330). Therefore many types 
of resection are practiced, varying from local resection of 
the hepatic duct confluence with its tumour to extended liver 
resections and vascular reconstructions. 
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The various liver resections eligible for the treatment of 
a tumour of the hepatic duct confluence are described in de-
tail in the manuals on liver surgery (49, 56, 121, 142, 206, 
565, 582). Seen from the principal scissure the resection may 
be extended to the right as well as to the left according to 
the portal or suprahepatic intersegmental planes. Wedge resec-
tions disregarding the intrahepatic anatomy, are objectionable 
because of the risk of bile leakage, necrosis and abscess 
formation (430) . Resection of the pre-hilar quadrate lobe is 
the smallest hepatectomy practiced concomitantly with excision 
of a confluence tumour. Besides, left and right hemihepatecto-
my and right lobectomy are the most commonly applied liver re-
sections to remove a confluence tumour. 
Resectability 
The current local criteria of potentially curative resectabi-
lity are (294) : 
- main stems of portal vein and hepatic artery free of 
tumour 
- main branches of portal vein and hepatic artery contra-
lateral to a tumour extension in one of the hepatic ducts 
free of tumour 
- distal extension of the tumour leaves a long part of the 
distal common bile duct free of tumour 
- proximal extension of the tumour respects at least uni-
laterally the secondary duct confluences 
The tumour is generally considered as not curatively resecta-
ble in the following situations: 
- invasion of tumour of the main stem of the portal vein or 
hepatic artery (7, 178, 294, 330, 354, 489) 
- invasion by tumour of the main brain branches of the portal 
vein or hepatic artery bilaterally or contralaterally to a 
tumour extension in one of the hepatic ducts (66) 
- bilateral invasion of the secondary confluences of the 
hepatic ducts (137, 289, 572) 
- liver metastases (137)(ipsilateral or solitary liver 
metastases may be resectable) (458) 
- metastases at distance (7, 137, 178), poor general con-
dition or short life expectancy of the patient 
The concept of resectability, expressed as a percentage of 
all possible treatments performed, only makes sense of it re-
lates to surgeons who have the preconceived intention and are 
able to resect the tumour if possible as the best way of 
treatment. The word 'resectability' has no meaning if it mere-
ly indicates the amount of resections performed, however in-
cidentally these may have been. The resectability rate of the 
combined series of 13 surgeons who strive to resect cancers 
of the hepatic duct confluence is 33% (15-61%) (Table VI). 
These series include resections postoperatively considered as 
curative as well as incomplete resections since both types can 
seldom be distinguished from in each other in the reports 
(74) . 
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Table VI. Resectability of tumours of the hepatic duct confluence. 
Authors 
Balasegaram (25) 
Benjamin (37)/Blumgart 
Cameron et al. (109) 
Chltwood et al. (131) 
Evander (178) 
Iwasakl et al. (294) 
Launois et al. (330) 
Skoog and Thorén (512, 
Smith (517) 
Starzl (529) 
Tompkins et al. (564) 
Tsuchiya (570) 
Warren et al. (596) 
(68) 
558) 
patients 
31 
35 
treated by resection 
15 
17 
10 
5 
16 
9 
11 
8 
5 
8 
22 
9 
9 
Total no. of patients 431 144 (33%) 
Results and types of resections 
250 Patients were found in whom a tumour of the hepatic duct 
confluence was resected. The results of these resections are 
listed in Table VII. The mean postoperative mortality is 14.4% 
and the mean postoperative survival 19.5 months. Many of the 
operations presented concern incidental reports of a success-
ful operation. The results in series of at least three or at 
least five resections, have a striking resemblance to the re-
sults of all the resections together. The morbidity after re-
section consists of bile leakage, bile fistulae, cholangitis, 
haemorrhage, stress ulcers and subphrenic abscesses. The com-
plication incidence is poorly reported but may be estimated 
together at 25 to 50%. 
Table VII. Results of the total series of resection of primary tumours of 
the hepatic duct confluence (Appendix 1^  gives the results of these 
series in full). 
operative mean alive after (yrs) (%) 
patients mortality survival 
(months) fr 1 Ifr 
total all series 250 36 (14.4%) 19.5 91 69 43 33 21 
total series 
of at least 3 patients 201 27 (13.4%) 18.9 92 67 43 37 22 
total series 
of at least 5 patients 159 21 (13.2%) 18.3 87 67 41 36 22 
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The various types of resections can be divided according to 
the concomitant liver resection into 1^  resection confined to 
the hepatic duct confluence (or combined with cholecystectomy); 
2_ resection of the hepatic duct confluence and the quadrate 
lobe; 2 resection of the hepatic duct confluence and left hemihe-
patectomy; £ resection of the hepatic duct confluence and right 
hemipatectomy; 5^  resection of the hepatic duct confluence and 
right lobectomy; and £ resection of the hepatic duct confluence 
with major liver resection and resection of the portal vein or 
the hepatic artery. 
1 r ?.?.^ΐ.ί°й Л°QtÍíied _t<2, _th £ JlSEat i ç jiuçt _ç.Q.il£i.uençg. _ Lut -СйЩ-
Çiîl^iJitÖ! choleeystectomvL 
Îhe smallest form of resection is a curettage of a stalked 
papillary tumour (115). Local excision limited to the conflu-
ence itself is the most frequently performed resection. This 
resection was originally used to excise a tumour of the common 
hepatic duct (426) and was applied to a confluence tumour only 
in 1954 by Brown and Myers (87) Although this operation may be 
the least burdening for the patient, its radicality has to be 
doubted in view of the tumour characteristics. 
The reconstruction of the bile drainage to the intestines 
after a local resection of the hepatic duct confluence can be 
restored in the following ways: 
- hepatico-enterostomy with a Roux-Y jejunal limb; hepatico-
duodenostomy is also possible (208, 545, 589); 
- end-to-end anastomosis between the remaining oarts of the 
bile ducts (315, 384, 596): 
- connection of the left and right hepatic duct to one 
united orifice, which is end-to-end anastomosed with the 
common hepatic duct 
- end-to-side anastomosis of one hepatic duct with the 
other, followed by end-to-end anastomosis of the last 
duct whith the common hepatic duct (384) 
- end-to-end anastomosis between the left hepatic duct 
and the common hepatic duct and between the right hepatic 
duct and the spared cystic duct (385, 446) 
- ligation of one of the hepatic ducts and end-to-end 
anastomosis of the other with the common hepatic duct 
(315, 571), if required combined with percutaneous drai-
nage of the blocked part (270) 
- interposition of the gallbladder (208, 255, 606); 
- hepato-enterostomy if no bile ducts of a size sufficient for 
an anastomosis are available (110, 273, 303). 
The results of 75 tumour resections confined to the hepatic 
duct confluence are listed in Table VIII. 
The mean postoperative mortality is 11% and the mean postoper-
ative survival 19 months. Where reported, the cause of death 
of the patients who survived the operation was mainly due to 
a local recurrence of the tumour (39, 195, 208, 270, 273, 315, 
569) . 
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Table VIII. Results of local confluence resection for primary tumour of 
the hepatic duct confluence. 
Authors patients operative mortality mean survival (months) 
Bérard et al. (39) 1 
Brown and Myers (87) 2 
Cameron et al. (109) 10 
Camprodon et al. (110) 1 
Chitwood et al. (131) 5 
Crismer et al. (145) 1 
Finney (184) 1 
Fortner et al. (195) 1 
George et al. (20В) 3 
Heully et al. (263) 1 
Hoevels and Ihse (270) 1 
Hollender et al. (273) 1 
Karakousis and Douglass (303)2 
Kozaka et al. (315) 2 
Launois et al. (330, 333) 5 
McDerraott and Peinert (384) 
Nishimura et al. (420) 
Philippakia et al. (446) 
Quattlebaum (458) 
Rodgers et al. (471) 
Salembier (489) 
Saubier et al. (491) 
Skoog and Thorén (512,558) 
Smith (513) 
Terblanche et al. (545) 
Tsuchlya (570) 
Van Vroonhoven and Malt(589) 
Warren et al. (596) 
Whelton et al. (606) 2 
White (609) 1 
Total no. of patients 75 
0 
1 
0 
0 
0 
1 
0 
0 
0 
0 
0 
0 
0 
0 
1 
о 
о 
о 
о 
о 
1 
о 
1 
о 
о 
1 
1 
о 
1 
о 
8 (11%) 
ю 
8 
21 
16 
17 
16 
17 
12 
7 
7 
11 
15 
20 
33 
10 
7 
14 
12 
28 
20 
7 
8 
31 
7 
8 
27 
20 
23 
19 
2. £§§e9ìì2D_2f_ÌÌ}e_ììeEaìì£_^H2Ì_£°Ì}iìy£Dc®_2Dd Î h e quadrate 
lobe_ 
This operation is considered to be the ideal resection of a 
confluence tumour by many authors (9, 32, 39, 243, 330, 361, 
420, 531). An intestinal loop is required for the biliary re-
construction and is anastomosed with both hepatic duct rennants 
separately. If the secondary duct confluences are resected, 
the remaining duct remnants can be united on each side to form 
combined ducts (8, 39) or have to be anastomosed separately 
with the intestinal loop. Hepatojejunostomy is also reported 
to function properly (386). The results of 12 such operations 
are listed in Table IX. Local recurrence of the tumour is the 
usual cause of death in these patients too. 
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Table IX. Results of resection of the hepatic duct confluence and the quadrate 
lobe for primary tumours of the hepatic duct confluence. 
Authors patients operative mortality mean survival (months) 
Alexandre et al. (8,9) 
Bërard et al. (39) 
Bismuth et al. (56) 
Hart and White (243) 
McDermott (386) 
Nishimura et al. (420) 
Stephen (531) 
Total no. of patients 
2 
12 
0 
0 
0 
0 
0 
0 
1 
1 (8%) 
25 
18 
78(aì 
11 
36 
? 
26 
20 
not included in mean survival 
3_ resec. t i ο η _qf. _th.e hepatic _duc.t _çon.floenee. _a nd _1 e ft. _h em i.-
hepatectomy 
By a hemihepatectomy the resection of the proximal bile ducts 
is enlarged maximally at one side and a large area of potential 
hepatic dessemination is also removed. Moreover it makes the 
operative view ideal (7) . The bilio-enteric reconstruction is 
performed mostly by a hepáticojejunostomy with a Roux-Y loop. 
Good results are also described of periductal hepatojejuno-
stomy (7, 304, 5 7 2 ) . The results of 41 resections are listed 
in Table X. The operative mortality is 7% and the mean survi-
val 21 months. Again the usual cause of death in patients who 
survived the operation is local tumour recurrence. 
d. t^.'^.C-'tion._of,_the_„hepatic._duct._canjEluence._an.d._ri.ght__hemi-
hepatectomv 
Nine patients who underwent this operation could be traced, 
two without any further information(235, 3 1 0 ) . Two patients 
died in the postoperative period, at least one from liver 
insufficiency (432, 4 5 8 ) . Postoperative survival is reported 
in three of the five remaining patients, being seven months 
in two patients (300, 489) and more than four years in the 
last one (270) . 
5 J^section._qf._t.he. hegati.c__du.ç.t J^^lfluence._and jçigh;t 
ГоЬес tomv 
The results of this operation in 15 patients are listed in 
Table XI. The postoperative mortality was caused by liver 
insufficiency in three patients (330, 432, 4 7 6 ) , by portal 
vein thrombosis in one (435) and by uncontrolable bleeding 
from a stress ulcer in one (476). In one of the survivors the 
postoperative course was laborious because of marginal liver 
function (330). The problem of the small liver remnant may be 
obviated by constructing - in a separate operation before the 
actual resection - a cholangiojejunostomy with the liver part 
to remain after the resection, as described on page 19 (473). 
Also in this group of patients the reported cause of death 
was due to tumour recurrence (435, 4 7 5 ) . 
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Table X. Results of resection of the hepatic duct confluence and left heml-
hepatectomy for primary tumour of the hepatic duct confluence. 
Authors patients ooerative mortality mean survival (months) 
Akwari and Kelly (7) 
Alexandre et al. (8,9) 
Bérard et al. (39) 
Engler (175) 
Fortner et al. (195) 
Haynes et al. (246) 
Hoevels and Ihse (270) 
Hellender et al. (273) 
Kelly (304) 
Launois et al. (330, 333) 
Longmire et al. (357) 
Mann (373) 
HcDermott and Peinert (384) 
Mistilis and Altemeier (402,14) 
Nicoli et al. (418) 
Nishimura et al. (420) 
Quattlebaum (458) 
Skoog and Thorén (512, 558) 
Tsuchiya (570) 
Tsuzuki and Uekusa (572) 
Tsuzuki et al. (574) 
Warren et al. (596) 
? 
8 
2 
0 
0 
0 
0 
0 
0 
1 
0 
0 
0 
1 
0 
0 
0 
0 
0 
0 
1 
0 
0 
0 
Total no. of patients 41 (7%) 
33 
8 
7 
10 
21 
9 
4 
19 
2β 
13 
? 
30 
15 
14 
12 
38 
13 
18 (2 oatients) 
7 
+24 
21 
6 reseçtion_of_the_hepatiç_duçt_çonfluence_with_major_liver_ 
reseçtion_and_reseçtion_of_the portal vein or_the hepatic 
Seven patients whose confluence tumour was treated in this 
way are to be discussed in Chapter 4. Three patients died in 
the first postoperative month. The mean postoperative sur-
vival of the other patients is 15 months (range 12-18 months) 
Three of the four survivors died from local recurrence 
(361, 574) (Chapter 4; Table XXX). 
32 
Table XI. Results of resection of the hepatic duct confluence and right 
lobectomy for primary tumour of the hepatic duct confluence. 
Authors patients operative mortality mean survival (months) 
12 
12 
Bird et al. (46) 
Blumgart et al. (63, 
Launols et al. (330) 
Nicoli et al. (418) 
Ong and Lee (432) 
den Otter (435) 
Rohner (476) 
Tsuzuki (574) 
64) (a) 
1 
1 
2 
1 
1 
3 
4 
2 
0 
0 
1 
0 
1 
1 
2 
0 
13 
36 
Total no. of patients 15 5 (33%) 17 
extended left hepatectomy 
2.4.2. Paratumoral bilio-enteric bypass 
Intrahepatic bilio-enteric diversion 
An intrahepatic bilio-enteric anastomosis is best situated as 
far from the liver hilus as possible to prevent future in-
volvement by the tumour. Moreover a hazardous and protracted 
exploration of the fibrous hilus is avoided, especially if 
this operative field is already scarred by previous opera-
tions. To find a bile duct as wide as possible, however, one 
prefers to keep somewhat near the hilus (467, 498) . Both re-
quirements are best met by the well-described use of the dila-
ted duct of segment III according to Soupault and Couinaud 
(521). Various other possibilities of intrahepatic bile diver-
sions have also been developed mainly by Franch surgeons, and 
are therefore especially practiced in France. A Roux-Y or 
omega jejunal loop is mostly used as enteric part of the ana-
stomosis. The stomach may also serve this goal (133, 158, 438) 
and interposition of an isolated jejunal segment (318), dacron 
velours prosthesis (434) or silicone prosthesis (318) has 
also been described. 
The hepatic bile ducts can be approached either unlaterally 
or bilaterally in the hilus or in the periphery of the liver 
(48, 50, 121, 142, 186, 216, 273, 322, 394, 430, 480): 
1 Hepatic ducts in the hilus, if necessary after transection 
of the parenchymatous bridge between the segments III and IV 
(118), mobilisation (120) or resection (121) of segment IV 
or after opening of the principal scissure (117). 
- left hepatic duct (Hepp and Coyinaud, 1956)(254) 
The left hepatic duct always runs extrahepatically (57) and 
so strictly speaking does not belong to the intrahepatic 
biliary system. Opening and lowering of the hilar plate re-
veals the duct. 
- right hepatic duct 
In addition to the direct anastomosis between the right he-
patic duct· and a Roux-Y loop (349) there is the possibility 
of hepaticocholecystoduodenostomy: the base of the 33 
gallbladder is anastomosed with the right hepatic duct 
and the gallbladder fundus with the duodenum (116, 484). 
2 (A) Ducts in the periphery (left side) 
- peripheral bile ducts of the segments II and III after 
partial excision of the left lobe 
- anastomosis with jejunal loop (Longmire and Sanford, 
1948) (139, 352) 
- anastomosis with stomach (Dogliotti and Fogliati, 1956) 
(158); 
bile duct of segment III 
- after partial excision of segment III (143, 253, 438) 
- after hepatotomy to the left of the ligamentum teres 
insertion (Duboucher, 1954; Soupault and Couinaud, 1957) 
(164, 520, 521) 
- after punction cholangiography and resection of a wedge 
of liver tissue up to the demonstrated bile duct, guided 
by the punction needle which is left in place (253, 460, 
498, 503); 
subcapsular dilated bile ducts (101, 490) 
2 (B) Ducts in the periphery (right side) 
peripheral ducts of segments V and VI after resection of 
the anterior edge of these segments (258, 438) 
- duct of segment V 
After resection of segment IV followed by a transverse 
hepatotomy into the left side of segment V (Prioton et al. 
1968) (457)(48, 50, 69) 
- duct of segment VI after transection of the liver along 
the right portal scissure between segments V and VI 
(Salembier, 1982) (489) 
- ducts of segment V after transection or punction of the 
gallbladder bed (216, 230, 317, 322, 490,513, 595, 618) 
- peripheral duct dissected after cholangiographically 
guided wedge excision (253, 460, 498, 503) 
- subcapsular dilated ducts (101, 490). 
Several biliary diversions particularly on the left lobe 
are standardised. Most authors consider the use of the segmen-
tal duct III after Soupault and Couinaud (521) as the best, 
the safest and most efficient intrahepatic biliary diversion 
(43, 48, 128, 143, 164, 167, 207, 216, 233, 258, 266, 277,328, 
330, 371, 394, 409, 484, 489). Between this duct and the 
anterior liver surface there are no large calibre vessels. 
Needle aspiration, if required with cholangiograohy, may be 
useful to identify the duct. 
Through a large hepatectomy 1 cm to the left of the liga-
mentum teres the duct is found, cranio-anterior to the accom-
panying portal vein branch of segment III, and anastomosed 
with a Roux-Y loop (521), jejunal omega loop (164), stomach 
(133) or gallbladder fundus (148). Transection of the accom-
panying portal vein branch is originally described (147, 521), 
but is not imperative (216). In strongly enlarged livers the 
hepatotomy can be performed rather more to the left (258, 457, 
504) . 
Complete (141) or partial (253, 255) resection of segment 
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Ill provides the same bile duct but terminally transected. 
After subtotal (158) or partial (350, 352, 353) resection of 
the left lobe both segmental ducts II and III can be used. 
Results 
The results of paratumoral bypass operations in 400 patients 
with a tumour of the hepatic duct confluence are listed in 
Table XII. The operative mortality is 23.8% and the mean post­
operative survival 11.2 months. Just like the results of the 
resections, there appears to be a great similarity Detween the 
results of large and small series. This group must be even more 
heterogeneous than the resection group . As after resection the 
postoperative morbidity consists of bile leakage and fistulas, 
cholangitis, haemorrhage, subphrenic abscesses and gastroin­
testinal ulcers. Probably these complications are more frequent 
after bypass operations than after resections. However, the 
incidence of these complications is seldom accurately reported. 
Table XII. Results of the total series of paratumoral bilio-enterlc bypass for 
primary tumour of the hepatic duct confluence (Appendix II gives 
the results of these series in full). 
operative mean alive after (yrs)(%) 
patients mortality survival 
(months) % 1 lb 2 3 
total all series 400 95 (23.8%) 11.2 60 37 19 В 1 
total series 
of at least 3 patients 382 93 (24.3%) 11.1 
total aeries 
of at least 5 patients 349 88 (25.2%) 11.1 65 38 22 12 2 
total series 
of at least 10 patients 306 75 (24.5%) 11.2 65 37 24 11 2 
Table XIII. Results of paratumoral bilio-enterlc bypass on hilar level 
for primary tumour of the hepatic duct confluence. 
Authors patients operative mortality mean survival (months) 
Bertrand et al. (43) 2 1 24 
Levasseur et al. (349) 1 0 15 
Longmire et al. (357, 359) 2 0 12 
Mercadler et al. (394) 5 2 11 
Salembier (489) 2 2 
Total no. of patients 12 6 (50%) 16 
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The results of 12 patients with a hilar paratumoral diversion 
on the left or right hepatic duct just beside the tumour are 
listed in Table XIII, while Table XIV shows the results of bi­
lateral diversion in 10 patients. The results of 89 diversions 
after Soupault and Couinaud (521), 42 Dogliotti (158) and 
Longmire (352) procedures, and 18 peripheral diversions on the 
right hemi-liver are given in Tables XV, XVI and XVII respec­
tively. 
When comparing the results of the various operations, the 
bilateral and hilar diversions seem to be somewhat better than 
the results of the other types although the groups are too 
small and the patients too heterogeneous for significant con­
clusions . 
Table XIV. Results of bilateral paratumoral bilio-enteric bypass for 
primary tumour of the hepatic duct confluence. 
Authors patients operative mortality mean survival (months) 
Bertrand et al.(43) 2 0 18 
Dalmas et al. (148) 2 0 12 
Prioton et al. (457) 3 0 19 
Ragins et al. (460) 1 0 24 
Schutt (500) 1 0 26 
Seigert et al. (503) 1 0 20 
Total no. of patients 10 0 19 
Table XV. Results of paratumoral bilio-enteric bypass using cholangio­
jejunostomy on segmental duct III after Soupault and Couinaud for 
primary tumour of the hepatic duct confluence. 
Authors patients operative mortality mean survival (months) 
Arianoff et al. (19) 2 1 6 
Chigot et al. (128 (a) 20 7 9 
Corlette and 
Bookwalter (137) (b) 1 0 18 
Couinaud (143) 8 4 5 
Gautier et al. (207) 1 0 5 
Huguet and Salem (277) (c) 16 1 7 
Huguet et al. (286) (с) 13 4 17 
Launois et al. (330) 13 4 6 
Malt et al. (371) 4 0 12 
Mercadier et al. (394) 7 3 19 
Mourgue Molines et al. (407) 2 1 16 
Salembier (489) 2 0 4 
Total no. of patients 89 25 (28%) 10 
(a) operative mortality as death in first two operative months 
(b) combined with transtumoral drain in right hepatic duct and 4500 rad irrad. 
(c) these series may have mutual overlap 
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Table XVI. Results of peripheral paratumoral hepato- or cholangio-
enterostomy on the left liver lobe for primary tumour of the 
hepatic duct confluence. 
Type of operation authors pati 
Dogllotti 
Longmire or 
resection 
of segment III 
Hepp et al.(253) 
Salembier (489) 
subtotal 
Alvarez (16) 
Arianoff et al.(19) 
Hepp et al. (253) 
Launois et al. (330) 
Longmire (355, 357) 
Përissat et al.(443) 
Ragins et al. (460) 
Salembier (489) 
Sullivan et al.(539) 
White (609) 
subtotal 
2 
6 
Total no. of patients 
ents 
β 
34 
42 
operative moz 
0 
2 
1 
3 
0 
1 
2 
4 
1 
1 
0 
0 
2 
13 
15 
(25%) 
(33%) 
(36%) 
tality mean survival 
(months) 
9 
6 
7 
4 
10 
8 ( a ) 
7 
9 
3 
29 
16 
9 
9 
(a) 1 patient excluded in mean survival (exceeds 4^ years) 
Table XVII. Results of peripheral paratumoral bilio-enteric bypass on the 
right hemi-liver for primary tumour of the hepatic duct confluence. 
Type of operation authors patients operative mortality mean survival 
(months) 
cholangio­
jejunostomy 
hepato-
jejunostomy 
cholangio-
cholecystectomy 
Arianoff et al.(19) 
Bodner (69) 
Crismer et al. (145) 
Osborne et al. (434) 
Ragins et al. (460) 
Salembier (489) 
Schamaun (498) 
subtotal 
Alvarez (16) 
Longmire et al.(357) 
Pérlssat et al.(443) 
subtotal 
Wagenaar (591) 
Wong (618) 
subtotal 
Total no. of patients 
2 
4 
1 
1 
1 
1 
1 
1 
2 
2 
1 
1 
11 
5 
2 
18 
0 
1 
0 
0 
0 
1 
0 
0 
0 
0 
0 
0 
2 
0 
0 
2 
30 
8 
12 
15 
15 
? 
12 
13 
(11%) 10 
2.4.3. Transtumoral drainage 
The internal bile drainage can be restored by pushing an intra-
luminal drain through the tumour. This can be done both 
operatively and non-operatively. 
Operatively 
The procedure consists of stretching of the tumour from inside 
by dilators or bougies, followed by intubation with a side-
holed drain (12, 13, 34, 60, 128, 285, 286, 292, 312, 545, 546, 
548, 564). The dilatation of the tumour is a blind procedure 
and has to be done carefully and in the right direction to 
prevent a false passage or portal vein damage (285, 360). 
Blockade of a lateral bile duct by the drain can be avoided by 
tubographic control (609). Silastic is the best drain material 
for long-term Intubation (59, 83, 106, 208, 285, 455). If pos-
sible, bilateral drainage is to be preferred (107). In unila-
teral drainage, intubation of the hepatic duct of the larger 
right hemi-liver is advised (51, 208, 548). Operative trans-
tumoral drainage can be achieved by three main types of in-
tubation: 1 ascending, terminal drain; 2 transhepatic drain 
and 2 sunken drain and endoprosthesis. 
1^  ascending, terminal drain 
Via a choledochotomy the tumour is dilated and the drain 
inserted. The choledochotomy is closed around the drain or 
connected to a jejunal loop and the rear end of the drain is 
brought outside the abdomen. 
2 transhepatic drain (Goetze, 1951) (214) 
After having dilated and passed the tumour,a bended probe is 
carefully carried up in the liver as long as possible in-
side the bile duct, but finally through the liver parenchyma 
to the anterior surface of the liver. A drain is connected to 
the probe and railroaded through the tumour and liver. The 
anterior end of the drain is brought out of the abdomen. 
The posterior end of the drain is left in the common bile duct 
or is led outside as a U-tube via the choledochotomy and the 
abdominal wall, if needed combined with a choledochojejunostcny 
(78, 95, 205, 214, 285, 453, 454, 455, 478, 493, 514, 545). 
In case an ascending insertion of the drain is impossible be-
cause of inaccessibility of the hilar bile ducts by tumour 
spread, then retrograde insertion via a transhepatically punc-
tured biliary radicle may be tried (137, 285, 455). 
Many variations of transhepatic drains exist such as terminal, 
T-, Y-, U-, O-, transversal and transanastomotic drains and 
their combinations (205, 455). A standard abdominal drain 
should be added to a transhepatic drain as bile leakage from 
the drain tract always occurs (106, 454). Replacement of the 
drain every three or four months is recommended (108, 455). 
If an extension of the drain outside the abdomen is present, 
daily irrigations with normal saline and if necessary with. 
antibiotics (548) are advised. 
3 sunken drain and endoprosthesis 
- A silastic drain of about 10 cm length is placed through the 
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dilated tumour and the choledochotomy is closed over ±t 
(208, 228, 285, 469) . In the same way a plastic or metal endo-
prosthesis can be inserted (244, 419, 483) . 
There is little agreement about the best type of drain. 
Dislocation, obstruction and cholangitis are complications of 
all drains. Drains with external extensions have the advantages 
but also the disadvantages of a lasting access to the bile 
ducts and the opposite accounts for sunken drains (Table 
XVIII). All effects have to be considered in respect of the 
mostly short life expectancy of the patient. The disadvantage 
of an external extension is sometimes considerable and may be 
avoided by burying the extension in a subcutaneous pocket 
(65). The main disadvantage of a sunken drain is its 
inaccessability. 
Obstruction and dislocation of a sunken drain occur in 9% and 
4% of cases respectively (228, 285). 
Table XVIII. Advantages and disadvantages of the various types of trans-
tumoral drains. (The notation is relative and has only comoa-
rative value). 
sunken drain terminal drain T-drain via terminal transh. 
endoprosth. via common duct common duct transh.drain U-drain 
Advantages 
visual assessment - + 
(röntgen, scopy) 
bacteriol.examin. - + 
therapy 
dislocation - + 
correction 
relief of 
obstruction - ++ 
replacement - ++ 
of drain 
Disadvantages 
risk transhepatic -
passage 
extent of operation + ++ 
chance of ++ +++ 
dislocation 
chance of + ++ 
cholangitis 
chance of + + 
obstruction 
chance of - + 
subphrenic abscess 
chance of - + 
bile leakage 
chance of - + 
drain pinching 
pain abdominal - + 
outlet opening 
inconvenience - + 
+ + ++ 
+ + + 
+ + ++ 
+ ++ +++ 
+ ++ +++ 
++ +++ ++++ 
+ +++ 
++ ++ +++ 
+ + + 
+ ++ +++ 
+ ++ +++ 
+ ++ +++ 
+ + ++ 
+ + ++ 
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216 
200 
190 
152 
33 (15.3%) 
33 (16.5») 
30 (15.8%) 
24 (16%) 
11.4 
11.5 
11.4 
12 
69 
71 
71 
36 
35 
34 
19 
17 
17 
14 
14 
15 
4 
4 
4 
Table XIX. Results of the total series of operative transtumoral drainage 
for primary tumour of the hepatic duct confluence (Appendix III 
gives the results of these series in full). 
operative mean alive after (yrs) (%) 
patients mortality survival 
(months) ii 1 1^ 2 3 
total all series 
total series 
of at least 3 patients 
total series 
of at least 5 patients 
total series 
of at least 10 patients 
The results of transtumoral drainage in 216 patients are 
listed in Table XIX. The postoperative mortality is 15.3% and 
the mean postoperative survival 11.4 months. 
Non-operatively 
The last decade a significant development has occurred with 
non-operative transtumoral drainage by percutaneous transhepa-
tic or endoscopic transpapillar access. These techniques can 
be performed under local anaesthesia or sedation and form a 
welcome addition to the treatment of patients with high opera-
tive risk or short life expectancy (16 9) . 
Percutaneous transhepatic drainage (91, 161, 165, 169, 224, 
241, 269, 271, 297, 299, 366, 411, 451, 468, 612, 613) is per-
formed in addition to a PTC. After percutaneous dilatation of 
the tumour, preferably by a Grüntzig balloon catheter (93, 376) 
a transtumoral catheter or endoprosthesis with an internal 
diameter of 1-3 mm is inserted. 
The complications of this procedure are cholangitis (7-27%), 
intrahepatic vascular lesions (9-16%) and dislocation or ob-
struction of the drain (5-33%) (91, 269, 271, 411). The more 
flexible and wider the drain, the smaller the risk of cholan-
gitis (91). The average duration of survival of patients with 
malignant bile duct obstruction treated in this way, is three 
months (91, 224, 411, 451) and the mortality in the first month 
is 0-28% (91, 224, 612). Survival can be increased to 11 months 
by temporary irradií.tion with radioactive material placed in-
side the drain (188). 
Transpapillary insertion of an transtumoral endoprosthesis 
can also provide terminal palliation with survival of 1^ to 
4 months (140, 287). 
2.4.4. Radiotherapy 
Adenocarcinoma is relatively radioresistant (560) and a 
statistically proven beneficial effect of radiotherapy on bile 
duct cancer does not exist (564). Radiotherapy can be adminis-
tered both externally and internally. 
External radiotheiapy 
After operative marking of the tumour and construction of a 
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bile drainage, a usual dose of 5000 to 6000 rad (3000-7500) is 
given by a linear accelerator, betatron, or Cobalt 60 source 
(60, 63, 107, 109, 137, 217, 226, 275, 313, 314, 342, 343, 399, 
449, 518, 572) . A tumour dose of 4000-6000 rad is regarded as 
potentially curative (238, 34 2, 3 99, 449) and may be supplemen­
ted by an extra dosage of 4000 rad on the complete regional 
area (342) . Peroperative irradiation of 3000 rad in 10 to 20 
minutes is also applied (294, 560). 
Irradiation by 3000 rad induces a light fibrosis, atrophy 
and degeneration of the hilar tumours (560) and 6000 rad causes 
a strong fibrosis (135, 217, 226). For that reason radiotherapy 
of the bile duct may require a permanent U-drain (208, 529) . 
Radiotherapy with these doses is usually well tolerated (342, 
395) but lethal radiohepatitis is reported (60). 
The value of radiotherapy on the duration of survival is 
suggested by the the results in Table XX, but comparability of 
both groups is dubious. Radiotherapy may re-establish a bile 
drainage through a duct previously blocked by tumour, although 
it is not clear in how far this may be due to a concomitant 
surgical procedure (Table XXI). At all postmortem examinations 
of irradiated patients tumour tissue is still present in spite 
of the radiotherapy received (217, 226, 342, 560) . The benefit 
of radiotherapy is for these reasons denied by some investiga­
tors (30, 290, 339, 606) and recommended by others (238, 289, 
314, 342, 343, 518, 529, 581). Perhaps irradiation may play a 
role as adjuvant therapy after intended radical resection (238, 
314) . 
Table XX. Mean duration of postoperative survival with and without radio­
therapy for primary tumour of the hepatic duct confluence, 
irrespective the surgical therapy applied. 
Authors 
with radiotherapy 
patients mean survival 
(months) 
without radiotherapy 
patiente mean survival 
(months) 
Black et al. (60) 12 
Cameron et al. (107) 6 
Hanna and Rider (238)<:l) 14 
Lees et al. (343) 9 
Tsuzuki and Uekusa (572) 4 
Whelton et al. (606) 5 
Total no. of patients 50 
9 
14 
12 
17 
23 
16 
? 
б 
3 
9 
2 
В 
28 
6 
10 
1 
4 
6 
16 
(а) 
also includes other bile duct cancers 
Internal radiotherapy 
Local implantation of radioactive material has been proposed 
to administer a very high dose of irradiation to the tumour 
without damage to the surrounding tissues (149). Implantation 
of radioactive gold seeds made a histologically proven tumour 
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Table XXI. Results of radiotherapy for biliary tract cancer (bile ducts and 
gallbladder). 
Authors 
Green (226) 
Green (226) 
Hudgins (275) 
Iwasaki (294) 
Kopelson (313) 
Kopelson (313) 
Leer (342) 
Pilepich (449) 
Smoron (518) 
patii 
2 
2 
3 
β 
7 
5 
11 
11 
β 
Terblanche (546)1 
Todoroki (561) 11 
snts place tumour 
comm.hep.duct? 
corran, hep. duct 
bile ducts 
biliary tract 
biliary tract 
biliary tract 
biliary tract 
biliary tract 
bile ducts 
confluence 
biliary tract 
surg.drainage 
(type) 
_ 
transtumoral 
? 
external 
transtumoral 
-
various types 
transtumoral 
? 
transtumoral 
** 
rad.dose 
(rad) 
4600-6000 
4600-6000 
3250-5000 
3000 
5000 
5000 
6000+4000 
4000-6000 
4500 
6000 
3000 
mean surv. 
(months) 
19 
10 
4 
1-11 
1- 6 
io 
7 
12 
10? 
palliât 
effect 
+ 
+ 
+ 
? 
+ 
+ 
? 
+ 
50% 
+ 
+ 
192 
rest to disappear indeed (384). Insertion of Iridium 
(188, 262, 408) or radium (135) through a percutaneous trans-
tumoral tube may offer new hope on the effects of radiotherapy. 
Quantities of 20,0 00 rad on the bile duct wall and the tumour 
and of 14,000 rad 1 cm around the duct can be reached in this 
way, resulting in necrosis of the tumour but also in an ex-
tensive necrosis of the periductal tissues (135) . Hence late 
fibrotic strictures of the bile duct and perhaps even of the 
portal vein have to be feared, although the hilar vessels seem 
less to suffer from irradiation (511) . Lower doses of radiat-
tion cause less fibrosis, but then again at autopsy it appears 
that the tumour has not been eradicated in patients who re-
ceived 4400 rad (188). The duration of survival achieved by 
this method equals that of operative transtumoral drainage. 
Finally a palliative effect has been reported of intravenous 
injection of rose bengale radioactivated with Iodinel33 which 
is concentrated in the liver parenchyma and excreted in the 
bile (20) . 
2.4.5. Liver transplantation 
Liver transplantation has past its experimental stage (53,170) 
but remains a tremendous enterprise with a 50% one year sur-
vival (105). Four patients could be traced who survived a liver 
transplantation for carcinoma of the hepatic duct confluence 
(104, 526, 295). One patient died from systemic candidiasis 
and brain abscess after three months (295), the other three 
died from tumour recurrence or liver metastases after 12, 25 
and 54 months respectively (295), which gives a mean post-
operative survival of 19 months. However scrupulous the pre-
and peroperative examinations may be, micrometastases will 
always be missed (105) and their growth will be unrestricted 
because of the immunosuppression. 
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2.4.6. Chemotherapy 
Adriamycin and 5-fluoro-uracil are the chemotherapeutic agents 
most commonly used in the treatment of bile duct cancers. 
Adriamycin has probably some effect on hepatocellular carcino-
ma (431) as suggested by an investigation to which I contri-
buted as a referring district medical officer in Zambia (586) . 
Adriamycin is excreted in the bile in a high concentration 
provided the excretory function of the liver is not hampered 
by an obstruction of the bile flow (24, 234, 467). The impact 
of chemotherapeutics on bile duct cancer, however, is small 
(7, 152, 234, 290, 489). In only one report a beneficial 
effect may be probable (343) . Other reports only mention in-
cidental remissions with a survival of 12 to 30 months (127, 
152, 195, 234, 404, 471, 506, 579, 619). A combination of 
chemotherapy and radiotherapy has been advised (403, 567) . 
In view of the doubtful benefit and the serious side effects 
the role of chemotherapeutics in the treatment of bile duct 
cancers is small. 
2.4.7. External drainage 
External drainage is only indicated as a terminal palliation 
to relieve the patient from pruritis and jaundice, since other-
wise it just adds a biliary fistula to the disease (480) . The 
former cutaneous hepatectomy (23) is replaced by an operative-
ly or percutaneously inserted drain. The average survival af-
ter contruction of external drainage is three to five months 
(309, 572). This is as long as the survival after explorative 
laparotomy in which no form of drainage can be achieved (7, 
286) . 
2.5. Conclusion 
Prior to the diagnosis the clinical course of the disease con-
sists of a non-specific obstructive jaundice. The postoperati-
ve course is rather monotonous as well and consists of an only 
temporary or partially relieved obstructive jaundice often 
with superadded iatrogenic cholangitis (351) . An earlier diag-
nose is impossible but refraining from diagnostic or therapeu-
tic loitering is imperative to preserve the possibility of a 
hepatectomy without an increased risk (168) . 
Proper bile drainage is the primary therapeutic goal, as 
patients die from recurrent bile obstruction. Even if adequate 
drainage can be achieved, the final results still will be de-
termined by the continuing growth of the malignant tumour. 
Long survival is reported mainly after resection, but also 
after palliative procedures with and without radiotherapy. 
This may be more indicative of the slow growth of some of the 
tumours than of the value of the therapies applied (5) or may 
indicate the histological difficulty to discern malignant from 
benign tumours. 
However different the various groups of patients may be, 
resection of the tumour at the earliest possible moment offers 
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Table XXII. Cumulative results of the various surgical treatments of 
primary tumour of the hepatic duct confluence. 
operative mean alive after (yrs)t%) 
Type of operation patients mortality (%) survival (months) 
is 1 2 3 
resection 250 14 20 91 69 33 21 
all patients 
paratumoral bypass 400 24 11 60 37 8 1 
all patients 
transtumoral drain 216 15 11 69 36 14 4 
all patients 
resection 201 13 19 92 67 37 22 
series ^3 patients 
paratumoral bypass 349 25 11 65 38 12 2 
series £ 5 patients 
transtumoral drain 190 16 11 71 35 14 4 
series ^ 5 patients 
resection 159 13 18 87 67 36 22 
series £5 patients 
paratumoral bypass 306 25 11 65 37 11 2 
series £10 patients 
transtumoral drain 152 16 12 71 34 15 4 
series ^10 patients 
the best treatment. The combined results of therapy are dis-
played in Table XXII and Fig. 4. 
The resection series of at least three patients and the para-
tumoral and transtumoral series of at least five patients are 
included in Table XXII and Fig. 4 as these series are the 
largest representatives. 
Comparable to the treatment of gallbladder cancer (84, 179) 
and middle bile duct cancers (212, 310) extension of liver re-
section only incidentally provides a longer survival in 
patients with cancers of the hepatic duct confluence. However, 
many of the confluence cancers that have been fatal by bile 
obstruction, at autopsy still appear to have been resectable 
(13, 172, 396, 458, 559). 
Early and efficient application of the diagnostic tools for 
accurate assessment of obstructive jaundice and an aggressive 
surgical approach are required to make such a treatment possi-
ble. 
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3 years 
resection 
ρ ara tumoral bypass 
transtumoral drainage 
Fig. 4. Survival after surgical treatment of primary 
tumours of the hepatic duct confluence as from 
the moment of operation. 
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3. The surgical treatment of hilar bile duct cancer 
in The Netherlands 
E.J. Boema, H.H.M, de Boer and M.N. van der Heyde 
From the Departments of Surgery, Municipal Hospital, 
Arnhem and St Radboud Hospital, Catholic University, 
Nijmegen 
Despite the general conception that cancers of the hepatic 
duct confluence grow slowly and disseminate late (309) the 
treatment remains unsatisfactory. 
Many questions related to pathology and treatment are still 
not answered. The final solution regarding the best way to 
treat these tumours will have to wait for a prospective study 
which compares the various treatments (66). The value of such 
prospective studies seems doubtful until the moment that we 
are better informed about the pathology and the effects of 
treatment, which can only come from retrospective studies. 
For that reason a retrospective study was carried out to in-
vestigate the properties of these tumours and the results of 
treatment in 51 patients. Twenty one patients were treated in 
the Municipal Hospital of Arnhem and 30 patients in six uni-
versity or teaching hospitals in The Netherlands. 
The hospital files of 51 patients treated between 1960 and 
1980, were studied. The group consisted of 29 men and 22 women 
(1.3:1) with a mean age of 61 years (range 28 to 86) at the 
time of operation. The patients were divided into three groups 
according to the greatest diameter of the tumour in order to 
assess a possible relation between the size of the tumour and 
the results of treatment: 
Group I (17 patients) tumour diameter $ 2 cm 
Group II (19 patients) tumour diameter 2-5 cm 
Group III (15 patients) tumour diameter >5 cm 
The mean age in Group I and Group II was 59 years (range 34 to 
86 and 28 to 79 years respectively) and in Group III 67 years 
(range 52 to 84). In 49 patients an operative treatment was 
performed and in two patients a percutaneous transhepatic 
drainage was inserted. 
3.1. Pathology and clinical course 
In all but one patient jaundice was mentioned as the first 
symptom. Pain was recorded 16 times and itch 17 times. The 
complaints and symptoms began on an average four months prior 
to operation (range 1 to 14 months), there was no difference 
between the three groups. 
The biochemical pattern was dominated by the obstructive 
jaundice type. The serum alkaline ohosohatase level was ana-
lysed before the appearance of jaundice or rise of bilirubin 
level in five patients and was increased in all five cases. 
Where recorded, the specific pre-operative assessment 
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of the cause of obstructive jaundice was mainly based on 
percutaneous transhepatic cholangiography. 
Twenty patients had been operated before for the same com-
plaints and symptoms. Only on seven occasions the tumour was 
recognised at that operation and the patient was referred. 
In this study the term 'the operation' will be defined as the 
first operation during which the tumour was recognized and the 
patient was treated, if treatment was possible. 
Tumour presentation 
The whole series of 51 patients had a cancer of the hepatic 
duct confluence. As already indicated the diameter of the 
tumours did not exceed 2 cm in 17 patients (33%) and was 5 cm 
at most in 36 patients (71%; Group I and II). The macroscopic 
type of the tumour was recorded in 38 patients: firm and 
nodular in 32 patients and papillary in six. 
Biopsies from the primary tumour were taken in 27 patients 
and proved to contain tumour in 22. Biopsies from lymph nodes 
or suspected liver areas were examined in 29 patients and 
proved to be tumour-positive in 20. In the other patients the 
diagnosis was confirmed either at autopsy or at a second oper-
ation. In two cases a negative result of a frozen section ex-
amination of the primary tumour turned out to be positive 
later on. 
Local invasion and metastatic dissemination 
In 20 of the 49 operated patients, palpable invasion of the 
adjacent liver tissue or dissemination elsewhere in the liver 
was recorded during operation. In Group I only one patient was 
reported to have liver metastases. Metastases in the regional 
lymph nodes were present in 15 patients. Intra-abdominal meta-
stases outside the regional area were found in 10 patients 
during operation, all these metastases were situated in the 
peritoneum. 
Local extension of the tumour to the portal vein or hepatic 
artery was seen in six patients, all with a tumour of less than 
5 cm in diameter. The three patients with arterial involvement 
had metastases in the liver and regional lymph nodes. In two 
of the three patients with portal vein involvement no metasta-
ses were found at operation nor at autopsy after four months 
in one patient nor at re-operation after 26 months in the 
other. Ascites was mentioned in one of these patients. 
Operative mortality and survival did not differ from the pa-
tients without involvement of the hilar vessels. 
In 17 patients an autopsy was performed 0 to 2 years after 
operation (mean 9 months). Local and regional spread was found 
at two autopsies one month after operation. Although not men-
tioned during operation this spread must have existed during 
the operation. Twice extra-abdominal metastases were recorded 
situated in the lungs, pleura, mediastinal nodes and spine. 
One of the two patients who were drained percutaneously and 
examined by autopsy one month later showed multiple metastases, 
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in the second patient none were present. In nine of the 14 
autopsies in Group I and Group II 0 to 2 years (mean 10 months) 
after operation, no metastases were recorded. 
No metastases were recorded in 12 patients of Group I, in 
seven of group II and in one of Group III at the time of 
operation (Table XXIII). 
Table XXIII. Number of patients with or without macroscopic metastases 
recorded at the time of intervention. 
Size of tumour 
(0) 
Group I 
tumour s 2 cm 
Group II 
2 cm< tumour « 
Group I and 
tumour ί 5 cm 
Group III 
tumour > 5 cm 
Total no. 
5cr 
II 
patients 
17 
ι 19 
36 
15 
51 
with liver 
metastases 
1 
10 
11 (31%) 
12 
23 (45%) 
with metastases 
in region, 
4 
7 
11 (31%) 
6 
17 (33%) 
.nodes 
with metastases 
at distance 
2 
1 
3 (8%) 
8 
11 (22%) 
without 
metastases 
12 
7 
19 (53%) 
1 
20 (39%) 
Histology 
All tumours consisted of adenocarcinoma originating from the 
bile duct. Differentiation of tumour cells was reported in 33 
cases: well differentiated in 21 and moderately or poorly 
differentiated in 12. The stroma was called highly fibrous or 
sclerotic in all 17 cases of the nodular tumours it was stated. 
Postoperative course 
Forty nine patients died within 32 months after intervention. 
The data after discharge from the hospital could not be traced 
in one patient. Only one patient is still alive at the time 
of writing (December 1982). The exceptional case history of 
this patient is described as it may show the possible value of 
radiotherapy: 
At the age of 49 years, this male patient (MHA 3) was opera­
ted on for obstructive jaundice caused by an obstruction of 
the hepatic duct confluence. At laparotomy a nodular tumour 
was found in the confluence with a diameter of 2 cm. This 
tumour consisted of a sclerosing adenocarcinoma of poor 
differentiation. Bile drainage was restored by transtumoral 
intubation with a transhepatic drain (Fig. 5). Postoperati­
vely radiotherapy was administered which consisted of a total 
48 
dose of 6000 rad directed at the tumour. Four months later 
the drain was removed and a cholangiojejunostomy was con-
structed between a dilated duct of liver segment III and a 
Roux-Y jejunal loop (521) while the liver hilus was left un-
touched. Now, eight years later, the patient is in good 
health, has a normal alkaline phosphatase level, there is no 
evidence of tumour. 
The histology of the tumour was reviewed (F.B. Bronkhorst, 
pathologist) since one of the criteria of malignancy, peri-
neural invasion, is recently described in benign pancreatic 
tumours (138) . The malignancy of this tumour, however, was 
incontestable (Fig. 6). The survival of this patient is not 
included in the general results as it is so disproportionally 
longer than the survival of the other patients. 
Fig. 5. Patient MHA 3: Tubogram via the initial trans-
hepatic transtumoral drain, indicating the tumour 
of the hepatic duct confluence. A hemoclip marks 
the tumour radiologically. The drain has made a 
false passage and runs only partially through the 
tumour which resulted in an insufficient drainage. 
Therefore this drain was removed and replaced by a 
transtumoral bypass. 
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Fig. 6. Peripheral nerve with invasion of perineural 
lymph spaces by clearly malignant cells of a poor-
ly differentiated adenocarcinoma (patient MHA 3) 
(HE x500) , 
Forty nine patients were operated on, 11 died in the first 
month after operation (22%). The mean postoperative survival 
of the others was nine months (range 1 to 36 months). 
No differences were seen in mortality and mean survival between 
Group I and Group II (14%, 10 months respectively). In Group 
III the operative mortality was 43% and the mean survival two 
months (range 1 to 7 months)(Table XXIV). 
Two of the 18 patients with a tumour diameter of at most 
5 cm without reported metastases died in the first postopera-
tive month, the mean postoperative survival of the others was 
14 months (range 4 to 32 months) (patient MHA 3 not included). 
An operation was carried out in 17 patients with equally sized 
tumours but with metastases. Four of these patients died with-
in one month, the others had a mean postoperative survival of 
only six months (range 1 to 11). There was no difference in the 
cause of death of the patients with or without metastases. 
From these data no relationship could be demonstrated be-
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Table XXIV. Operative mortality (first month) and mean postoperative survival 
related to the size of the tumour. 
(a) 
Size of tumour patients operative mortalitv mean survival (months) 
M 1 
Group I 
tumour s 2 cm 16 2 11 
Group I I 
2 cm< tumour S 5 c i n l 9 3 10 
Group I and I I 
tumour $ 5 cm 35 5 (14%) 10 
Group I I I 
tumour > 5 cm 14 б 2 
T o t a l n o . o f p a t i e n t s 49 11 (22%) 9 
77) 
One patient from the Municipal Hospital Arnhem (MHA 3) excluded 
tween the macroscopic or microscopic type of the tumour on the 
one hand and the operative mortality, time of survival or the 
incidence of metastases on the other. This applies to the 
entire group of 4 9 operated patients as well as to Group I 
(16 patients), Group II (19 patients) and Group III (14 pa­
tients) separately. 
Cause of death 
Fifty of the 51 patients died, the cause of death could be 
traced in 47. Fourty-five patients (96%) died 0 to 36 months 
after the intervention from the consequences of biliary ob­
struction, being cholangitis or liver insufficiency and in 
most cases from a combination of the two. Only two patients 
could have died from conditions not related to the biliary ob­
struction. A gastro-intestinal bleed in the premortal phase 
was reported in fives cases and originated from gastroduodenal 
ulceration in the three patients who were examined at post­
mortem. Tumour cachexia was described in five patients, four 
times accompanied by jaundice. In these five patients carcino­
matous peritonitis was seen at ooeration. No autoosies were 
conducted. 
3.2. Therapy 
The tumour was resected in four patients. Palliative recon­
struction of an internal bile drainage was performed in 29 
patients. Transtumoral drainage was carried out as the main 
treatment in 21 patients,operatively (19 patients), percuta­
neous ly (1 patient) or by a combination of the two (1 patient). 
In eight patients a paratumoral bilio-enteric bypass was per­
formed
 r
at the hilar level (2 patients) or intrahepatically 
(6 patients). In one patient an unsuccessful transtumoral drai­
nage was changed to a temporary successful intrahepatic bypass. 
Twice external drainage was carried out, in one case percuta-
neously without operation. 
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In 16 of the 51 patients no more than an explorative laparo-
tomy was done for lack of any therapeutic solution. 
Radiotherapy was applied as additional treatment in 12 
patients. 
In six patients the reconstruction of the bile drainage ap-
peared to fail postoperatively and so no bile drainage was 
achieved in 22 of the 51 patients (45% '. ) . 
Resection 
All four resections were performed in patients with a tumour 
of at rtost 2 cm in diameter. Three times a local resection of 
the hepatic duct confluence was performed and bilio-enteric 
continuity restored by a hepaticojejunostomy between both left 
and right hepatic ducts and a Roux-Y loop. In one patient the 
resection consisted in a diathermic removal of a stemmed 
intraductal papillary carcinoma. In at least two patients the 
resection edges were not free of tumour. Both patients recáved 
5000 rad postoperatively. 
In all patients a well functioning bile drainage was ob-
tained, but they died from recurrent bile duct obstruction 7 
to 32 months after the operation (mean 22 months). Autopsy was 
done in two patients and revealed a local recurrence of the 
tumour and multiple metastases in the liver. One patient show-
ed no signs of macroscopic metastases at operation 26 months 
after incomplete resection; six months later he died. 
Non-resective restoration of internal bile drainage 
Transtumoral drainage 
Transtumoral drainage was accomplished operatively by a trans-
hepatic drain in 10 patients, by a terminal, ascending drain 
or a T-drain in eight, by an endoprosthesis in one patient and 
in one patient the tumour was just dilated. 
Four of these 20 patients died in the first month after the 
operation. The mean postoperative survival of the others was 
nine months (range 1 to 24 months). A satisfactory postoperat-
ive relieve of the bile obstruction was obtained in 13 of the 
16 surviving patients (Table XXV). No differences could be de-
monstrated between the results in the patients of Group I and 
those of Group II, nor between the results obtained by the 
different types of transtumoral drains. The drains had to be 
changed once in four months because of obstruction. 
Paratumoral bypass 
In nine patients a paratumoral bypass was constructed, eight 
times as the primary or main procedure and once after three 
efforts to achieve transtumoral drainage had failed. Twice the 
bypass was made at hilar level by a hepaticojejunostomy be-
tween the left hepatic duct and a Roux-Y loop (254). Four 
times a dilated branch of the intrahepatic duct of liver seg-
ment III was used just to the left of the umbilical fissure 
(521). Twice a dilated duct behind the bed of the gallbladder 
in segment V was connected to the jejunum and once a hepato-
jejunostomy on segment VI was performed (50). 
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Two of the nine patients died in the first postoperative 
month from cholangitis or a leaking anastomosis. In five of 
the seven surviving patients a satisfactory relief of the bile 
obstruction was obtained postoperatively, the other two remain­
ed jaundiced. Change of a transanastomotic drain or correction 
of the anastomosis had to be done once in four months. The four 
patients with a proper follow-up showed a mean postoperative 
survival of six months (1 to 12 months). There was no demon­
strable difference neither between the results of the hilar and 
peripheral bypasses nor between the results of Group I and 
Group II (Table XXV). 
Radiotherapy 
Twelve patients were postoperatively treated with external 
radiotherapy. In none of them the tumour diameter exceeded 5 
cm. Six were treated by a rotative irradiation of 6000 to 7500 
rad with Cobalt^0, administered in a split course of 30 daily 
sessions (D. Mietet and P. van der Made of the Department of 
Radiotherapy, Municipal Hospital, Arnhem), During the prece­
ding operation the tumour had been three dimensionally marked 
with clips and a bile drainage had been constructed. The other 
six patients received 3000 to 7000 rad. 
Patients whose bile drainage had been effectively restored 
could stand the irradiation better than those lacking proper 
relief of the obstruction. One of the patients is alive, eight 
years after treatment. The mean postoperative survival of the 
other 10 patients irradiated shortly after the operation 
(Group I: 5; Group II: 5) was 11 months (range 8 to 20 months), 
the same as of the 18 patients with an equally sized tumour 
who survived the operation but did not receive radiotherapy. 
Table xxv. Results of surgical transtumoral and paratumoral bile 
drainage. 'a' 
Size of tumour 
(0) 
patients operative mortality mean survival satisfactory 
(months) drainage 
Groupai and II 
tumour s 5 cm 
transtumoral 
paratumoral 
Group III 
tumour > 5 cm 
transtumoral 
paratumoral 
17 
7 
3 
2 
Total no. of patients 
transtumoral 20 
paratumoral 9 
2 
2 
2 
0 
4 
2 
10 
7 
13/15 
4/5 
0/1 
1/2 
13/16 
5/7 
(ч) 
one patient has been excluded from the duration of survival of each group, 
because of disproportionate length of survival, re-operation after several 
transtumoral intubations or missing follow-up 
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Table XXVI. Results of postoperative external radiotherapy for primary 
tumour of the hepatic duct confluence in 12 patients. 
Patient tumour histology 
no. size 
(a) 
surgical radiation postop. autopsy local 
therapy dose (rad) survival tumour ext. or 
(months) present metas. 
1 
3 
4 
θ 
9 
10 
36 
37 
39 
43 
45 
51 
II 
I 
II 
I 
I 
II 
II 
I 
II1 
II 
I 
I 
poorly diff. 
nod.sclerosing 
poorly diff. 
nod.sclerosing 
poorly diff. 
nod.sclerosing 
well diff.(a) 
nodular 
well diff. 
nod.sclerosing 
poorly diff. 
nodular 
nodular 
sclerosing 
well diff. 
papillary 
'unspecified 
well diff. < a ) 
nodular 
well diff. 
nodular 
well diff. < a' 
nodular 
paratumoral 
bypass 
paratumoral 
bypass 
transtumoral 
drain 
transtumoral 
drain 
paratumoral 
bypass 
transtumoral 
drain 
transtumoral 
drain 
resection 
transtumoral 
dram 
exploratory 
laparotomy 
resection 
transtumoral 
drain 
6000 
6000 
6000 
6000 
6000 
6000 
3000 
5000 
7000 
5000 
5000 
5000 
12 
96 
8 
8 
9 
10 
14 
20 
24 
9 
7 
9 
+ , yes 
alive 
-
-
-
-
-
+ , yes 
+ , yes 
+ , yes 
+ , yes 
" 
yes 
yes 
no 
yes 
yes 
(b) 
metastases present at the time of operation 
radiotherapy administered three months before death 
There was also no difference in survival between the patients 
of Group I and Group II who had been irradiated. No demonstra­
ble connection could be found between the results of irradiat­
ion and the histological type of the tumour or the kind of 
surgical therapy. The adenocarcinoma in the hepatic duct con­
fluence still existed in all five irradiated patients who were 
examined postmortem, these patients died 3 to 20 months after 
the operation. In four of them no metastases had been recorded 
during the operation, three showed dissemination at autopsy 
(Table XXVI). 
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Survivors of more than one year 
Nine patients lived for more than one year after operation. 
All had a tumour not exceeding 5 cm in diameter and in none 
of them metastases were reported at the time of operation. 
For the whole series this means 18% and for Group I and Group 
II 25%. Four patients were alive two years after the operation 
(8% and 11% respectively). There was no correlation between 
the duration of survival and factors as age of the patient, 
period of preceding jaundice, histological type of the tumour, 
size of the tumour as long as it did not exceed 5 cm diameter, 
kind of operation, administration of radiotherapy or cause of 
death. 
3.3. Discussion 
The tumour symptoms were aspecific. The only feature thatmay 
have aroused suspicion before the patient became jaundiced, 
was an isolated alkaline phosphatase level. Two thirds of the 
tumours were smaller than 5 cm in diameter at the time of ope-
ration. The larger the tumour, the more often local extension 
and metastases occurred in the liver. The size of the tumour 
was not related to lymphogenic dissemination or to local ex-
tension to the portal vein or hepatic artery. Involvement of 
the portal vein was not associated with an increased incidence 
of liver metastases or a shorter postoperative survival. 
There was no demonstrable relationship between the macrosco-
pic or microscopic type of the tumour and dissemination or 
local extension. In 20 of the 51 patients (30%) no metastases 
were recorded at the time of operation, a percentage that 
corresponds well with other investigations (60, 235, 290, 396, 
556) In patients whose tumour diameter did not exceed 5 cm, 
this percentage rose to 53% and in patients with a maximal tu-
mour diameter of 2 cm even to 71%. 
The patients died from the consequences of unrelieved or re-
current bile duct obstruction before the malignant properties 
of the tumours became manifest. Of all the investigated para-
meters only the size of the tumour, the presence of metastases 
and the kind of therapy seemed to have an impact on the post-
operative survival. Assessment of the various types of surgi-
cal therapy was hindered by the relative incomparability of 
the treated patients. Nevertheless the four resections result-
ed in a far better mean survival without a higher mortality 
than the other operations (Table XXVII). 
Probably all these resections were incomplete regarding the 
scantiness of the resections performed, the tumour-positive 
edges in at least two patients and the cause of death in all 
four patients. Consequently the hepaticojejunostomies were 
constructed with tumour containing tissue. Still the patients 
had a mean postoperative survival of 22 months. This confirms 
the supposition that these tumours are growing slowly, and 
furthermore it indicates that resection should be preferred 
to all other modalities even as a palliative procedure. 
Theoretically a resection could have been possible in all 12 
patients without metastases or local tumour extension of 
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Table XXVII. Comparative results of surgical treatment In 33 patients with 
carcinoma of the hepatic duct confluence. 
Treatment patients operative mean satisfactory patients alivelyears) 
mortality survival drainage 
(1 month) (months) (patients) \ 1 1^ 2 3 
resection 4 0 22 4/4 4 3 3 2 0 
transtumoral 20 4 9 13/16 13 4 2 1 0 
drainage 
paratumoral 9 2 6 ( л ) 5/7 3 2 1 1 1 
bypass 
patient MHA 3 excluded 
group I and perhaps even in some of the seven patients without 
tumour spread of group II. 
No differences were seen in operative mortality and duration 
of survival between transtumoral and paratumoral drainage 
(Table XXVII). The role of radiotheraoy was limited. 
With the exception of one patient, the mean survival of pa­
tients who did receive radiotherapy equalled that of patients 
who did not. Moreover the tumours were not eradicated and had 
disseminated without hindrance. Nevertheless one patient (MHA3) 
is in good health eight years after a palliative operation and 
radiotherapy. Incidentally, long-term survivors are reported 
after palliative drainage procedures both with (285, 343, 548) 
and without (12, 78, 286) radiotherapy. Temporary local implan­
tation of radioactive material may be promising (188). 
(Recently we treated a patient with a confluence tumour and 
metastases in the caudate lobe. The treatment consisted of 
transtumoral U-tube drainage and local radiotherapy after 
introduction of the irradiation source in the tube. This 
patient died after four months from thrombosis of the in­
ferior cavai vein and pulmonary and extensive hepatic dis­
seminations) . 
Only when the tumour has almost completely blocked the bile 
outlet of the liver, jaundice develops and only then the pa­
tient seeks medical assistance. At that time, the stage of tu­
mour growth, size and spread of the tumour, and the consequen­
ces of the already existing partial or unilateral bile duct 
obstruction are of major importance to the treatment. Jaundice 
can not be regarded as an early symptom since the mean durat­
ion of pre-operative jaundice is independent of tumour size. 
The tumour has already invaded the surrounding tissues at the 
stage when the bile duct lumen is almost completely blocked 
(561) . An undelayed diagnosis can only prevent damage to all 
the liver segments by a complete bile obstruction. 
The aim of therapy is twofold: 1^  a lasting reconstruction 
of the bile drainage of as much as possible liver tissue and 
2 removal of the malignancy. If resection is possible, it is 
the treatment of choice even in case the resection will be 
incomplete. 
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Although the resectability of a hilar bile duct cancer can be 
assumed by thorough pre-operative examination, the resectabi-
lity can only be ascertained by scrupulous operative explora-
tion (66, 332, 357). Palliative drainage should be considered 
only if the feasibility of resection has been excluded. 
Both a paratumoral bypass and a transtumoral intubation have 
its own indications and can be employed together (137). The 
two sides of the liver should be drained to prevent infection 
in obstructed segments (457) . 
Patients who are not suitable for surgery or in whom no 
operative drainage can be achieved, can be treated by percuta-
neous transhepatic or endoscopic transpapillary drainage (140, 
224). In a patient whose life expectance is only a few months, 
the indication for palliation is mainly defined by the presen-
ce of itching. In the absence of pruritis the best solution 
for a terminal patient may be to withdraw from any treatment. 
In 45% of the patients discussed in this study, no bile 
drainage could be accomplished. A thorough knowledge, skill 
and presence of all feasible ways of examination and treatment 
are essential to offer these patients proper treatment. The 
first operation is the patient's chance of a life time. 
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4. Characteristics and resection of cancer of the hepatic 
duct confluence involving the portal vein (Royal Post-
graduate Medical School, Hammersmith Hospital, London) 
Introduction 
Portal vein involvement is generally considered to rule out 
resection of an otherwise localised hilar bile duct carcinoma. 
Ipsilateral affection of the main branches of the portal vein 
and hepatic artery still can be treated by removal of the 
tumour and vessels involved together with the hemi-liver of 
the affected side. Theoretically, even a tumour with contra-
lateral involvement of the main branches of the hilar vessels 
may be resectable by removing the tumour and the affected 
vessel segments. This leaves the one hemi-liver with just an 
arterial blood supply and the other side with only a portal 
blood supply which "should be tolerated by men as well as by dogs 
(604). Additional major hepatectomy would leave the remaining 
part of the liver with only one type of blood supply, which is 
a critical situation. Just as every other vessel the portal 
vein can be divided and resutured. Therefore portal vein invol-
vement by a bile duct cancer may be treated by resection of 
the affected part of the vein in conjunction with the tumour, 
and followed by reconstruction of the vein. 
The best treatment of tumours of the hepatic duct confluence 
is resection of the tumour. A prospective study was carried 
out in 24 patients with angiographically demonstrated venous 
involvement in the Surgical Hepatobiliary Unit (head Professor 
L.H. Blumgart) to assess the pathology and the possibilities 
of resection of confluence tumours affecting the portal vein. 
4.1. Material and methods 
From May 1979 to November 1982, 78 patients were treated for 
tumour of the hepatic duct confluence.Angiographic studies 
were performed as part of the pre-operative resectability ex-
amination in 53 patients. Portal vein involvement by the tumour 
was demonstrated in 24 of the 51 patients (45%) . There were 13 
women and 11 men. The mean age was 53 years (range 3 3 to 69). 
In general the patients were referred from other hospitals, 
where the diagnosis was made by clinical and laboratory exami-
nation, ultrasonography and percutaneous transhepatic cholan-
giography (PTC). The mean duration of pre-operative jaundice 
was 2k months (range 1 to 7 months). During the investigations 
into the resectability of the tumours (63) nutritional disor-
ders were treated and in 17 patients the biliary tree was pre-
operatively decompressed by percutaneous transhepatic drainage 
(PTD) (392) for a mean time of 23 days (range 8 to 43 days). 
Two patients were not suitable for operation and were treated 
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by percutaneous transhepatic drainage. They died within two 
months. The other 22 patients received operative treatment. 
The size and extension of the tumours were assessed by com-
bining the Cholangiographie, operative and histopathological 
findings. In all 24 patients a coeliac arteriography was per-
formed and if necessary supplemented by a superior mesenteric 
arteriography. The venous phase of the arteriogram provided 
sufficient information about the portal vein and its branches 
in 19 patients. Four times a direct splenoportography was add-
ed and once a percutaneous transhepatic portography. The 
vascular involvement was determined by combining the angio-
graphic data with the operative and histopathological findings. 
The presence of partial liver atrophy and of metastases was 
derived from the combined findings of ultrasonography, angio-
graphy, CT scan, operative investigation and histopathological 
examination. 
4.2. Pathology 
In all operated patients the tumour consisted of a nodular 
mass. In 17 patients the diameter or largest width of the tu-
mour did not exceed 5 cm. The mean extension of the tumour in 
the left hepatic duct was 2 cm (range 0 to 5 cm) and in the 
right duct 1.5 cm (range 0 to 3 cm). Regarding the tumours 
where the width did not exceed 5 cm the mean extension on the 
left side was 1.5 cm (range 0 to 3 cm) and on the right side 
1.3 cm (range 0 to 3 cm). All tumours consisted of adenocar-
cinoma of the bile duct with fibrous stroma. The differentia-
tion of tumour cells was established in 15 patients: well 
differentiated in nine, moderately differentiated in four, 
poorly in one and mixed in one. 
The portal vein of these 24 patients was involved at the ori-
gin of the left portal vein branch in 19 and of the richt branch 
in nine. The bifurcation of the portal vein was involved in 11 
patients, six times on the left only, once on the right side 
only and four times on both sides. Fourteen times the affected 
portal vein branch was occluded completely and in the other 
cases the lumen was narrowed. In 11 patients the hilus was 
dissected at operation. In four of these cases the venous in-
volvemejit was more extensive than expected from the angiogra-
phy. Once an encasement expected to be bilateral turned out to 
be single-sided only (Fig. 7 and 8). 
Portal hypertension, diagnosed by measurement of a raised 
portal pressure, splenomegaly or the presence of wide and 
heavily bleeding splanchnic veins, was present in five pa-
tients (23%). In all patients the portal vein obstruction was 
serious: bilateral in three patients and unilaterally complete 
with bifurcation involvement or with displacement of the con-
tralateral branch in two. In four of these five patients the 
left portal vein branch was completely occluded. In three pa-
tients ascites was noted which did not coincide with the portal 
hypertension. In eight patients the tumour was resected and 
careful histopathologic examination of the resected specimens 
was carried out (Professor K. Weinbren). 
Although no systematic serial sections were made of the 
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Fig. 7. Venous phase of coeliac axis arteriogram with 
missing left portal vein branch which is total-
ly obstructed by a cancer of the hepatic duct 
confluence.Copyright ©1983, Dr DJ Allison, London. 
involved portal vein segments, a penetration of the tumour 
through the vessel wall into the lumen was never demonstrated. 
At most the tumour abutted on the wall and actual invasion in-
to the wall was demonstrated in only one specimen. 
Involvement of a main branch of the hepatic artery was seen 
in 10 of the 24 patients (42%), five times of the left and 
five times of the right branch (Fig. 9). In nine patients the 
occlusion was partial and in one total. A crossed vascular 
involvement which consisted in affection of the portal vein 
branch of the one side and of the artery branch of the other 
side, was present in three patients. Again penetration of the 
vessel wall by the tumour was not demonstrated. 
Atrophy of a part of the liver was seen in eight patients 
(33%), six times of the left and twice of the right hemi-liver. 
In six of the eight cases of hemi-liver atrophy there was total 
occlusion of the ipsilateral portal vein branch and in two a 
partially occluded portal vein branch was accompanied by a 
stenosed hepatic artery branch. 
Local extension of the tumour into the parenchyma of the 
caudate lobe was found in nine of the 22 patients operated on 
(43%) . In 11 patients (50%) the tumour extended into the base 
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Fig. 8. Percutaneous transhepatic portogram. 
Involvement of the portal vein bifurcation 
by a cancer of the hepatic duct confluence, 
compromising the origins of both the right 
and left portal vein branches. 
Copyright ©1983, Dr DJ Allison, London. 
of the quadrate lobe. Concomitant tumour extension into the 
caudate and quadrate lobes was found in five patients (23%) . 
Liver metastases were found in five of the 22 patients 
operated on (23%). There was no correlation between the loca-
lisation of the metastases and the side of vascular involve-
ment. Metastases in the regional lymph nodes were seen in nine 
patients (41%) and extended to the peripancreatic or para-
aortal nodes in four. Distant metastases (peritoneum, 
lung, vertebra) were found at the time of operation in two 
patients. 
4.3. Therapy 
Twenty two patients were operated on. In eight patients the 
tumour was resected. A paratumoral bypass was constructed in 
seven patients and in five the treatment consisted of trans-
tumoral drainage only. Twice just a laparotomy was performed. 
Radiotherapy was administered in one patient. Six of these 
patients died within the first month after operation (27%) . 
The mean postoperative survival of the others was eight months 
(range 1 to 29 months). Six patients are alive at the time of 
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Fig. 9. Coeliac axis arteriogram. 
Missing left hepatic artery which is totally 
obstructed by a cancer of the hepatic duct 
confluence. Copyright ©1983, Dr DJ Allison, London. 
writing (December 1982), on a mean of 10 months after opera-
tion (range 1 to 29 months). 
One of the aims of this chapter is to deal with extensive 
resections and vascular reconstructions. Therefore the non-
resective operations will be discussed briefly. 
Non-resective operations 
Paratumoral bypass 
A paratumoral bypass was constructed in seven patients by 
anastomosing a Roux-Y jejunal loop with a dilated bile duct 
at the hepatic side of the tumour. In five patients the bile 
duct of segment III was used, in one the left hepatic duct and 
in one a hepatojejunostomy was performed on the left lobe. In 
three of the seven patients the contralateral hemi-liver was 
drained by a transhepatic transtumoral tube. 
Two patients died from cholangitis and septicaemia or liver 
failure in the first postoperative month. The mean postopera-
tive survival of the other five patients was seven months 
(range 1 to 11 months), one of them being alive seven months 
after operation. One patient received 5000 rad oostoperative 
external irradiation and died 11 months after operation, 
autopsy was not done. 
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Transtumoral drainage 
Dilatation of the tumour followed by transtumoral drainage of 
the right heDatic duct as a procedure complete in itself, was 
performed in five patients. No postoperative death was seen, 
the mean survival was seven months (range 1 to 10 months). 
One patient is alive 10 months after operation (Table XXVIII). 
Death in the two non-resective groups was caused by either 
cholangitis with sepsis or recurrent bile obstruction with 
liver failure and usually by a combination of the two. 
Table XXVIII. Results of surgical treatment of carcinoma of the hepatic duct 
confluence involving the portal vein. 
Operation patients operative mean survival alive after (years) 
mortality (months) 
Η ι Us 2 3 
resection 8 3 ]1 3 2 1 1 0 
paratumoral 7 2 7 4 0 0 0 0 
bypass 
transtumoral 5 0 7 3 0 0 0 0 
drainage 
Resections 
In five patients the tumour was resected together with a right 
lobectomy and in three patients with a left hemihepatectomy. 
Three times a lateral segment of the portal vein bifurcation 
was included in the resection. The defect was repaired by 
direct suturing. Twice the complete portal vein bifurcation 
was removed, followed by end-to-end reconstruction. A tumour 
free resection margin was obtained in four of the six in whom 
an intended curative resection was performed. 
Three of the eight patients died within the first postopera­
tive months, one from liver necrosis and two from septicaemia. 
The mean survival of the other patients was 11 months (range 1 
to 29 months) at the time of writing (December 1982)( Table 
XXIX). The case histories of six patients are discussed here. 
In all patients the biliary drainage was restored by an end-to-
side hepaticojejunostomy between the remaining hepatic duct and 
a Roux-Y jejunal loop over a transanastomotic transhepatic 
U-tube. 
4.4. Patients 
1 This 59-year old man was referred for treatment of obstruc-
-
 tive jaundice of 3^ months duration. Ultrasonography and 
PTC demonstrated an obstruction in the hepatic duct confluence. 
PTD was established. The venous phase of a coeliac arteriogra­
phy demonstrated encasement of the origins of the left and 
right portal vein branches. 
At operation a nodular tumour of 3 cm diameter was found at 
the right side of the hepatic duct confluence,no metastases 
were detected. The tumour was removed in conjunction with the 
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right liver lobe and a larqe part of the caudate labe. Feroperative 
blood flow measurement (22a,378a) showed a 130% increase of the 
blood flow in the retained left lobe. The tumour consisted of 
a well-differentiated sclerosing adenocarcinoma which extended 
around the right branches of the portal vein and the hepatic 
artery and into the caudate lobe. A lymph node in the hilus 
adjacent to the tumour was tumour positive but the resection 
margins were free of tumour. The postoperative course was 
excellent and the patient is alive 29 months after operation. 
COMMENT: Although the angiography suggested bilateral in-
volvement of the portal vein branches, it appeared at opera-
tion that especially the right branch was affected and that 
the bifurcation and left branch could be freed from peritumo-
ral fibrosis. 
2 A 53-year old man was referred for treatment of obstructi-
ve jaundice of two months duration. Ultrasonography and 
PTC showed a lesion in the hepatic duct confluence. A PTD was 
inserted and cytological examination of the bile demonstrated 
adenocarcinoma cells. The venous phase of a coeliac arterio-
gram delineated a narrowed right portal vein branch. CT scan 
did not demonstrate metastases or liver atrophy. 
At operation a 2x2x5 cm sized nodular tumour was found which 
extended along the right hepatic duct and compromised the ori-
gin of the right portal vein branch. No metastases could be 
detected. Resection of the tumour with excision of a lateral 
segment of the portal vein bifurcation and right lobectomy was 
performed. The tumour consisted of a well-differentiated scle-
rosing adenocarcinoma. The resection margins were free of tu-
mour. Postoperative recovery was uncomplicated. 
COMMENT: At the end of the dissection when the left hepatic 
duct had to be cut, a firm nodule was felt at that spot which 
was suggestive of tumorous extension. Frozen section revealed 
fibrous tissue only, which was postoperatively confirmed in 
the paraffin sections. Even at the end of a dissection, a tu-
mour up to that moment considered to be resectable can be ir-
resectable. 
2 This 4 3-year old woman presented with a two months ob-
structive jaundice. Ultrasonography and PTC demonstrated 
an obstruction in the hepatic duct confluence which extended 
in the left hepatic duct, PTD was brought in. Coeliac arterio-
graphy showed encasement of the common hepatic artery and left 
portal vein, and a complete occlusion of the left hepatic ar-
tery. A CT scan showed left sided liver atrophy. 
As the curative possibilities were little, she was operated 
with palliative intention. A 3 cm sized nodular tumour was 
found which consisted of a well differentiated sclerosing ade-
nocarcinoma disseminated in the atrophic left lobe. The tumour 
was resected by a left hemihepatectomy in conjunction with the 
common hepatic artery and a lateral segment of the portal vein 
bifurcation. The portal vein was repaired by direct suture. 
The right hemi-liver was left with portal blood supply only. 
In the removed specimen two small tumour positive lymph nodes 
were found in the liver hilus. The cut edge of the right hepa-
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tic duct contained tumour. 
In spite of an initial postoperative recovery she had to be 
re-operated two weeks later because of partial liver necrosis, 
from which she died 29 days after the first operation. 
COMMENT: Only after the final transection of the right heoa-
tic duct it became clear that curative resection still could 
not be achieved. The right portal vein with a laterally sutu-
red portal vein bifurcation provided the only afferent blood 
supply to the remaining right hemi-liver which was apparently 
not enough. 
4 This 58-year old woman was referred for treatment of ob-
structive jaundice of two months duration which was caused 
by a localised obstruction of the hepatic duct confluence as 
shown by PTC. PTD was established. Angiography demonstrated a 
narrowed left hepatic artery and a totally obstructed left 
portal vein branch. 
At operation a nodular mass of 3 cm diameter was found in 
the hepatic duct confluence nearly surrounding the origin of 
the left portal vein branch. The left liver lobe was somewhat 
atrophic. No metastases could be detected. The tumour was re-
moved in conjunction with a left hemihepatectomy, excision of 
a lateral part of the portal vein bifurcation and ligation of 
the right hepatic artery branch, leaving the right hemi-liver 
with portal blood supply only. The tumour consisted of a mode-
rately differentiated sclerosing adenocarcinoma. Tumour tissue 
extended to the resection surfaces of the right hepatic duct 
and portal vein branch. 
Four days later the patient had to be re-operated because of 
necrosis of the cut surface of the retained right hemi-liver, 
including the biliary anastomosis.The hepaticojejunostomy was 
recreated. After one month dehiscence of the anastomosis re-
occurred, but this time because strongly regenerated liver 
tissue had disrupted the biliodigestive connections. A hepato-
jejunostomy was successfully constructed and resulted in good 
palliation for one year. Then the jaundice recurred and meta-
stases in the abdominal scar and in the lung became evident. 
An endoprosthesis was inserted percutaneously but the patient 
died four days later, 14 months after the initial operation. 
Autopsy was not performed. 
COMMENT: At the first operation a slice of liver tissue was 
vascularised insufficiently but the rest of the right hemi-
liver showed good regeneration though supplied by portal blood 
only. The regenerated liver tissue later on even caused dis-
ruption of the reconstructed biliodigestive anastomosis. This 
anastomosis consisted of a connection of the jejunal loop with 
four separate bile duct orifices, which were two by two connec-
ted with each other and formed two common bile channels. 
The disruption consisted in a division of the interconnected 
bile ducts, producing again the original four separate ducts. 
These were successfully covered by the jejunal loop in a 
hepatojejunostomy. 
65 
5 When 33 weeks pregnant this 33-year old woman became 
jaundiced. One week later she delivered a premature but 
healthy baby girl. The jaundice was obstructive in nature and 
was shown by ultrasonography and PTC to be caused by an ob­
struction of the hepatic duct confluence. The venous phase of 
a coeliac arteriogram showed total obstruction of the right 
portal vein branch. 
At operation a 2x2x2 cm nodular tumour of the hepatic duct 
confluence was found. There were no metastases. After distal 
transection of the common bile duct the portal vein was dis­
sected liverwards. The portal vein bifurcation appeared to be 
adherent to the tumour. The left corner of the porta hepatis 
near the base of the umbilical fissure was dissected from a 
caudal to a cranial direction. The left portal vein branch and 
left hepatic duct were transected. Then the main stem of the· 
portal vein was cut just upstream of the bifurcation and re-
anastomosed with the distal side of the transected left portal 
vein branch. In this way the bifurcation and the right branch 
of the portal vein were excluded from the portal blood stream 
and the portal blood was led directly into the left hemi-liver. 
This required 15 minutes occlusion of the portal blood stream. 
Then the tumour was resected in conjunction with a right Іоь 
bectomy and excision of the portal vein bifurcation. 
The tumour consisted of a well differentiated sclerosing 
adenocarcinoma with initial spread in the pre- and retrohilar 
liver tissue. Two lymph nodes near the cystic duct entrance 
were tumour positive. The resection margin of the left hepatic 
duct and the adjacent liver tissue contained tumour as well. 
After good progress in the early postoperative period, her 
condition began to deteriorate. A subphrenic collection was 
drained but 10 days after the operation she died from uncon-
trolable septic shock. Autopsy гел/ebled no specific abnormali­
ties and no septic source was found. The portal vein anastomo­
sis and the hepáticojejunostomy were patent. 
COMMENT: When approached from a caudal direction, the left 
part of the porta hepatis can be explored by opening the cove-
ring peritoneum and hilar plate. The first structure encoun-
tered is the left portal vein and cranial to that lies the 
left hepatic duct (page 91). Both structures can be dissected 
without prior transection of liver parenchyma and consequently 
the described diversion of the portal blood stream can be per-
formed prior to the hepatectomy. A hepáticojejunostomy as it 
is, unhampered in its construction by a portal vein anastomo-
sis, is imperfect in a quarter of the patients (178). As the 
left portal vein branch and the left hepatic duct lie close 
to each other, insertion of stay sutures before transection 
is beneficial to the subsequent reconstruction. Portal vein 
reconstruction is done before biliary reconstruction, in time 
as well as in place, and therefore the hepaticojejunostomy 
has to be carried out cranially of the portal vein ana-
stomosis, which requires a scrupulous and strictly systematic 
technique (588). 
The operation had an excellent course and resulted in a well 
vascularized and bile-drained left liver lobe with good ana-
66 
stomosis. The cause of the final tragic outcome remains a 
mystery. 
£ This 46-year old woman was referred for treatment of ob-
structive jaundice of six weeks duration. PTC and ERCP had 
shown an obstruction of the hepatic duct confluence. PTD was 
installed. Angiography showed encasement of the right hepatic 
artery and left portal vein branch. CT scan did not show meta-
stases or atrophy. 
At operation the gallbladder appeared to be attached to the 
left liver lobe on the left side of the ligamentum teres, no 
quadrate lobe could be identified. A 2x2x4 cm nodular tumour 
was found in the right side of the hepatic duct confluence, 
сQuipromisinq the right hepatic artery and the portal vein bifur­
cation with the origins of its left and right branch. No meta­
stases could be discovered.Because of the abnormal anatomy, at 
first transection of the liver along the anomalous gallbladder 
bed was necessary to reach the left portal vein. Then the tu­
mour was resected in conjunction with the portal vein bifurca­
tion and with an atypical extended right hepatectomy along the 
plane between the left sided gallbladder bed and the inferior 
cavai vein which included the right part of the caudate lobe. 
The portal blood supply to the remaining left lobe was inter­
rupted for 6 0 minutes and reconstructed by an end-to-end ana­
stomosis between the portal vein and the left branch. 
The tumour consisted of a well differentiated adenocarcinoma 
that abutted on the portal vein but did not invade the vein wall. 
There was initial invasion of the pre- and retrohilar liver 
tissue. The cystic lymph node contained tumour tissue but all 
resection margins were free of tumour. 
Postoperative recovery was slow but without major problems. 
Four months after the operation, the patient is still recover­
ing and in a good condition. 
COMMENT: A left sided gallbladder in itself is a rare and 
harmless anomaly and is mostly detected accidently (231, 261, 
370, 417). The abnormal anatomy in this patient, however, com­
plicated the liver resection as an atyoical plane of transec­
tion had to be used. This resulted in considerable blood loss 
from crossing suprahepatic veins which necessitated clamping of 
the portal vein for 6 0 minutes. This was well tolerated by the 
patient arri did not cause haemodynamic disturbances. Man and 
monkey usually well tolerate acute occlusion of the portal 
circulation and even ligation of the portal vein is compatible 
with life (129, 381, 534). Moreover complete vascular isolation 
of the liver up to one hour has been shown hardly to interfere 
with the postoperative function and regeneration of the re­
tained liver parenchyma (281). 
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Table XXIX. Resections of carcinoma of the hepatic duct confluence 
involving the portal vein in eight patients. 
Patient liver resection management involvement resection margin postop.survival 
v.porta hif./a.hepática (months) alive/ 
cause of death 
1 right lobectomy 
+ caudate lobe 
free of tumour 29 alive 
2 right lobectomy 
3 left hemihepatectomy 
(palliative) 
4 left hemihepatectomy 
5 right lobectomy 
6 right lobectomy 
7 right lobectomy 
(palliative) 
excision lat 
segment and 
direct repair 
free of tumour 
excision lat. excision tumour oositive 
segment and a.hep.com. 
direct repair no repair 
excision lat. ligation tumour oositive 
segment and a.hep. 
direct repair dextra 
excision bif. 
and end-to-
end repair 
excision bif. 
and end-to-
end repair 
tumour positive 
free of tumour 
tumour positive 
14 
alive 
necrosis 
liver 
remnant 
tumour 
recurrence; 
sepsis 
cholangitis 
sepsis 
alive 
0 cholangitis 
sepsis 
8 left hemohepatectomy free of tumour alive 
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4.5. Discussion 
The bifurcation of the portal vein is in direct contact with 
the hepatic duct confluence (268). In consequence early inva­
sion of the bifurcation by a confluence tumour can be expected. 
The angiographically screened and operatively verified inciden­
ce of portal vein involvement in this series was 45%. Presuma­
bly this incidence is representative for all cancers of the 
hepatic duct confluence since the tumour characteristics in 
this specific series did not differ from those reported in 
Chapters 3 and 4, and since angiography was only routinely 
performed in patients not primarily unsuitable for resection. 
Corresponding figures were found for initial invasion of the 
adjacent tissue of the caudate and quadrate lobe. 
As reported (616) the angiographic data were in agreement 
with the findings at operation. Real vein wall invasion by the 
tumour was demonstrated only once and penetration into the 
lumen in none of the patients. Apparently the vascular encase­
ments were due to obtrusion of the sclerotic tissue on the 
vessels. It seems that the abundant peritumoral fibrous reac­
tion, so typical of confluence tumours, strangles the vessel 
before the actual tumour tissue can reach the vessel wall.This 
means that vascular involvement in itself is no contra-indica-
tion to resection of a proximal bile duct cancer if the invol­
ved vascular segment can be removed together with the tumour. 
There was no relation between the size of tumour and vascu­
lar involvement. Apparently both small and large confluence 
tumours can affect the portal vein. Likewise a large tumour 
may as well spare the portal vein (72) . All tumours consisted 
of the common nodular sclerosing adenocarcinoma with the usual 
preponderance of the well differentiated type. Concomitant 
arterial involvement was found in 42% of the patients (10/24). 
Again no actual invasion or penetration of the arterial wall 
by the tumour was demonstrated (617). The tumours were situated 
slightly more on the left side of the confluence and the origin 
of the left portal vein branch was more often affected than the 
right branch. 
The incidence of hepatic metastases in this specific series 
corresponds well with other series and showed no relation with 
the side of portal vein or hepatic artery involvement. Also 
lymphatic and distant metastases occurred as often in these 
patients as in the average population of patients with bile 
duct tumours.This supports the concept that impairment of the 
hilar vessels by the tumour mostly consists in an obtrusion by 
the sclerotic reaction that surrounds the actual tumour. 
Portal hypertension only developed in case of serious obstruc­
tion of the portal flow. One normal branch of the portal vein 
with an unobstructed main stem and bifurcation warrants an 
adequate outflow tract for the splanchnic blood. This could be 
expected, as even after right lobectomy the portal pressure 
does not rise (У0), although elevation in pressure may develoo 
postoperatively because of compression of the portal system in 
the retained liver segments by hyperplasia of the parenchyma 
(68). Complete obstruction of a portal vein branch or partial 
obstruction of the ipsilateral main branches of the portal 
69 
vein and of the hepatic artery can cause atrophy of the 
hemi-liver concerned. 
As the characteristics and dissemination patterns of conflu-
ence tumours with vascular involvement do not differ from tu-
mours without vascular involvement, the treatment of both types 
of tumours is essentially the same. Although technical problems 
may arise, and liver resection will be necessary in most cases, 
theoretically resection of the tumour still is the best treat-
ment, however high the operative mortality may be at present. 
Although the actual tumour does not usually invade the portal 
vein wall, the vein is so closely approached that tumour clear-
ance requires at least a resection of the adjacent vein seg-
ment. 
The right branch of the portal vein in general measures only 
2 cm before dividing in the right lateral and riaht paramedian 
branch and runs there already intrahepatically. The left branch 
has a transverse extrahepatic stretch of about 4 cm, from which 
only minor branches are given off to the quadrate and caudate 
lobes. At 4 cm from the main bifurcation the left portal branch 
sharply bends anteriorly, launches the branch to segment II and 
then widens in the umbilical part (recessus of Rex). For that 
reason resection of the portal vein bifurcation leaves especi-
ally at the left side an extrahepatic vein remnant suitable to 
re-anastomose. 
Just like the bifurcation of the portal vein the confluence 
of the hepatic ducts is situated at the right side of the liver 
hilus, and like the right branch of the portal vein the right 
hepatic duct has an extrahepatic course of only 1 cm before it 
divides into its lateral and paramedian branch. The left hepa-
tic duct has a length of about 5 cm before entering the left 
liver lobe. Because of the submucosal spread and the possibili-
ty of multifocal or diffuse occurrence of the cancer the extra-
hepatic biliary system has to be removed as extensive as pos-
sible. Consequently a wide excision of a confluence tumour has 
to include on the right side the first parts of the secondary 
hepatic ducts. On the left side, a remnant of the left hepatic 
duct can be retained for later reconstruction. 
Therefore resection of a confluence tumour together with 
portal vein bifurcation is best combined with: 1_ diversion of 
the portal blood flow to the left lobe; 2 right lobectomy, and 
3 hepáticojejunostomy with the left hepatic duct remnant. 
—
 Right lobectomy is a well established procedure (362, 525, 
528), as is left hepáticojejunostomy by means of a Roux-Y loop 
(330). Resection and reconstruction of the portal vein in 
combination with a liver resection is less known. 
Eight of the 24 tumours of this series were resected (33%). 
Five times this required a concomitant right lobectomy and 
three times a left hemihepatectomy, twice a resection of the 
complete portal vein bifurcation and three times a resection 
of a lateral segment of the bifurcation, once a resection of 
the common hepatic artery and once a ligation of the arterial 
branch to the liver remnant.Still the resection margins of 
the hepatic duct remnants contained tumour tissue in four of 
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the eight cases, although the impossibility to obtain tumour 
clearance was expected in two pre-oneratively. Twice a remain-
ing right hemi-liver was supplied with portal blood only. One 
of these patients showed a good liver regeneration in spite of 
a stormy postoperative course that required two re-operations. 
The second patient died from liver necrosis.Therefore recon-
struction or both types of afferent blood supply should be 
pursued. 
After partial excision, _the_j3ort_al _yein can be reconstructed 
by 1_ end-to-end anastomosis, 2_ l^TntërpösTHïön"'öï"~avrKTÖg"düs 
graft, and 3_ by transposition of the splenic vein. 
1_ end-to-end anastomosis of the portal vein remnants. After 
mobilisation of the head of the pancreas, right colon and 
mesenteric root the portal trunk can be brought up 6 cm (185, 
192, 193, 357, 369); 
2 interposition of autologous graft, e.g. internal jugular 
vein (98, 198, 225, 444, 510, 541), homologous vein graft 
(185, 198, 541) or vascular prosthesis (356, 424, 522); 
3_ transposition of the splenic vein. The splenic vein can be 
mobilised from the dorsal side of the pancreas, distally 
transected and re-anastomosed with a portal vein remnant in 
the liver hilus, as proposed by Longmire (357). use of the 
splenic vein in a comparable way was successful in bridging 
defects of the superior mesenteric vein (97, 114, 154) and in 
the treatment of Budd-Chiari syndrome by interposition of a 
vein graft or prosthesis between the splenic vein and the pul-
monary artery (189), pulmonary vein (346) or right atrium 
(242, 327, 364). 
Three cases of right lobectomy with concomitant resection 
of the portal vein bifurcation and subsequent end-to-end 
reconstruction of the portal vein remnants could be traced in 
the literature (Table XXX). Two patients treated by Fortner 
(193) soon died after the operation, one from persistent 
bleeding and the other from septicaemia and portal vein throm-
bosis . The patient operated on by Longmire (357) recovered 
after a stormy postoperative course but died one year later 
from recurrent tumour growth (361) . Four other patients who 
underwent a major liver resection with resection and repair of 
the portal vein and the extrahepatic biliary tract have also 
been listed in Table XXX, as well as three patients in whom 
the portal blood was diverted from the liver remnant by a 
porto-caval shunt. 
The four patients in Table XXX treated by Fortner died 
shortly after the operation, in all the already abandoned cold 
perfusion technique was used (191, 194, 197). The two patients 
reported by Tsuzuki (574) also had their arterial supply to 
the retained right hemi-liver resected and reconstructed, one 
by interposition of a saphenous graft and one by an anastomo-
sis with the right gastro-epiploic artery. At least three of 
the four patients with a carcinoma of the hepatic duct con-
fluence, who survived resection of the tumour in conjunction 
with a hepatectomy and resection of the portal vein bifurca-
tion, later on died from recurrent tumour growth. 71 
Table XXX. Results of major liver resection in conjunction with resection 
of the hepatic duct confluence and portal vein bifurcation. 
Authors 
Fortner 
et al (193) 
Fortner 
et al. (193) 
Longmire 
et al. (357) 
Fortner 
et al. (193) 
Schamaun 
(499) 
Maillard 
et al.(369) 
Kajitani 
(300) 
Fortner 
et al. (193) 
Tsuzuki 
et al.(574) 
Tsuzuki 
et al. (574) 
indication 
carcinoma of 
hepatic duct 
confluence 
carcinoma of 
hepatic duct 
confluence 
carcinoma of 
hepatic duct 
confluence 
hepatocellular 
carcinoma 
Echinococcus 
alveolaris 
cysts 
Echinococcus 
alveolaris 
cysts 
carcinoma of 
hepatic duct 
confluence 
carcinoma of 
hepatic duct 
confluence 
carcinoma of 
hepatic duct 
confluence 
carcinoma of 
hepatic duct 
confluence 
type of 
hepatectomy 
right 
lobectomy 
right 
lobectomy 
right 
lobectomy 
right 
lobectomy 
right 
lobectomy 
right hemi-
hepatectomy 
partial right 
hepatectomy 
left hemi-
hepatectomy 
left hemi-
hepatectomy 
left hemi-
hepatectomy 
type of oortal 
vein reconstr. 
porto-caval 
shunt 
end-to-end 
repair 
end-to-end 
repair 
end-to-end 
repair 
porto-caval 
shunt 
end-to-end 
repair 
porto-caval 
shunt 
end-to-end 
repair 
end-to-end 
repair 
end-to-end 
repair 
postoperative survival 
(months)/cause of death 
0 
0 
12 
0 
5 
0 
16 
0 
15 
18 
liver 
insufficiency 
haemorrhage 
recurrent 
tumour growth 
septicaemia.portal 
vein thrombosis 
incarcerated 
diaohraqmatic 
hernia 
haemorrhage from 
suprahepatic veins 
? 
haemorrhage 
recurrent 
tumour growth 
recurrent 
tumour growth 
The three major oostoperative complications are 1 thrombosis 
of the reconstructed portal vein, 2 insufficiency of the liver 
remnant, and 3 cholangitis with abscesses and septicaemia. 
Portal vein tKrombosis should be dealt with by immediate re-
operation and thrombectomy (296) . A proper way of liver support 
to cover a period of insufficiency is not yet known. The pre-
sence of a well functioning portal and arterial blood supply 
to a bile-drained liver remnant of not less than 20 to 25% of 
the original liver tissue is the best guarantee against liver 
insufficiency. The danger of infection is clear. 
72 
Part В Investigation into the possibility of a 
curative resection 
5. Analysis of the poor results 
Of all treatments resection gives the best result in every 
aspect. Additional liver resection to a resection of the tumour 
does not increase the operative mortality as long as the re­
section does not exceed a left hemihepatectomy. Irrespective 
of the portal vein management, right hemihepatectomy and right 
lobectomy have a combined operative mortality of 35% and a 
mean postoperative survival or 17 months (1 to 48 months) when 
performed for hepatic confluence tumours (combined series of 
31 patients from Chapter 2.4.1.; 4.3. and 4.5.). 
Cure is virtually never achieved as the patient still dies 
from recurrence of the tumour after l^ years. Extension of 
resection seems not to provide better results as tumour recur­
rence still occurs in due time, however extensive the excision 
may have been. However, a wide resection which includes a par­
tial hepatectomy or even the hilar vessels, is performed only 
if local resection is impossible because of tumour extension. 
Tumour spread, extent of resection and scantiness of tumour 
clearance match each other, and so do the results. 
Periductal and intraductal spread of the tumour are in the 
main responsible for the appalling frequency of recurrence. 
Periductal spread of the tumour 
Criteria to define or to determine the stage of tumour growth 
at the time of treatment are unknown (75) . Tumour growth in the 
thin walled bile duct soon reaches the periductal tissues. When 
the tumour has progressed so far that it blocks the bile duct 
lumen, it already has invaded the periductal tissues. Conse­
quently the same holds true for the moment of treatment. 
Metastatic tumour growth in regional lymph nodes is reported 
in one third of the patients. Lymphatic metastases can easily 
be overlooked since the lymphatic system is situated on the 
posterior side of the liver hi lus and hepatoduodenal ligament. 
Incipient invasion of the abundant lymphatic network around 
the bile ducts is likely to be present in almost all patients. 
If a lymphatic vessel, however small it may be, is obstructed 
by the tumour a retrograde lymph flow may occur and conse­
quently retrograde carrying of tumour cells. It is unknown in 
how far the biliolymphatic permeability in bile duct obstruc­
tion results in passage of tumour cells through the wall of 
grossly dilated bile ducts into the lymphatic system. The 
highest lymph nodes in the porta hepatis are situated between 
the left side of the portal vein bifurcation and the anterior 
surface of the caudate lobe. When there is at least an initial 
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invasion of the lymphatic system in the liver hilus, then the 
complete regional area of abundant lymphatic structures in the 
hilus and the hepatoduodenal ligament must be considered to be 
affected by tumour. 
The curious venous network which drains into the quadrate 
lobe, described by Petrén and Karlmark (445), is invaded in up 
to 82% of the patients (433). Therefore initial invasion of 
the quadrate lobe by this route is plausible in most Datients. 
The parenchyma of the quadrate and caudate lobes is so near 
to the hepatic duct confluence that incipient invasion by the 
malignant tumour should be common rather than exceptional. 
Besides, the problems in histopathologic appreciation discus-
sed on page 13, also apply to the judgement of all resection 
margins. 
Intraductal spread of the tumour 
Submucosal spread in the duct wall occurs over long distances 
and it is wise to consider a primary bile duct carcinoma as a 
regional rather than as a local affection of the bile duct 
(433). Attention is usually directed to the proximal and distal 
extensions of the tumour along the right, left and common he-
patic ducts. Probably intraductal extension of the tumour also 
occurs along small branches from the confluence area into the 
adjacent liver tissue of the segments IV and I. Such extensions 
may develop before a major duct becomes blocked as they will 
produce no symptoms. Finally, multifocal bile duct carcinoma 
occurs in 9% of the patients and all these may have the indi-
cated spread (page 12). 
Conclusion 
As it is plausible that intraductal and periductal tumour 
spread has already occurred at the time of treatment, the com-
plete hepatoduodenal ligament, the liver tissue adjacent to 
the tumour (segments I and IV) and the extrahepatic biliary 
tract including the complete right hepatic duct, have to be 
regarded as a pool of potential tumour invasion. Resection of 
all lymphatic tissue of the hepatoduodenal ligament, leaving 
only the bare portal vein and hepatic artery will - similar to 
retropancreatic dissections in the treatment of pancreas car-
cinoma (196, 272) - microscopically be insufficient. 
Generally, resection of the confluence, part of the biliary 
tract and the periductal liver tissue gets proper attention, 
but the retroductal tissues as portal vein bifurcation, hilar 
lymphatic tissues and the caudate lobe are never resected en 
bloc, except in case of liver transplantation. Even after 
liver transplantation the tumour appears to recur and such a 
recurrence can only arise from tumour-invaded structures in 
the retained rest of the hepatoduodenal ligament. 
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6. The possibility of a radical block resection 
6.1. Requirements 
The poor results of the current types of resections are to be 
expected as these resections do not follow correct oncologic 
principles. A radical block resection is the generally accept-
ed procedure of choice for the surgical treatment of a malig-
nant tumour. This treatment consists of removal in one piece 
of the undisturbed tumour, a considerable amount of apparently 
normal tissue around the tumour and the area of regional lymph 
drainage. Hampered by the concentration of vital structures at 
the hilus of the liver, resection seems impossible for a can-
cer of the hepatic duct confluence (5, 374, 406, 599). Accor-
ding to oncologic principles, a potentially curative resection 
of such a malignant tumour should consist in a block resection 
of 1_ the complete extrahepatic biliary tract (which includes 
the left hepatic duct); 
2 the complete right hepatic duct and the central parts 
of the right lateral and right oaramedian ducts; 
3 the liver segments IV, V and I; 
£ the complete hepatoduodenal ligament with the oortal 
vein, hepatic artery, bile duct and lymphatic tissues 
up to and including the pancreatoduodenal nodes and 
the nodes around the base of the common heoatic artery, 
leaving the bare inferior cavai vein as rsosterior dis-
section margin. 
After such a resection, restoration of the outflow tract of 
the splanchnic portal blood as well as the reconstruction of 
the biliary drainage and of the double afferent vascularisation 
of the remaining liver segments II and III on the left side 
and VI, VII and VIII on the right side is practically impos-
sible. Moreover such a resection will be an all-or-nothing 
operation and even by the end of the resection it will be im-
possible to assess the chances of success of a subsequent re-
construction. 
Nevertheless the described block resection is the only 
rationale for a potentially curative operation and may provide 
the only way out of the cul-de-sac in which the treatment of 
proximal bile duct cancers has ended up (168). The feasibility 
of such a resection should still be considered because of the 
very properties of the liver, namely the huge functional re-
serve capacity and regeneration power (6, 436, 494), the seg-
mentally framed vascular and biliary system (142, 206, 247, 
267) and the capacity to tolerate a normothermic ischaemia of 
45 minutes (281, 282, 283). 
Theoretically the resection required can be performed by 
resecting the hepatoduodenal ligament and the entire liver, 
followed by autotransplantation of the left lobe and the right 
lateral sector. This type of surgery is successfully applied 
in renal operations (103, 340, 425, 549) . Simple gravity per-
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fusion with 4 С Ringer's lactate offers four hours to perform 
a similar autotransplantation of liver parts (103, 497). How­
ever the precarious outflow tracts may rather be left alone 
and from oncologic point of view the main suprahepatic veins 
do not need to be sacrificed either. Therefore resection in 
situ is preferable to the formidable and hazardous procedure 
of total resection and autotransplantation. 
To preserve as much as possible liver tissue it would be 
ideal the reconstruct the afferent vascularisation and the 
biliary drainage of both the left lobe and the right lateral 
liver sector. Such a procedure is much more difficult and un­
certain than the reconstruction of only one liver part. Each 
part consists of 20 to 30% of the total liver parenchyma. The 
smallest amount of liver tissue required for a good survival 
of the patient is 20 to 25% of the normal liver (49, 525, 527, 
528). Therefore preservation of only the right lateral sector 
(segments VI and VII) ör the left lobe (segments II and III) 
may be sufficient. 
Extended left hepatectomy, which leaves only the right la-
teral sector, is an exceptional and difficult operation (530). 
Right lobectomy, leaving only the left lobe, is a well esta-
blished procedure (49, 525, 565). In experienced hands the 
operative mortality is nil to 10% (5, 279, 527, 528), in col-
lective studies this percentage varies from 17 to 25% (200, 
201, 406). This operation is the only standard hepatectomy 
that provides sufficient opportunity to perform a wide resec-
tion of the hepatic duct confluence (277). Usually the opera-
tion is well tolerated by the patients (5, 49, 279, 383, 436, 
525, 528, 565, 566). 
After resection of 75% of the liver in dogs, the portal 
pressure rises slightly (367). In men no rise in portal pres-
sure is seen after right lobectomy (90, 284, 379), but the 
perfusion of the retained left lobe may rise 200 to 300% (379). 
Apparently the capacities of the left portal vein branch and 
the intrahepatic portal system of the left lobe are sufficient 
to cope with all the portal blood, while the suprahepatic ve-
nous system provides an adequate outflow tract for the combi-
ned portal and arterial flow. 
For these reasons the required radical block resection is 
possible if 20 to 25% of normal, well vascularised and bile-
drained liver tissue can be preserved· Anatomically the left 
liver lobe can meet this requisite best. 
6.2. Possibilities of afferent vascular reconstruction 
The arterial stump of the retained liver part can be re-
anastomosed with the dissected splenic or gastro-epiploic ar-
tery or connected to a major artery by interposition of a ve-
nous graft or vascular prosthesis. Intracarenchymatous implan-
tation of the splenic artery into the retained liver segments, 
comparable to implantation of the arteria mammaria interna in-
to the myocardium (584), has been described in animals (151, 
203, 220, 221, 222, 293, 461). The implantation has to be per-
formed in a preceding operation as connections with the intra-
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hepatic vascular system need time to develop. Besides the 
resulting blood supply is considerably smaller than the ori-
ginal supply by the hepatic artery (151, 293). 
The portal vein remnant of the retained liver part can be 
re-anastomosed with the splanchnic portal system as outlined 
on page 71. Since the complete portal vein has to be removed, 
the gap to bridge between the root of the portal vein and the 
portal remnant of the retained liver part is too wide for an 
end-to-end anastomosis. Autologous vein provides the best 
material for an interposition. Therefore a transposition of 
the splenic vein or an interposition of an autologous vein 
graft are the most suitable known ways to replace a complete-
ly removed portal vein. When the splenic vein is dissected 
and peripherally transected, it can be transposed behind the 
stomach to the retained liver part and anastomosed with the 
cut edge of the portal branch remnant. As there are no valves 
in the portal system (157, 479, 615) the portal blood can 
flow unimpeded in the reverse direction. The use of the cen-
tral splenic vein as an outflow tract for the portal blood is 
applied in the central splenorenal shunt for portal hyperten-
sion (47, 134), in splenothoracic shunts for Budd-Chiari syn-
drome (364) and to bridge defects in the superior mesenteric 
vein (97). 
Theoretically a peripheral entrance of the portal blood in-
to the liver must be possible, just like a peripheral outlet 
of the bile. By a peripheral hepatotomy a large portal vein 
can be sought. The construction of a connection between such 
a vein and the extrahepatic system by means of the transposed 
splenic vein or the interposition of a vein graft should be 
possible. In this way the portal vein is bypassed even before 
it has to be transected. A splenic vein implanted into the 
liver parenchyma was tested in dogs but stayed patent only as 
long as portal hypertension was present (126, 220, 293). An 
anastomosis between the re-opened umbilical vein and the 
portal vein root or splenic vein seems a feasible possibility 
for a paraportal bypass to the left lobe (Chapter 6.3.) . 
The entire procedure is simplified if reconstruction of only 
one afferent blood supply would be enough. A liver part can 
regenerate when supplied with portal (21, 604) or arterial 
(85, 264, 499) blood only. After hemihepatectomy the regene-
ration of a liver remnant only supplied with portal blood, is 
virtually as good as it is when perfused with both portal and 
arterial blood, but regeneration is deficient in case only 
arterial blood is provided (604) . The role of the functional 
competition between the transplant and the liver of the host 
has been underestimated (265, 496) in the interpretation of 
the many confusing results of experimental auxiliary liver 
transplantation (341, 363, 398, 400, 456). Still, reconstruc-
tion of the portal blood supply probably prevails over arte-
rial reconstruction. Besides, diversion of the portal blood 
by a portocaval shunt also requires an anastomosis and causes 
encephalopathy in more than half of the patients with a pre-
viously normal portal circulation (98, 185, 193, 369, 499). 
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The survival of a patient entirely depends on the function 
and regeneration of the small liver remnant. A further reduc-
tion of the reserve and regenerative capacities is not admiss-
able to meet technical problems. All alternatives 
considered result in a smaller, ill-balanced or uncertain 
blood supply. Therefore both portal and arterial vascularisa-
tion of the retained liver part have to be reconstructed com-
pletely. 
The various types of direct vascular reconstruction have 
been separately employed with good results. The combination of 
a right lobectomy and resection of the portal vein bifurcation 
followed by blliodigestive and portal vein reconstruction of 
the liver remnant is also feasible. Still in the widest re-
sections nowadays performed, the left hepatic duct confluence 
and the left portal vein branch are transected only halfway 
along their course - very close to the tumour - to preserve 
stumps of sufficient length to re-anastomose. Moreover in all 
known resections most of the hepatoduodenal ligament is left 
alone as is usually done with the caudate lobe. Lastly all 
common methods of portal vein reconstruction have an unavoid-
able all-or-nothing character as a successful outcome of these 
reconstructions cannot be predicted once a wide resection of 
the portal vein is performed. 
6.3. Outline of a radical block resection 
A study was initiated to investigate the practibility of a 
resection that would meet the oncologic requisites (page 73). 
For this purpose 40 normal, adult cadaver livers were anatomic-
ally explored. It soon became clear that the reconstructive 
possibilities of the left lobe were such that the tumour area 
together with the right lobe, caudate lobe and complete hepa-
toduodenal ligament could be removed at a distance of at least 
4 cm from the hepatic duct confluence. 
The confluence of the hepatic ducts lies in the right corner 
of the porta hepatis. Therefore the plane of a radical resec-
tion can virtually follow the umbilical fissure on a good 4 cm 
distance from the confluence with preservation of the 'sub-
hilus' of the left lobe. The left hepatic duct can be cut at 
this level. The collapsed umbilical vein in the ligamentum 
teres enters the end of the umbilical part of the left portal 
vein (recessus of Rex) and can be reopened to a width virtual-
ly equal to that of the left portal vein branch. The reopened 
umbilical vein forms a good access to the hepatic portal sys-
tem at the outermost left corner of the porta hepatis just 
outside the plane of resection. The hepatic artery branch to 
the left lobe runs in the last 2 cm of its extrahepatic course 
just beside the edge of the left lobe. This part of the artery 
can be preserved and provides an arterial remnant sufficient 
for re-anastomosis. In the 22% of patients in whom the main 
arterial branch to the left lobe arises from the left gastric 
artery (397) no reconstruction may be necessary at all. 
The portal, arterial and biliary reconstructions can all be 
performed in different areas without mutual interference. 
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The space available for reconstruction of the hepaticojejuno-
stomy at the umbilical fissure is not impeded by a recon-
structed accompanying portal vein branch just beside it. The 
bile duct of segment III can also be used for biliary draina-
ge. In that case the accompanying portal vein branch of seg-
ment III has to be preserved when dissecting the bile duct. 
Irreversibility of the procedure can be avoided by the re-
construction of a separate blood supply to the left lobe 
prior to the actual radical block resection which is proposed 
as follows: 
The reopened umbilical vein is anastomosed end-to side with 
the central part of the splenic vein (^ igs. 10 and 11). Then 
the portal blood reaches the complete liver by 
1^  the portal vein itself and 2^  by the paraportal bypass form-
ed by the conduit of the splenic vein - umbilical vein - re-
cessus of Rex. The function of the bypass is judged by clamp-
ing of the portal vein, as at that time all the portal blood 
is diverted through the umbilical bypass to the liver. The 
procedure has to be abandoned when the bypass does not func-
tion, in that case all other modalities of treatment still re-
main available. 
Prior to the transection of the portal vein arterial recon-
struction of the left lobe should preferably be performed. 
The last part of the extrahepatic tract of the left hepatic 
artery is dissected and cut close to its entrance into the 
left lobe. If the common hepatic artery and the first centi-
metres of the gastroduodenal artery can be saved without seri-
ously violating the radical intention of resection, such a 
gastroduodenal artery remnant provides the ideal large vessel 
for reconstruction of the left lobe. This depends on the indi-
vidual anatomy but as a rule the artery together with the 
para-arterial lymph nodes will have to be included in the re-
section, in which case the splenic artery is the only direct 
alternative. As the size of the splenic artery resembles that 
of the hepatic artery, the most adequate and simple recon-
struction probably consists in peripheral transection follow-
ed by an anastomosis of the transposed splenic artery with the 
left hepatic artery branch (Fig. 12). Interposition of a 
saphenous vein graft between the base of the common hepatic 
artery and the left hepatic artery or use of a transposed gas-
tro-epiploic artery can be good alternatives and can moreover 
save the arterial supply of the spleen. 
If both the umbilical bypass and the separate arterial cir-
culation to the left lobe function properly, the left portal 
vein branch is cut and closed at the base of the umbilical 
fissure just before the transition in the recessus of Rex. 
When this is done both the right and left hepatic lobes each 
have their own separate afferent blood supply (Fig. 13). 
Still radical resection can be abandoned and other methods 
of treatment can be applied. The haemodynamic situation to be 
expected after resection is imitated by clamping of the bases 
of the portal vein and the hepatic artery. In the same way 
afferent vascular isolation is achieved of the area to be re-
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confluence of hepatic ducts 
with tumour 
d. hepaticus comm. 
right liver lobe 
-d.hepaticus sin. 
• left branch of v.portae 
-left branch of a.hepática 
.left liver lobe 
recessus of Rex 
gallbladder 
a gastro-duodenalis-
v.mesenterica sup. 
v. portae 
lig teres 
a lienalis 
v. lienalis 
a. hepática comm. 
Fig. 10. The anatomy of the hepatoduodenal ligament and the 
porta hepatis with cancer of the hepatic duct con-
fluence. 
sected. Up to that moment the portal blood supply has not been 
interrupted to any part of the liver and the arterial ischae-
mia of the left lobe is restricted to the oeriod needed for 
the reconstruction of the arterial diversion. 
After creation of an independent afferent blood supply to 
the left lobe, the bases of the portal vein and the hepatic 
artery are cut. Then resection of the complete hepatoduodenal 
ligament and the right lobe virtually flush with the umbilical 
scissure are performed in a partiallv bloodless field (Fig. 
14). This vascular isolation does not cover the portal branch-
es to the left side of the quadrate lobe,which sprout from the 
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left branch of v. portae 
recessus of Rex 
para-portal 
umbilical bypass 
v. l i e n a l i s 
Fig. 11. The collapsed umbilical vein in the ligamentura 
teres has been reopened and anastomosed end-
to-side with the central part of the splenic 
vein. The portal blood has a double inflow tract 
to the liver. 
recessus of Rex, and the retro- and supraheoatic venous circu-
lation. Bile drainage can be reconstructed in the usual way 
with a hepaticojejunostomy between the remnant of the left he-
patic duct beside the base of the recessus of Rex and a Roux-
Y jejunal limb. The final result is comparable with the situa-
tion after standard right lobectomy and bilio-enteric recon-
struction. 
Apart from treatment of a tumour of the hepatic duct conflu-
ence, the described procedure may also be used for primary or 
secondary liver tumours in the hilus, gallbladder and for 
Echinococcus alveolaris cysts that involve the heoatoduodenal 
ligament. The paraportal umbilical bypass without a concomi-
tant liver resection may be useful in the treatment of lacera-
tions of the portal vein (382), arteriovenous fistulae (389, 
580), isolated portal vein thrombosis or cancers of the com-
mon bile ducts. 
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arterial branch 
to left lobe 
transposed a lienalis 
para-portal 
umbilical bypass 
Fig . 12. Double p o r t a l inflow to the l i v e r and transposed 
a r t e r i a l supply to the l e f t lobe. 
transected 
left branch of v. portae 
arterial diversion 
of left lobe 
transposed a. lienalis 
para-portal 
umbilical bypass 
ν l ienal i s 
Fig. 13. Right and left liver lobes each have their own 
separate afferent blood supply. 
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bile duct for 
hepaticojejunostomy 
arterial diversion 
of left lobe 
para-portal 
umbilical bypass 
plane of resect ion 
Fig. 14. Proposed radical block resection of a cancer of 
the hepatic duct confluence after orevious con-
struction of a complete and independent afferent 
vascularisation of the left lobe. 
6.4. The umbilical vein 
In the foetus the placental blood is conducted by the umbili-
cal vein and ductus venosus Arantii through the liver to the 
inferior cavai vein and the heart (326, 502). Nearly always 
the umbilical vein enters the portal system at the end of the 
left portal vein branch, rarely a transition is seen into the 
portal vein bifurcation or the right branch (305) . During the 
first postnatal months the lumen of the umbilical vein reduces 
by proliferation of subintimai connective tissue and finally 
the vessel is closed (99) , but the endothelium and surrounding 
musculo-elastic zone remain intact throughout life. Therefore 
the lumen of the umbilical vein can be reopened and dilated at 
any age for access to the portal system (26, 70, 81, 82, 99, 
607, 608). 
The vein runs from the umbilicus in cranial direction just 
dorsal to the right side of the linea alba. Halfway between 
the umbilicus and xiphoid process the collapsed vessel bends 
and continues in the ligamentum teres to the blind end of the 
recessus of Rex in the umbilical fissure of the liver. The 
intraperitoneal stretch of the umbilical vein measures 12 cm 
(range 8.5 to 20 cm) and has no side branches or valves. 
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Its microscopic structure is similar to that of other veins 
(81). At the umbilico-portal junction the tunicae mediae and 
adventitiae of both vessels merge into each other but the 
lumen is obstructed by a well defined, 1 cm wide fibrocolla-
genous plug, which may be a remnant of an umbilico-portal val-
ve. In 95 to 97% of postmortem specimens, the lumen of the 
vein and the umbilico-portal junction can be reopened and di-
lated instrumentally to a diameter of 5 to 8 mm without false 
passage (26, 40, 81). A pressure over 60 mm Hg opens the lu-
men as well,except at the umbilico-portal junction which re-
mains closed even after exposure to a pressure of 300 mm Hq 
(81). 
In vivo the umbilico-portal junction can become as wide as 
the portal vein under influence of a chronic portal hyperten-
sion, as is the case in liver cirrhosis and Cruveilhier-
Baumgarten syndrome (346) . In general an open umbilical vein 
carries the portal blood away from the liver but in 9% of the 
cases the open umbilical vein serves as an inflow tract (92). 
The technique of external dilatation of the umbilical vein 
to gain access to the portal vein for diagnostic or therapeu-
tic purposes is described in detail ( 26, 70, 82, 94, 132, 
336, 337, 598, 610, 611). Usually the vein is entered at the 
upper end of its extraperitoneal course and is dilated with 
Bakes' dilators. Although at that level the lumen is smaller 
than in the intraperitoneal part of the vein the carmulation 
is successful in 90 to 95% of the patients (306, 338, 611). 
This procedure is applied for direct hepatoportography (232, 
237, 305, 337, 598, 611), for investigations on selective 
pressure, flow and metabolism of the portal system (610), for 
the administration of chemotherapeutics (305, 536, 543, 598) 
or antibiotics (447) and for temporary portal decompression 
(607) . For portal decompression an open umbilical vein can be 
anastomosed with a systemic vein (345, 347, 447, 598), although 
such a shunt is only incidentally reported to be successful on 
the long term (576) . The umbilical vein is anastomosed with 
various arteries to arterialise the intrahepatic portal system 
(1, 2, 96, 202), while for liver transplantation the umbilical 
vein has been proposed as inflow tract for the portal blood 
(155). 
Conclusion 
According to literature in about 95% of cases, the umbilical 
vein can probably be opened and anastomosed with another vein 
of the extrahepatic portal system. Even if construction of 
such an alternative connection between the intra- and extra-
hepatic portal systems is technically feasible, it remains 
uncertain whether it can properly take over the function of 
the portal vein. 
6.5. Access to the base of the portal vein and the central 
parts of the splenic vein 
The base of the portal vein and the posterior pancreatoduo-
denal nodes are reached by mobilisation of the right colon 
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flexure and dissection of the avascular plane between the 
right kidney, right adrenal gland, inferior cavai vein and 
aorta at the dorsal side and duodenum, head of the pancreas, 
mesenteric root and superior mesenteric vessels at the ventral 
side, the so-called 'extended Kocher manoeuvre' (98, 130, 327, 
415, 444). The central part of the splenic vein is exposed at 
its cranial side by incision of the peritoneum at the base of 
the lesser sac along the cranial margin of the pancreas. 
Apart from the splenic vein and the portal confluence, the 
plane between pancreas and posterior abdominal wall is almost 
avascular. The splenic artery and the splenic vein are brought 
into view by pulling the pancreas in a caudal direction. 
Many small, short veins enter the splenic vein from the pos­
terior side of the pancreas, so dissection of the splenic vein 
should be confined to an area at its cranial side necessary 
for the lateral anastomosis with the umbilical vein. Full dis­
section of the splenic vein from the left side of the pancreas 
is required if transposition of this vein to the liver is 
wanted in case the umbilical vein is too short or not avail­
able. To that end mobilisation of tail and body of the pan­
creas is the best approach after distal transection of the 
splenic vein (47, 134). 
6.6. Vascular isolation 
Radical resection as outlined in paragraph 3 of this Chapter 
is already facilitated by selective afferent isolation of the 
area to be resected. The risk of bleeding and air embolism 
during the retro- and suprahepatic phases of resection can be 
reduced by a total vascular isolation of the liver. To that 
end occlusion of the hepatic veins or the retrohepatic cavai 
segment must be added to the afferent vascular isolation. 
Suprarenal and suprahepatic clamping of the inferior cavai 
yejη have serious haemodynamic consequences in patients with­
out a collateral circulation (428) and should not exceed 30 
minutes (182) . The circulatory load is diminished by simul­
taneous clamping of the aorta just above the coeliac trunk 
(21, 204, 248, 250, 278, 428, 620) or by an endocaval shunt. 
Only subhepatic insertion of an endocaval shunt, either supra-
renally (89, 125, 136, 182, 568, 620) or via the femoral vein 
(163, 249, 551, 552) has to be considered, as the operation 
can probably be carried out by laparotomy only. 
Suprahepatic control of the inferior cavai vein can be 
performed just above or just below the diaphragm. In the 
rather simple supradiaphragmatic approach the inferior cavai 
vein is intrapericardially encircled via a small incision in 
diaphragm and pericardium (248, 250, 391, 620). Subdiaphrag­
matic control is more difficult but has the advantaqe to 
exclude the phrenic veins. Almost 2 cm of the inferior cavai 
РІП can be dissected by careful dissection of the loose fi­
brous tissue around the inferior cavai vein between the liver 
and the diaphragmatic orifice (276, 329). 
Livers of dogs and pigs can stand a normothermic ischaemia 
of at least 45 minutes without serious consequences, provided 
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adequate splanchnic decompression is taken care of (324, 367, 
368, 375, 422, 540, 585). Normothermic ischaemic periods of 
one hour are tolerated by the human liver without danger and 
do not interfere with the regenerative capacity (136, 160, 281, 
283, 578, 593) . Therefore the safe period of normothermic 
ischaemia of the human liver can now be fixed on 45 minutes 
(183, 282), ten years ago this was still believed to be 30 
minutes (49, 86). Irrigation of the peritoneal cavity with a 
cold solution of normal saline prolongs this period (382) but 
no liver resection needs to last any longer (197,204,248, 358, 
551) . 
The described methods of vascular isolation may be useful 
during extensive liver resections and vascular reconstructions, 
but for prevention of thrombosis in the reooened umbilical 
vein a strong and continuing perfusion through the umbilical 
bypass is essential. Resection of the caudate lobe will be 
alleviated when the portal vein is cut and deviated upwards. 
One of the advantages of a previously constructed portal vein 
diversion is the very possibility to cut and dissect the por-
tal vein quietly. Consequently, during resection of the cau-
date lobe the umbilical bypass should be functioning which 
requires an uninterrupted venous outflow of the left lobe. 
Therefore, other methods should be aoplied for retro- and 
suptrahepatic venous control, if necessary. 
The following procedures can be considered: 
- simple, brief clamping of the suprarenal cavai vein, in con-
junction with positive pressure ventilation; 
- use of an endocaval balloon shunt, placed in such a position 
that the inflated balloon selectively blocks the outlets of 
the hepatic veins to be cut (163, 380, 448); 
- subtotal isolation of the retrohepatic cavai vein as descri-
bed by Raia and Huguet (276). In this method the outlets of 
the suprahepatic veins into the inferior cavai vein are dis-
sected until the right and middle suprahepatic veins and the 
inferior cavai vein can be encircled together just below the 
outlet of the left suprahepatic vein.By pulling the encircling 
loop the suprahepatic cavai vein and the main venous outflow 
tracts of the right liver lobe are blocked, while the venous 
outflow of the left lobe remains unhampered. 
Clamping of the subhepatic cavai vein completes the required 
subtotal isolation of the retrohepatic cavai segment. The 
method may be hazardous but has been successfully employed 
(276) . Its main disadvantage is the bad tolerance of supra-
renal clamping of the inferior cavai vein by patients without 
a paracaval collateral circulation. This drawback can be met by 
combining the method with the insertion of an endocaval shunt. 
The application of the endocaval balloon shunt may be the 
most suitable method, as it stretches and presents the cavai 
segments to be spared. 
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7. Anatomical investigation into the feasibility of a 
radical block resection 
An anatomical study was carried out to investigate the possi-
bilities of a radical block resection. At autopsy, of 40 
adult patients who had died from other causes than liver or 
bile duct diseases, the liver was taken out together with the 
ligamenta teres and falciforme, part of the diaphragm, retro-
hepatic cavai vein, complete hepatoduodenal ligament with 
gallbladder, arterial coeliac trunk, stomach antrum, pylorus, 
duodenum and head of the pancreas with the adjacent central 
splenic vein and superior mesenteric vein (F.B.Bronkhorst, 
pathologist). The specimens were dissected. 
Soon, during dissection of the fifth specimen, the possibi-
lity became clear to use the umbilical vein, so that in the 
next 35 dissections the umbilical vein was reopened and the 
described radical block resection performed, leaving the 
left lobe with the inferior cavai vein, umbilical vein and 
left hepatic artery stump. In five cases the umbilical vein 
was anastomosed end-to-side with the central splenic vein. 
The hepatoduodenal ligament and the porta hepatis were par-
tially or completely dissected to assess the mutual relation 
between vessels and bile ducts and to find the place where the 
structures to the segments of the left lobe took off. In this 
context the words'left' and 'right' indicate the left and 
right side of the patient with the liver in situ. The diameter 
of the vessels was approximately determined by stretching the 
lumen over the same inserted forceps. The distance between the 
forceps blades was measured and the area and diameter of the 
cross section of the lumen calculated. In some cases porto-
grams, arteriograms, venograms or cholangiograms were made. 
Initially GRF-glue was applicated to prevent the leaking of 
contrast medium through the cut edge of the liver remnant (71, 
278) but later on this was abandoned as the glue did not stick 
properly to the cold postmortem specimen, and no leakage was 
seen through the avascular umbilical scissure. 
7.1. The paraportal umbilical bypass 
Reopening of the umbilical vein was preceded by cutting the 
parenchymatous bridge which often connects segments III and IV. 
In this way the recessus of Rex was exposed, covered only with 
the left offshoot of the hilar plate and with the peritoneum. 
The ligamentum teres was freed from the rest of the falciform 
ligament and the anterior edge of the liver. By opening the 
upturning fold of loose fibrous tissue between the ligamentum 
teres and the umbilical fissure, another 1 to 2 cm could be 
gained. 
The umbilical end of the now completely mobilised ligament 
was freshly transected. The collapsed umbilical vein was visi-
ble as a little white strand. By pulling the sides of this 
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Strand with two vascular forcepses an intima-lined lumen was 
found, in which a closed, moistened oair of slender, blunt 
scissors could be inserted. Spreading of the scissors opened 
the lumen. While withdrawing the scissors were closed and 
after moistening they were re-inserted and spread on a some-
what deeper level perpendicularly to the former dilatation, 
and so on. The delicate vein walls easily gave way. The proce-
dure had to be carried out cautiously and with careful identi-
fication of the lumen to prevent intimai damage or perforation. 
At the transition into the recessus of Rex there was more 
resistance to the dilating scissors. By carefully proceeding 
step-by-step the umbilico-portal junction could be penetrated 
easily which was indicated by the appearance of blood in the 
umbilical vein and by a sudden lack of resistance to the in-
trusion of the scissors. Opening of the scissors in all di-
rections somewhat more vigorously than before resulted in an 
equal dilatation of the junction. To prevent a false passage 
at this level, it was important to keep the ligamentum teres 
stretched in a direct line with the recessus of Rex, which in 
vivo runs almost anteroposteriorly. The spreading of the scis-
sors in the depth of the vein could be facilitated by wrink-
ling the distal portion of the ligamentum teres somewhat down 
over the inserted scissors. 
The procedure could easily be performed in about ten minutes. 
A careful and atraumatic technique is essential since the 
feasibility of the proposed resection virtually depends on the 
outcome of this dilatation. 
In all 40 livers the umbilical vein joined the left portal 
vein branch at the end of the recessus of Rex. In 32 of the 35 
specimens (91%) the umbilical vein could be reooened and the 
left portal vein easily be reached (Fig. 15). Three times a 
false passage was made at the umbilico-portal junction. During 
the dilatation of these junctions, the ligamentum teres was 
held angled to the recessus of Rex. A reopened umbilical vein 
with a mean length of 10 cm could be obtained, in 16 of the 17 
specimens with a ligamentum teres that had been cut close to 
the abdominal wall during autopsy. The distance between the 
umbilico-portal junction and the splenic vein was 7 to 8 cm 
if measured at the central side and decreased to about 6 cm if 
measured at levels more upstream the splenic vein. The avail-
able length of the umbilical vein was ample sufficient to 
bridge this distance. Once a usable lumen could be found only 
in the last 4 cm before the umbilico-portal junction. The mean 
diameter of the umbilical vein was 8.9 mm but decreased at 
the umbilico-portal junction to 7.7 mm. As the mean diameter of 
the left portal vein branch, just before the beginning of the 
recessus of Rex, was 8.2 mm this means that the umbilical vein 
is virtually as wide as the left portal vein branch (Table XXXI). 
After longitudinal cutting of the umbilico-portal junction 
two or three saccular dilatations were vaguely seen, resem-
bling valve rests. In the junction the intima lining was in-
terrupted circularly for a distance of 2 to 3 mm, but both 
vessels clearly shaded off each other macro- as well as micro-
scopically (Fig. 16). 
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Table XXXI. Lengths {in cm) and mean diameter (in mm) of a number of 
portal vessels measured in normal postmortem specimens. 
Portal vessels length/diameter no. of specimens 
length 
portal vein 
umbilical vein 
diameter 
portal vein 
left portal vein branch 
central splenic vein 
umbilical vein 
umbilico-portal junction 
mean 6.8 (range 6 to 9) 
mean 10.3 (range >6 to >13) 
mean 10.2 (range 8.4 to 11.0) 
mean 8.2 (range 7.3 to 9.0) 
mean 7.9 (range 6.7 to 9.4) 
mean 8.9 (range 7.3 to 9.9) 
mean 7.7 (range 6.7 to 8.7) 
9 
16 
14 
14 
10 
13 
21 
Fig. 15. Portogram of a postrnortem liver made via the 
reopened umbilical \7ein, showing equal distribu-
tion of the contrast material over the complete 
hepatic portal system. The portal vein has been 
clamped just upstream of its bifurcation, indica-
ted by forceps. 
8 9 
Transitional zone between a branch of the portal 
vein or the recessus of Rex (left) and the umbi­
lical vein (right)· A in the vicinity of the 
portal vein hepatic tissue can be recognized 
(lower left portion of the field), continuity can 
be seen between the different coats of both veins; 
В Reduplication of the lining membrane or valve­
like structure protrudes within the lumen ( > ) , 
part of the liver is visible in the lower left 
portion of the field (El.van Oieson, x36). 
After assessment of the required length of the bypass, the 
ligamentum teres was transected obliquely and the last centi-
metre of the umbilical vein was carefully freed of surrounding 
fat. A Satinsky clamp was placed laterally on the splenic vein 
and an end-to-side anastomosis was made between the umbilical 
and the splenic vein with a running Prolene(R) 5x0 suture for 
the posterior side and with interrupted stitches for the ante-
rior side (Figs. 11 and 17). 
7.2. The left liver lobe and its subhilus 
Portal system 
When the left corner of the porta hepatis was dissected, the 
transition of the left portal vein branch into the recessus of 
Rex was the first structure encountered after opening of the 
peritoneum and the hilar plate. The artery to the left lobe was 
situated at some distance to the left of the left portal vein 
branch. At the level of the umbilical vein the left hepatic 
duct or its main branches were in cranial oosition to the 
portal vein branch. 
As the loose perivascular tissue provided a well dissectable 
plane, cautious encirclement of the vein at this level could 
be performed with a dissecting forceos. This dissection should 
be done carefully as a tear in the vein on this Doorly access-
ible place will present major problems. Two slender vascular 
clamps were placed in anteroposterior direction and the vein 
was transected, leaving outside the clamps cuffs of vessel wall 
just long enough to warrant a closure by vascular sutures. The 
level of this transection was at a mean distance of 4 cm from 
the portal vein bifurcation (Table XXXII). Portograms made 
after completion of the resection via the reopened umbilical 
vein, showed complete filling of the portal system of the left 
lobe (Fig. 18). 
Arterial system 
The proper hepatic artery usually divided about halfway the 
hepatoduodenal ligament. The last part of the arterial branch 
to the left lobe had a diameter of about 2.5 mm and ran at 
some distance caudally to the left portal vein branch and rat-
her superficially in the hepatoduodenal ligament or lesser 
omentum. It entered the left lobe dorsallv to the base of 
the recessus of Rex. In three of the 13 examined specimens the 
artery divided before entering the left lobe (Table XXXII). 
Arteriograms made via the arterial stunro showed complete 
filling of the arterial tree of the left lobe (Fig. 18). 
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Table XXXII. Data on the anatomy of the vascular and biliary structures of 
the subhllus of the left liver lobe in the umbilical fissure. 
(number of examined specimens in brackets) . 
mean distance between portal vein bifurcation and 
transection margin of left portal vein branch (14) 
mean distance between confluence of the 
hepatic ducts and transection margin of left 
hepatic duct(s) (13) 
minimal mean length of left hepatic duct ( S) 
position of confluence of segmental ducts (15) 
II and III in relation to the 
umbilical fissure 
position of the left hepatic duct(s) in (14) 
relation to the left portal vein branch in 
the umbilical fissure 
position of the bifurcation of the segmental (13) 
arteries II and III in relation to the 
umbilical fissure 
position of the left lobe artery (branches) (11) 
in relation to the base of the 
recessus of Rex 
Biliary system 
When followed upstream, the left hepatic duct shifted 
gradually from a position anterior to the left portal vein to 
a cranial position. At the umbilical fissure the duct was 
cranial to the vein and the base oí the recessus of Rex. 
The confluence of the bile ducts of segments II and III was 
situated at the right side of the umbilical fissure in six of 
15 examined specimens (40%) (Table XXXII). In vivo a patient 
with such a late secondary confluence will require two separa-
te biliodigestive anastomoses after transection of the liver 
in the proposed way. 
When the left portal vein branch had been divided the hepa-
tic duct(s) to the left lobe was (were) encountered. No proper 
dissectable plane existed between the duct and the strongly 
adherent liver capsule posterior to the duct. However, it was 
simple to encircle the duct by penetrating the capsule or to 
transect directly the duct and the adjacent caosuìe with a 
knife. The mean distance between the transection level of the 
duct and the main confluence was over 4 cm (Tabel XXXII). 
Cholangiograms made via the remnant of the left hepatic duct 
showed complete filling of the biliary tree of the left lobe 
(Fig. 18). 
Parenchymatous transection and suprahepatic venous control 
After transection of the left branches of the portal vein, 
hepatic artery and hepatic duct, the parenchymatous part of 
right lobectomy was carried out just to the right side of the 
umbilical scissure. The portal branches from the recessus of 
Rex to segment IV were carefully dealt with since in practice 
4.1 cm (range 3.5 to 5 cm) 
4.3 cm (range 3 to 5 cm) 
3.4 cm (range 1 to >5 cm) 
6 times to the right 
9 times to the left 
cranial 
duct II dorsal 
duct III cranial 
3 times to the right 
10 times to the left 
dorsal 
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g. 17. Postmortem liver: A. reopened umbilical vein, 
anastomosed end-to-side with the central splenic 
vein; È. bile duct and hepatic artery have been 
turned upwards to show the portal vein and the 
paraportal umbilical bypass (see also Fig. 11); 
С. portal vein transected. 
ah = a.hepática b= bile duct 
vci= v.cava inf. vl= v.lienalis 
vras= v.mesent.sup. vp= v.portae 
vu = v.umbilicalis 
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these will be the only perfused afferent vessels to the area 
to be resected. The largest of these branches had a mean dia­
meter of б mm (range 5 to 8 mm) (6 specimens) and could be 
transected at 1 cm distance from the recessus. 
Both the middle suprahepatic vein,entering the inferior 
cavai vein or the left hepatic vein, and the huge right supra-
hepatic vein were divided at intrahepatic level, which in 
practice is safer than extrahepatic control (66, 197, 284, 
528) and moreover guarantees an undamaged left suprahepatic 
vein (4). Venograms made via the orifice of the left supra­
hepatic vein showed complete filling of the venous suprahe­
patic tree of the left lobe (Fig. 18). 
In the specimens, resection of the caudate lobe could not 
be performed properly. The lobe was situated at the cranio-
dorsal side of the rest of the liver, anterior to and parti­
ally around the left side of the inferior cavai vein. 
In some specimens the lobe even lay near to the caudodorsal 
side of the left suprahepatic vein. As the lobe was so closely 
related to the dead, flaccid inferior cavai vein an intrapa-
renchymatous resection was mostly performed, leaving a cuff of 
liver tissue on the vein. Proper assistance is indispensable 
for this resection, and an endocaval balloon that stretches 
and presents the inferior cavai vein will be helpful. 
The mean weight of the left lobe was 330 gram (range 145 to 
730 gram) which was 22% (range 11 to 33%) of the complete 
liver (mean weight 1500 gram; range 1000 to 2850), 28 spec. 
By the end of dissection and resection the remaining speci­
men consisted of the left hepatic lobe with its suprahepatic 
venous outflow tract to the retrohepatic cavai vein undistur­
bed, its portal inflow tract displaced to the reopened umbi­
lical vein, its hepatic duct ending in the umbilical fissure 
and its artery cut 2 cm from there (Fig. 19) . The plain of 
resection remained at least 4 cm from the hepatic duct con­
fluence. Angiograms showed that the left lobe was supplied 
completely via the remaining structures and that no other af­
ferent or efferent channels existed. 
7.3. Conclusion 
From the results of postmortem investigations can be concluded 
that after construction of a complete and separate afferent 
blood supply of the left lobe, radical block resection of the 
area of the hepatic duct confluence, the right liver lobe and 
the complete hepatoduodenal ligament is possible both anato­
mically and technically. No indications could be found to deny 
the supposition that the result of such a procedure is func­
tionally equal to a standard right lobectomv with bilio-enteric 
reconstruction. 
Nevertheless the capacity of the paraportal umbilical bypass 
in action is as yet unknown. An animal experiment to investi­
gate the efficacy of a paraportal bypass and its application 
together with arterial revascularisation and liver resection 
was carried out and will be described in Chapter 8. 
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Postmortem left liver lobe: A. portogram 
(injection of contrast fluid into the re-opened 
umbilical vein); B.arteriogram (injection of 
contrast fluid into the arterial remnant to the 
left lobe); C. venogram (injection of contrast 
fluid into tïïe cavai orifice of the left supra-
hepatic vein); D. cholangiogram (injection of 
contrast fluid into the left hepatic remnant at 
the umbilical fissure). 
Fig. 19. A. Left liver lobe with access to portal venous 
system via reopened umbilical vein (forceps in­
serted), and with left arterial remnant. The left 
hepatic duct has been cut flush with the paren­
chyma; в· result after reconstruction of a para-
portal umbilical bypass and radical resection of 
right liver lobe, caudate lobe and the ligamentum 
hepatoduodenale in a postmortem specimen (see 
also Fig. 14). 
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8. Transfer of the afferent hepatic blood supply and 
hemihepatectomy in the dog 
Although the operation proposed is theoretically, anatomically 
and technically feasible, the practical value has to be proven 
in vivo. Right lobectomy with bilio-enteric reconstruction is 
an established procedure and transplantation surgery has de-
monstrated that all structures which enter and leave the liver 
can be transected and reconstructed both in animals and in 
man. The only new element is the reconstruction of a second 
portal inflow tract to the liver which allows subsequent tran-
section or resection of the portal vein. Therefore an investi-
gation was necessary especially into the action of a parapor-
tal bypass and into the results of partial hepatectomy with 
transposition of the portal and arterial blood supply to the 
liver remnant. 
The best results of such an investigation would be obtained 
by performing the same operations in animals as proposed in 
men, but unfortunately no proper umbilical vein could be found 
in the common laboratory animals. The only remnant of the um-
bilical vein in cadavers of pigs, dogs, goats, sheep, rabbits 
and monkeys consisted of a small, fibrotic strand without a 
lumen between the left and right liver lobes. Two alternative 
options remained to bypass the portal vein, namely 1. inter-
position of an autologous vein graft between the splenic vein 
and a portal branch beyond the portal bifurcation, and 2 trans-
position of the splenic vein to such a portal branch. The lat-
ter procedure was chosen for being the simplest of the two. 
After a pilot study and postmortem investigations in various 
animals, a protocol was set up. For lack of the human umbili-
cal access to the hepatic portal system, a different but com-
parable approach had to be found in the animal. Still this 
approach had to provide the possibility that the paraportal by-
pass could be constructed prior to transection of the portal 
vein and without interruption of the portal blood supply to the 
liver part that would remain after partial hepatectomy. The dog 
was found to be the most suitable animal as the liver lobes 
are divided by deep fissures and the portal vessels are 
large enough to enable macroscopic surgery. Apart from the 
caudate lobe, all six lobes each have a subhilus, situated at 
the bottom of these fissures. The dissection of the splenic 
vein is facilitated by the intraperitoneal position of pan-
creas and duodenum. Lastly the dog is very sensitive to portal 
hypertension (10, 129, 209, 459), and so a portal procedure 
successful in the dog could be expected to be successful in 
man as well. 
8.1. Outline of the operation 
In dog cadavers, access to the hepatic portal system could be 
obtained by dissection of the portal branch of a liver lobe up 
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quadrate lobe 
left- medial lobe 
Fig. 20. Anatomy of the liver and its afferent supply in 
the dog. 
into the liver tissue. After transection of this vessel at an 
intrahepatic level, the part at the central side could be 
anastomosed end-to-end with the distal end of the mobilised 
splenic vein. After clamping the portal vein the Oortal blood 
was diversed through the transposed snlenic vein and the ana-
stomosis into the dissected portal vein branch and from there 
on to the liver hilus and the rest of the liver (Figs. 20-23) 
Since extended liver resections are already recognised 
operations in man a 50% hemihepatectomy was opted for, to de-
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Fig. 21. Situation after dissection of the portal vein 
branch to the left lateral lobe, left hemihepa-
tectomy and dissection of the splenic vein. 
crease the risks of animals dying from the mere resection, 
The portal vein branch to the left lateral lobe was used for 
the paraportal bypass being the largest portal branch avail-
able in dogs. Consequently a left hemihepatectomy was per-
formed in this animal experiment (instead of right lobectomy 
as proposed in Chapter 6), leaving the right hemi-liver in 
situ. After transection of the portal vein the right liver 
remnant was supplied with portal blood by the splenoportal 
bypass alone. The required procedure of partial hepatectomy 
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Fig. 22. Left heniihepatectomy and paraportal bypass, 
constructed by end-to-ond anastomosis between the 
mobilised splenic vein and the dissected portal 
vein branch to the left lateral liver lobe. 
The retained right hemi-liver has a double portal 
inflow tract. 
with diversion of the entire afferent blood suoply was comple-
ted by transposition of the distal part of the hepatic artery 
to the central part of the splenic artery (Fig. 24). 
8.2. Operations performed 
In 23 dogs (Beagle, weight 8 to 15 kg), 46 operations were 
carried out. Anaesthesia was induced by sodium pentothal i.v. 
and maintained by a mixture of NjO/C^/ethrane, administered 
by a closed ventilation system after endotracheal intubation. 
During the procedure arterial and portal pressure, ECG and 
rectal temperature were monitored, angiography of the portal 
system performed and a liver biopsy taken. The dogs were 
placed supine on a heated mat and received up to 1000 ml 
sodium-glucose solution during operation. Autopsies were per-
formed in all animals and the portal and arterial anastomoses 
were microscopically examined as were the liver specimens. 
No blood transfusion or other treatment was administered. 
In 15 dogs a left hemihepatectomy, construction of a para-
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Fig. 23. Left hemihepatectomy, construction of a para-
portal bypass and transection of the portal vein. 
The portal vein is transected if the paraportal 
bypass appears to function properly. 
portal bypass and subsequent transection of the portal vein 
were performed four died shortly after the operation. After 
four to six weeks the remaining 11 dogs underwent reopera-
tion, in eight a hepatic artery diversion was performed. 
After another four to six weeks these animals were operated 
and subsequently sacrificed, except for one dog that under-
went arterial transfer at that time. 
In six dogs left hemihepatectomy, portal and arterial di-
version were done in one session. All died. In two dogs left 
hemihepatectomy was combined with arterial transfer only, in 
one in a single session and in the second arterial diversion 
was carried out four weeks after liver resection. These two 
animals underwent reoperation and were subsequently sacrifi-
ced four weeks after arterial transfer. 
Four to six weeks after reconstruction, the paraportal by-
pass was examined in 10 dogs and in nine of this series 
again after another six weeks. The arterial diversion could 
be examined four to six weeks after being laid out in nine 
dogs. 
In six dogs, a biliary diversion by way of an anastomosis 
between the gallbladder and a Roux-Y jejunal limb was added 
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portal bypass 
-a. lienaÌis 
(central part) 
a hepática 
(central part) 
a. hepática 
(peripheral part) 
Fig. 24. Left hemihepatectomy with diversion of the 
afferent blood supply to the retained right hemi-
liver in the dog. The portal vein has been re-
placed by a peripheral splenoportal bypass and 
the hepatic artery has been transected and re-
anastomosed with the splenic artery. 
to the hepatectomy and vascular diversion. Later on this was 
abandoned as being irrelevant for this study (Table XXXIII). 
8.3. Hemihepatectomy and paraportal bypass (21 dogs) 
Procedure 
A left' hemihepatectomy and construct 
were performed in 21 dogs. After med 
(internal diameter 1.3 mm) was inser 
and guided into the portal vein. The 
corded and an arteriogram was made о 
intrahepatic branches (Figs. 20 and 
encircled and the left hepatic lobes 
tal vein branch to the left lateral 
dissected from the surrounding liver 
clamped at its base and transected a 
ble. This provided a 1 to 2 cm long 
hepatic portal vein branch with a di 
for an anastomosis. A standard 50% 1 
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ion of a paraportal bypass 
ian laparotomy a catheter 
ted in a mesenteric vein 
portal pressure was re-
f the portal vein and its 
25). The portal vein was 
mobilised. Then the por-
lobe was scrupulously 
parenchyma, carefully 
s far distally as possi-
remnant of a prior intra-
ameter of 5 mm, suitable 
eft hemihepatectomy (509) 
Table XXXIII. Operations performed in dogs: left hemihepatectomy (h), 
construction of paraportal bypass and transection of portal 
vein (ρ), construction of arterial diversion (a), construc­
tion of biliary diversion (c). 
Dog no. first operation second operation third operation 
4-6 weeks after 1st 4-6 weeks after 2nd 
sacrifice after laparotomy 
sacrifice after laoarotomy 
sacrifice after laparotomy 
1 
2 
3 
4 
5 
6 
7 
β 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
h 
h 
h 
h 
h 
h 
h 
h 
h 
h 
h 
h 
h 
h 
h 
h 
h 
h 
h 
h 
h 
h 
h 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
Ρ 
Ρ 
Ρ 
Ρ 
Ρ 
Ρ 
Ρ 
Ρ 
Ρ 
Ρ 
Ρ 
Ρ 
Ρ 
a 
a 
Ρ 
Ρ 
Ρ 
Ρ 
Ρ 
Ρ 
a 
+ 
+ 
+ 
+ 
+ 
+ 
a 
a + с 
а + с 
Ρ 
Ρ 
а 
с 
с 
с 
а + 
а 
-
-
-
-
а 
-
а 
а 
-
-
-
-
а 
а 
а 
а 
-
sacrif 
sacrifice after laparotomy 
sacrifice after laparotomy 
sacrifice after laparotomy 
sacrifice after laparotomy 
sacrifice after laparotomy 
sacrifice after laparotomy 
ice after laparotomy 
was then carried out by removal of the left lateral and left 
medial lobes and half of the quadrate and caudate lobes 
(Figs. 21 and 26). 
Fiq. 25. _A. Normal portogram of the dog showing the sple-
(page 104) nie vein coming in from the left side of the 
dog and the portal vein with its hepatic bran­
ches; B. portogram just after left hemihepatec­
tomy, construction of a peripheral splenoportal 
bypass and transection of the portal vein; 
C. portogram one month after left hemihepatec­
tomy and diversion of the portal blood by a 
peripheral splenoportal bypass; D.portogram two 
months after C. 
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The splenic vein (5 mm wide at that level) was carefully 
dissected and distally cut. After injection with a heparin 
solution the distal side was ligated (Fig. 26) and moved cra-
nially, behind the stomach, up to the liver and the prepared 
portal stump. Stabilised by a vascular clamp, the very thin 
cut edge of the splenic vein was adapted to the portal branch 
by three stay sutures at 120° distance from each other. Sub-
sequently both vessels were end-to-end anastomosed with inter-
rupted Prolene (R) 6x0 stitches and with microvascular instru-
ments. The clamps were removed and simultaneously the portal 
vein was closed by pulling the surrounding loop. In this way 
the portal blood was forced to follow the new hepatic inflow 
tract. The portal pressure was recorded and the bowel conges-
tion judged. Now the retained liver lobes had a double portal 
inflow tract (Fig. 22). Only when the bypass was considered 
to function properly the portal vein was transected, a porto-
gram performed and the abdomen closed (Figs. 23, 25 and 26). 
Results 
The mean normal portal blood pressure was 6 mm Hg (range 4 to 
9 mm Hg) and the mean outside diameter of the portal vein 
11 mm (range 10 to 12 mm). Hemihepatectomy caused no change in 
portal or arterial blood pressures. After opening of the para-
portal bypass and closure of the portal vein, the portal pres-
sure rose in all dogs. If the pressure exceeded 30 mm Hg a 
marked bowel congestion developed and the arterial pressure 
dropped as described in total occlusion of the portal vein 
(29) . 
In all dogs the construction of the bypass was successful. The 
lumen of the splenic vein was, however, rather unequally nar-
rowed and in all veins stretches not wider than 3 mm re-
mained. Nevertheless, removal of ad^ntitial strings and espe-
cially careful grazing of the wall with a oair of vascular 
pincers resulted in a lumen wide enough to produce a fair de-
compression in all but one dog. In this dog, the second in 
the series, the pressure remained 31 mm Hg because of a poor 
anastomoses. Apparently this bypass provided a decompression 
Fig. 26. _A.Portal vein branch to left lateral lobe dis-
(page 106) sected between left medial, left lateral and 
caudate lobes; B. situation after left hemihepa-
tectomy with bulldog on preserved hilar stump of 
left lateral portal vein branch ;Ç . mobilised 
and distally transected splenic vein; D.splenic 
vein transposed to liver hilus and anastomosed 
end-to-end with hilar part of portal vein branch 
to resected left liver lobe, forming a periphe-
ral splenoportal bypass. 
LML = left medial lobe Pvb = portal vein branch 
LLL = left lateral lobe v l = v· lienalis 
CL = caudate lobe —* = dissected portal vein branch 
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Table XXXIV. Development of portal pressure (mm Hq) in dogs after hemi-
hepatectomy and diversion of the portal blood to the retained 
hemi-liver via a paraportal bypass, consisting of the splenic 
vein and the left lateral portal vein branch. 
Dog no. original just after bypass after bypass construction 
reconstruction 
after 4-6 weeks after 2-3 months 
1 
3 
4 
10 
12 
13 
18 
19 
20 
21 
mean 
(n - 10) 
4 
9 
5 
7 
5 
5 
6 
6 
5 
4 
6 
18 
15 
13 
16 
15 
12 
7 
12 
8 
6 
12 
10 
3 
4 
6 
7 
7 
5 
7 
6 
4 
6 
just enough immediately after reconstruction, but this bypass 
was closed and replaced by a bunch of collateral vessels after 
six weeks. In the other 20 dogs the mean portal pressure rose 
to 13 mm Hg (range 6 to 22 mm Hg) with a slight bowel conges-
tion, there were no changes in arterial pressure. 
In 15 dogs the first operation consisted in a hemihepatecto-
my and portal diversion only. Two of these dogs died soon 
after the operation from postoperative bleed due to technical 
failures. Two others died within 24 hours after the operation 
because of bypasses kinked or squeezed by postoperative oede-
ma of a small remnant of hepatic tissue beside the stump of 
the left lateral portal vein branch. In one dog (page 105) the 
anastomosis closed postoperatively. 
In 10 dogs these complications could be avoided and these 
animals had an uncomplicated postoperative course. At reopera-
tion four to six weeks later, the bypasses appeared to have 
widened to large vessels with a concomitant return of the 
portal oressure to the mean normal value of 6 mm Hq (Table 
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Fig. 27. Peripheral splenorenal bypasses two to three 
months after construction. 
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XXXIV). The livers in these dogs showed the bulging picture 
characteristic of regeneration. At the third operation and 
subsequent sacrifice two to three months after hemihepatecto-
my and portal diversion, the bypasses had developed into ves-
sels almost as wide as the original portal vein (Figs. 25 and 
27). The mean weight of the regenerated livers was twice that 
of the hemi-livers removed during the first operation. The 
splenoportal anastomoses were well healed and as wide as the 
rest of the bypasses. 
Discussion and conclusions 
Construction of a paraportal bypass provided the liver with 
a double inflow tract of portal blood. The diameter of the 
vessels forming the bypass was only half the diameter of the 
portal vein and the splenic vein was even further narrowed by 
spasm immediately after displacement. Nevertheless the bypass 
provided an outflow tract for the extrahepatic portal system 
and an inflow tract for the intrahepatic system sufficient to 
replace the function of the portal vein. This result is con-
sistent with reports that the lumen of the portal vein can 
be narrowed considerably before the portal flow is influenced 
(452) . 
The portal vein was transected only if it was clear that 
its function would be taken over by the bypass. Hemihepatec-
tomy and transection of the portal vein preceded by the re-
construction of a paraportal bypass, was a feasible and safe 
procedure, well tolerated by the dog which is more suscepti-
ble to an acute rise in portal pressure than man. The rise in 
portal pressure which reflected the raised resistance in the 
transferred splenic vein, subsided aò the bypass gradually 
widened. Narrow as it was in the beginning, replacement of 
the portal vein by the bypass did not interfere with a normal 
regeneration of the liver remnant. The anastomosis with fine 
interrupted stitches expanded as much as the rest of the 
bypass (166, 298). The turned blood flow in the hepatic 
branch of the portal vein did not raise any problems. 
Unfortunately a proper umbilical vein did not exist in the 
investigated animals. By means of the mobilised splenic vein 
the situation to be expected after the construction of a 
paraportal umbilical bypass could be imitated. The relation 
of the diameters between the splenic and portal vein in the 
dog (5:11 - 45%) was even less favourable than that between 
the umbilical and portal vein in man (7.7:10.2 - 75%). Since 
the peripheral splenoportal bypass functioned properly in the 
dog, it can be assumed that the umbilical bypass in man will 
function equally well. 
Prospects 
Although far from being easy, the construction of the anasto-
mosis between the splenic vein and hepatic portal vein branch 
was feasible in all dogs. A similar paraportal access to the 
intrahepatic portal venous system should be possible to any 
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place in the human liver where a vein of sufficient size can be 
reached and dissected. Comparable to intrahepatic lateral cho-
langiojejunostomy with a bile duct of segment III (521), it 
may be possible to construct an end-to-end anastomosis be-
tween the mobilised splenic vein and an intrahepatic portal 
branch or to connect both vessels with a vein graft. In fact 
the umbilical paraportal bypass proposed in Chapter 6 is simi-
lar and is just a utilisation of a human anatomical advantage. 
The mobilised splenic vein may as well be anastomosed end-
to-end with the remnant of any main portal branch in the liver 
hilus with a cuff long enough to allow a vascular suture. 
This method was suggested by Longmire (357) for reconstruction 
of the portal blood supply to the left lobe, but is never per-
formed (361). An analogue reconstruction may be considered for 
the right lateral liver sector as in about 2/3 of men the 
portal vein branch can be found in the notch which extends 
from the right side of the porta hepatis (206, 464). 
An end-to-end anastomosis between the mobilised splenic vein 
or a venous graft and the hepatic side of a transected main 
portal vein branch in the liver hilus will restore the ante-
grade flow of portal blood to the liver part involved. If such 
a reconstruction is performed before the portal vein is cut, 
the extrahepatic portal system remains decompressed in the 
meantime by the intact contralateral branches. After recon-
struction of the portal circulation the situation is similar 
to that after construction of an umbilical bypass to the left 
lobe, as outlined in Chapter 6. Transfer of the arterial 
supply to a near-by large artery completes the construction of 
an entire and separate afferent blood supply to the relevant 
liver part. During portal vein reconstruction the arterial 
supply is undisturbed and during the arterial shift there is a 
continuing flow through the restored portal branch. By then 
resection of the rest of the liver and the complete hepatodu-
odenal ligament can be safely performed. 
8.4. Arterial splenohepatic diversion (17 dogs) 
Procedure 
The trifurcation of the coeliac axis was approached in the 
lesser sac behind the level of the paraportal bypass or from 
the left side at the rear of the abdominal cavity. The first 
3 to 4 cm of the hepatic and splenic arteries were dissected 
and both vessels were cut at 2 to 3 cm from their origin. 
The central part of the splenic artery was then inserted end-
in-end into the distal part of the hepatic artery and fixed 
in this position by three to six interrupted Prolene(R) 6x0 
stitches (Fig. 24). In microvascular surgery such a sleeve 
anastomosis is reported to provide a fast and good anastomosis 
without stitches entering the perfused lumen (334, 335, 614). 
Results 
The construction of sleeve anastomoses were not so favourable 
as expected. The splenic artery which is already smaller than 
the hepatic artery had to be cut at 2 cm from its origin 
before becoming too small. The central part had to be bended 
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sharply to be inserted into the hepatic artery. This and the 
simultaneous construction of the anastomosis was impaired by 
the narrow operative field at the bottom of the lesser sac of 
the dog. Moreover the cut edges of both vessels did not always 
fit accurately because of the thick walls. Some narrowing was 
suspected at the anastomotic site though this could not proper-
ly be judged during the construction. 
Hepatic arterial diversion was performed in 10 dogs that had 
fully recovered from hemihepatectomy and portal blood trans-
fer (9 dogs) or from hemihepatectomy only (one dog), in one 
dog the diversion was performed with a concomitant hemihepatec-
tomy only. Two of these 11 dogs died in the second postopera-
tive week;both had a blocked arterial anastomosis. Microscopic 
examination of the liver of one dog revealed signs of venous 
liver congestion as seen in the outflow block syndrome. The 
nine surviving dogs were sacrificed after four to six weeks. 
In two the arterial anastomosis was blocked by an organised 
thrombus. One of these two dogs had been nearly moribund in the 
first postoperative week. The premortal arteriogram of the 
other showed a collateral circulation between the left gastric 
artery and the liver. 
Seven of the 11 arterial anastomoses were patent and well 
healed four to six weeks after reconstruction, but all seven 
showed a slight stenosis. The small gap between the two vessel 
walls was filled by an organised thrombus and covered with an 
intimai lining. The liver of the dog that had undergone just a 
hemihepatectomy and simultaneous arterial diversion had rege-
nerated normally. 
Discussion 
Splenohepatic arterial transfer both as an isolated operation 
and combined with a hemihepatectomy was well tolerated by the 
dog and could safely be performed in dogs recovered from hemi-
hepatectomy with transfer of the portal inflow tract to the 
retained hemi-liver. In this context the use of a sleeve ana-
stomosis was not beneficial. The procedure was not easier and 
no less time consuming than a standard or spatulated end-to-
end anastomosis. Disadvantages were a slight constriction of 
the vascular lumen, no expansion and the risk of a thrombosis 
spreading from the space between the sleeves, as was demonstra-
ted in four of 11 dogs. 
Immediately after transection of the splenic vein the spleen 
became congested and very vulnerable. Four times a hemisplenec-
tomy was performed which consisted in removal of the lower 
Dole. At reoperation four to six weeks after portal diversion 
the size of the spleen had not changed. However, the spleen 
and in particular the lower pole, had shrunk considerably if 
both splenic vein and splenic artery had been used for hepatic 
blood diversion one to two months before. 
Ill 
8.5. Hemihepatectoiny and simultaneous transfer of the 
portal and arterial blood supply (6 dogs) 
Results 
All six dogs died in shock within 24 hours. Four had been 
quite well in the first hours after operation. Postmortem exa-
minations revealed patent anastomoses and no other abnormali-
ties than ascites and slightly congested livers. Microscopic 
examination of the liver showed acute central and pericentral 
congestion and necrosis as seen in outflow block with shock 
(Fig. 28). 
Discussion 
Hemihepatectomy combined with diversion of the portal and 
arterial blood supply to the retained liver parts in one ses-
sion was lethal in the dogs because of an hepatic outflow 
block and shock. Unlike man, the dog has hepatic venous sphin-
cters reacting upon ischaemia by constriction which results 
in a blockade of the hepatic venous outflow (414, 524, 592). 
Diversion of the portal blood from the portal vein to the 
initially narrow bypass results in a temporarily decreased 
flow into the liver. Obstruction of the portal blood flow in 
the dog with an intact hepatic artery shows a reactive increa-
se of the blood flow in that artery (227, 311, 378). The resis-
tance in the splenohepatic arterial diversion was considerably 
higher than in the original hepatic artery, because of the 
relatively narrow lumen, the sharp curve of the splenic 
artery and the still further narrowing at the stenosing ana-
stomosis. This resulted in a substantial decline instead of a 
reactive increase of the arterial hepatic blood flow. 
Hemihepatectomy with a decreased portal òr arterial flow was 
well tolerated. However, a considerable sudden decline of both 
portal and arterial blood flow apparently caused liver ischae-
mia serious enough to give a hepatic outflow block in the 
dogs. If arterial and portal diversions are to be carried out 
simultaneously, it is advisable to use the largest artery and 
vein available and also the widest anastomoses possible for 
vascular reconstructions. 
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28. Section of the liver of a dog that died after 
progressive shock: A centrilobular pale areas 
which often merge together, immediately around the 
portal tracts plates of normal liver cells can 
still be recognised (HE x36); В Detail of hepatic 
lobule with normal liver cells around the portal 
tract (left) and necrosis of centrilobular cells 
with haemorrhage and congestion and almost no 
inflammatory response (HE xl40) . 
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9. The proposed radical block resection 
± Bilateral subcostal incision, extended Kocher manoeuvre, 
assessment of tumour dissemination, transection of the 
tissue bridge between segments III and IV. 
2 Dissection and distal transection of the ligamentum teres. 
2 Incision of the lesser omentum along the right side of the 
left lobe (sparing the left arterial branch), dissection 
of the left corner of the porta hepatis, encirclement of the 
left hepatic artery branch and of the left portal vein just 
before the recessus of Rex, palpation of the left hepatic duct. 
4 Transection of the common hepatic duct as close as possible 
to pancreas and duodenum, dissection and encirclement of 
the bases of the portal vein and hepatic artery, dissection of 
the central splenic vein. 
5^  Construction of a Roux-Y loop, mobilisation of the right 
liver lobe and preparations for right lobectomy. 
6 Opening of the umbilical vein. The portal vein base or the 
encircled left portal vein branch has to be closed at the 
moment of opening the umbilico-portal junction. Filling of the 
umbilical vein with heparin solution, distal ligation of the 
umbilical vein, release of the portal vein clamping. 
7 Careful clamping of the umbilical vein, distal transection 
at the level required, lateral clamping of the central 
splenic vein and end-to-side anastomosis between the umbilical 
vein and splenic vein (Fig. 11, page 81). Partial occlusion of 
the portal vein base may be required to bring about a suffi-
cient flow through the umbilical bypass. 
At this stage nothing has been divided yet and the liver has a 
double portal vascularisation. 
If no suitable umbilical vein can be obtained: 
7a Mobilisation, distal transection and retrogastric transpo-
sition of the splenic vein, filled with heparin solution, 
towards the left portal vein branch. 
8_ Transection of the hepatic artery branch to the left lobe 
2 cm before its entrance into the parenchyma and re-anasto-
mosis of the hepatic side of the artery with another large 
artery available, either directly (splenic artery or if possi-
ble gastroduodenal artery) or by interposition of a saphenous 
graft using the hepatic artery stump (Fig.12, page 82). 
9^ Transection of the left portal vein branch just before the 
recessus of Rex (Fig. 13, page 82). 
If no suitable umbilical vein can be obtained: 
9a Transection of the left portal vein branch 1 cm before the 
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recessus of Rex, end-to-enâ anastomosis between the hepatic 
part of the transected vein with the transposed splenic vein. 
Now the left and the right liver lobes each have a separate 
afferent vascularisation. 
1_0 «Total clamping of the bases of the portal vein and the 
hepatic artery, assessment of the haemodynamic situation to 
expect after radical resection. 
Still the procedure can be abandoned. The vascular reconstruc-
tion of the area to be retained is finished and tested; there 
is afferent bloodlessness of the area to be resected. 
11 Resection of the complete hepatoduodenal ligament and the 
right liver lobe with the caudate lobe (Fig. 14, page 83). 
12 Hepaticojejunostomy and fixation of the left lobe to pre-
vent postoperative vascular kinking by changement of the 
patient's posture. Partial or total splenectomy may be neces-
sary during or at the end of the procedure. 
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Summary 
Carcinoma of the hepatic duct confluence causes a non-specific 
obstructive jaundice only when the bile drainage of the liver 
is blocked almost completely. Therefore an earlier diagnosis 
is impossible and the poor results of the current treatment 
modalities have induced a therapeutic fatalism, especially 
with respect to the curative prospects. Still the patients 
die from the consequences of the localised bile duct obstruc­
tion and only seldom from a disseminated malignancy. There is 
ample but fragmentary and non-systematised literature on con­
fluence tumours. This thesis has a twofold aim: 
A to inventory the data on the properties of these tumours 
and on the various surgical treatments (Chapters 1-4), and 
В to find better therapeutic possibilities (Chapters 5-9). 
In Chapter 1 the anatomy of the liver, liverhilus and ligamen-
tum hepatoduodenale is reviewed. Emphasis is placed on the 
structures of the left liver lobe and on the lymphatic drainage 
of the liverhilus in view of the oncological implications and 
therapeutic possibilities described in Part B. 
Chapter 2 presents a literature survey of the pathology and 
therapy of confluence tumours. At the time of diagnosis the 
tumour mostly consists of a nodular, firm mass of some centi­
metres, composed of a well-differentiated adenocarcinoma with 
strong peritumoral fibrosis. Papillary types are present in 
6% of the patients and in 9% of the cases the tumours are mul­
tifocal or diffuse. Because of submucosal spread the tumour 
has to be regarded as a regional affection of the bile duct. 
Penetration of the thin bile duct wall exists in 70% of the 
patients and results in periductal tumour spread, in the peri­
neural and other lymph vessels, the peribiliary vascular net­
work, portal vein, hepatic artery or adjacent liver parenchy­
ma. 
Metastases in the regional lymph nodes are seen in 33% of 
the patients, direct spread or metastases in the liver in 50% 
and distant metastases in 15% of the cases. Some type of 
regional dissemination exist at the time of diagnosis in 1/2 
to 2/3 of the patients but in the others no metastases can be 
found, even after death. 
The stage of growth at the time the tumour is discovered is 
unknown. A total obstruction or local tumour spread may al­
ready exist unilaterally, as obstructive jaundice is the first 
and only symptom and appears only when the bile drainage of 
the liver is obstructed nearly completely. The aim of treat­
ment is to raise the bile duct obstruction and to remove the 
malignant tumour. Resection provides the best possibilities 
and paratumoral bypass or transtumoral drainage are consider­
ed only if resection is impossible. 
The pre-operative investigation is directed to the assess­
ment of tumour spread and the biliary and vascular anatomy. 
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Final assessment of resectability can only occur by laparotomy 
and exploration. The precarious bilio-enteric anastomosis is 
made preferably by a careful mucosal suture but hepato-entero-
stomy may be good as well. 
One third of the tumours is resectable. The mean operative 
mortality of 201 patients from series of at least three pa-
tients is 13% and the mean postoperative survival is 19 months. 
The operative mortality is not increased by a concomitant re-
section of the quadrate lobe or left hemi-liver, but increases 
to 3 5% when performed together with a right hemihepatectomy or 
right lobectomy. The usual cause of death is bile duct ob-
struction by recurrent tumour growth, irrespective of the ex-
tent of resection. 
The various types of paratumoral bypasses and transtumoral 
drainages are discussed. The mean operative mortality of 34 9 
and 190 patients respectively from series of at least five 
patients is 25 and 16% and the postoperative survival of both 
is 11 months. There is no clear difference between the results 
of the various bypass procedures. Radiotherapy and chemothera-
py have no convincing effects. Even after liver transplanta-
tion the patients die from recurrent tumour growth. External 
drainage may be indicated only as terminal palliation. The 
comparison of various methods of treatment is impaired by the 
relative incomparability of the patients. 
In Chapter 3 the various tumour characteristics and treatment 
modalities are discussed in a retrospective investigation of 
51 Dutch patients. Of these patients 84% had nodular sclero-
sing tumours and 16% papillary tumours. In 71% the tumour dia-
meter was smaller than 5 cm and in 33% it even did not exceed 
2 cm. There were no metastases at the time of operation in 
half of the patients with a tumour diameter of 5 cm at most. 
No relation could be found between type or differentiation of 
the tumour and local spread or dissemination. The cause of 
death was in general due to cholangitis or liver insufficiency, 
caused by recurrent biliary obstruction. 
The tumour was resected in four patients, resulting in a 
mean postoperative survival of 22 months although in at least 
two cases the resection was incomplete. There were no clear 
differences between the results of paratumoral (9 patients) 
and transtumoral (20 patients) drainage, the operative morta-
lity was 20 to 22% and the mean postoperative survival was 
six to nine months. No obvious effect of radiotherapy could be 
demonstrated except perhaps in one patient. 
Nine patients survived the first operative year and no rela-
tion could be found with age, duration of pre-operative jaun-
dice, type of tumour or operation, administration of radio-
therapy and cause of death. Only one patient is alive, eight 
years after paratumoral bypass and radiotherapy. It is con-
cluded that resection, if need be incomplete, is the best 
treatment. 
Chapter 4 contains the results of a prospective investigation 
in a specialised clinic in London into the properties and 
resection possibilities of confluence tumours with portal 
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vein involvement in 24 patients. Involvement of the bifurcation 
area of the portal vein was demonstrated by angiography in 45% 
of patients with a nodular, sclerosing confluence tumour and 
nearly half of these 45% also had involvement of the heaptic 
artery, caudate lobe or quadrate lobe. The vascular affection 
was not related to the size or differentiation degree of the 
tumour or to the occurrence of metastases. The involvement of 
the vessels did not consist in intraluminal invasion by the 
tumour but in compression or strangulation by peritumoral scle-
rotic tissue. Therefore vascular involvement is no contra-indi-
cation for resection. 
A paratumoral bypass or transtumoral drainage was constructed 
in 12 patients and resulted in an operative mortality of 17% 
and a mean postoperative survival of seven months. Resection of 
the tumour together with right lobectomy or left hemihepatecto-
my was performed in eight patients. In three of these cases a 
lateral segment of the portal vein bifurcation was removed and 
twice the complete bifurcation was resected, followed by end-
to-end repair. 
The case histories and operations of six patients are discus-
sed in detail, three of the eight patients died in the post-
operative period, the mean postoperative survival of the other 
patients was 11 months. Finally the methods of portal vein re-
construction are reviewed and the literature on hepatectomy 
with simultaneous portal vein resection is discussed. 
Chapter 5 presents an analysis of the poor results. In half of 
the patients no metastases are found but because of its charac-
teristic submucosal and periductal spread the tumour must 
already have invaded the tissues around the confluence at the 
time of treatment. In all current types of resection these tis-
sues are removed only partially and especially the retro-hilar 
structures are left alone. Therefore the usual tumour recurren-
ce is not surprising. 
In Chapter 6 the requirements and possibilities of a radical 
resection are discussed. Block resection of the right liver 
lobe, hilus and hepatoduodenal ligament, leaving the left lobe 
with complete portal and arterial vascularisation, is the best 
possiblity. Revascularisation methods of the remaining left 
lobe are discussed and an operative procedure is proposed in 
which the reconstruction of the vascularisation is performed 
prior to the actual resection. 
In man the umbilical vein remains after birth in collapsed 
but intact form in the ligamentum teres. By opening the umbi-
lical vein the left hepatic portal system can be entered and 
by anastomosing the re-opened umbilical vein with the splenic 
vein a communication is acquired between the splanchnic and 
the hepatic portal system, which can replace the portal vein. 
After construction of such a paraportal bypass the portal vein 
can be resected. The hepatic artery branch to the left lobe 
can be transected and re-anastomosed with another large upper 
abdominal artery, which results in a separate arterial supply 
of the left lobe. If both portal and arterial reconstructions 
appear to function well, the desired block resection of the 
right liver lobe and hepatoduodenal ligament can be carried 
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out safely. 
The literature on the use of the umbilical vein is reviewed 
and the conclusion is that the proposed application of the 
vein will probably be effective. Finally the access to the 
portal vein confluence and the desirability of retrohepatiû 
vascular isolation are discussed. 
Chapter 7 presents an anatomical postmortem investigation of 
40 livers into the feasibility of the proposed block resection. 
In 91% of the dissections the umbilical vein could be re-open-
ed to a lumen almost as wide as the left portal vein branch. 
After encirclement and transection of the left portal vein 
branch in the umbilical fissure of the liver, the portal venous 
system of the left liver lobe can be reached via the re-opened 
umbilical vein. The artery branch to the left lobe enters the 
parenchyma dorsally to the portal vein branch, the left hepatic 
duct is on this level cranial to the portal vein branch. 
The plane of transection along the umbilical scissure stays 
a good 4 cm from the hepatic duct confluence. After parenchyma-
tous transection the left lobe remains with the umbilical vein, 
arterial remnant and hepatic duct stump. The described portal 
and arterial revascularisation of the left lobe prior to tran-
section of the liver was a well feasible procedure in the 
autopsy specimen. The final result after radical block resec-
tion seems haemodynamically comparable to standard right lobec-
tomy and biliodigestive reconstruction. 
In Chapter 8 an experimental investigation is presented into 
the functional effectivity of paraportal bypasses, arterial re-
vascularisation and liver resection in 23 dogs. It appeared 
that no usable umbilical vein existed in laboratory animals 
and therefore the splenic vein was mobilised, distally transec-
ted and end-to-end anastomosed with the stump of a hepatic 
portal vein branch, which was preserved during left hemihepa-
tectomy. The retained right hemi-liver then had a double portal 
inflow tract. The portal vein could be cut safely when it was 
clear that the paraportal bypass functioned properly. The he-
patic and splenic arteries were cut during the same operation 
or six weeks later, followed by an end-in-end sleeve anastomo-
sis of the central side of the splenic artery into the distal 
side of the hepatic artery. Forty-six operations were perform-
ed. 
Left hemihepatectomy with replacement of the portal vein by 
the paraportal bypass was well tolerated by the dogs. The por-
tal pressure rose from 6 to 13 mm Hg because of the initially 
narrow lumen of the bypass, but at re-operation one to three 
months later the bypass had widened to a vessel almost as wide 
as the original portal vein and the portal pressure had re-
turned to normal. 
Arterial transfer as a separate procedure or together with 
hemihepatectomy resulted in a patent but narrow anastomosis 
in seven of the 11' dogs. Hemihepatectomy with simultaneous 
portal and arterial transfer in six dogs was lethal within 24 
hours. The animals died in shock, probably caused by a hepa-
tic outflow block induced by liver ischaemia. 
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The conclusion is made that a splenic paraportal bypass, com-
parable with a human umbilical bypass, can function properly. 
If in a patient no usable umbilical vein is available, a sple-
nic paraportal bypass may serve the same function. For a simul-
taneous portal and arterial transfer the larges available arte-
ry or venous graft interposition should be used with the widest 
anastomosis possible. 
Finally in Chapter 9, the proposed radical block resection is 
outlined step by step. 
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Samenvatting 
Het zeldzame carcinoom van de ductus hepaticus confluentie 
manifesteert zich pas in een aspecifieke obstructie icterus 
als de galafvloed van de lever vrijwel volledig is afgesloten. 
Een vroegere diagnose is daarom onmogelijk en de povere resul-
taten van de huidige vormen van behandeling hebben geleid tot 
een therapeutisch fatalisme, vooral voor wat betreft de cura-
tieve mogelijkheden. Toch sterven de patiënten aan de gevolgen 
van de gelokaliseerde galwegobstructie en slechts zelden aan 
een gedissemineerde maligniteit. Er bestaat een uitgebreide 
literatuur over confluentietumoren doch deze is fragmentarisch 
en niet gestructureerd. Deze dissertatie heeft een tweeledig 
doel: 
A het inventariseren van hetgeen bekend is over de eigenschap-
pen van deze tumoren en aver de verschillende chirurgische 
behandelingen (Hoofstuk 1 t/m 4); 
В het zoeken naar betere therapeutische mogelijkheden 
(Hoofdstuk 5 t/m 9). 
Hoofdstuk 1 bevat een anatomisch rappel van lever,leverhilus en 
ligamentum hepatoduodenale. In verband met de oncologische im­
plicaties en therapeutische mogelijkheden die beschreven worden 
in Deel B, wordt enige nadruk gelegd op de structuren van de 
linker leverkwab en op de lymphatische drainage van de lever­
hilus. 
Hoofdstuk 2 geeft een literatuuroverzicht van pathologie en 
therapie van confluentietumoren. Op het tijdstip van diag­
nose bestaat de tumor meestal uit een nodulaire, vaste massa 
van enkele centimeters grootte, opgebouwd uit een goed gedif­
ferentieerd adenocarcinoma met een sterke peritumorale fibro­
se. Beoordeling van de aanwezigheid van tumorcellen kan erg 
moeilijk zijn door uitgebreide fibrose. Papillaire vormen wor­
den bij 6% van de patiënten aangetroffen, en in 9% van de ge-
vallen betreft het multifocale of diffuse tumoren. Door sub-
mucosale verspreiding moet de tumor worden beschouwd als een 
regionale aantasting van de galwegwand. Penetratie van de dun-
ne galwegwand bestaat bij 70% van de patiënten en resulteert 
in periductale doorgroei van tumorweefsel in perineurale lymph-
spleten, grotere lymphe banen, peribiliaire vaat plexus, v. 
portae, a. hepática of aangrenzend leverparenchym. 
Metastasering in de regionale klieren wordt bij 33% van de 
patiënten aangetroffen, doorgroei of metastasering in de lever 
bij 50% en metastasering op afstand bij 15% van de gevallen. 
Een vorm van regionale metastasering bestaat bij 1/2 tot 2/3 
van de patiënten, doch bij de overigen ontbreekt elke vorm van 
aantoonbare disseminatie, zelfs na het overlijden van de pa-
tiënt. 
Het groeistadium waarin de tumor zich bevindt op het moment 
van ontdekking is onbekend. Aangezien icterus eerst ontstaat 
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als de galafvloed van de lever bijna volledig is afgesloten, 
kan unilateraal al een totale obstructie en lokale doorgroei 
zijn opgetreden met alle gevolgen van dien. 
Het doel van de behandeling is opheffing van de galwegob-
structie en verwijdering van de maligne tumor. Resectie biedt 
daartoe de beste mogelijkheden en eerst als resectie onmoge-
lijk is, komen paratumorale bypass of transtumorale drainage 
in aanmerking. 
Het pre-operatieve onderzoek is gericht op het bepalen van 
de uitbreiding van de tumor en op het bepalen van de biliaire 
en vasculaire anatomie.Definitieve vaststelling van de resec-
tabiliteit kan alleen geschieden tijdens laparotomie. De 
precaire bilio-enterische anastomose kan het beste worden ge-
maakt met een zorgvuldige mucosanaad,doch hepato-enterostomie 
biedt ook goede mogelijkheden. 
Een derde van de tumoren is resectabel. De gemiddelde opera-
tieve mortaliteit van 201 patiënten uit series van tenminste 
drie patiënten is 13% en de gemiddelde postoperatieve over-
levingsduur is 19 maanden. De operatiemortaliteit wordt niet 
vergroot door een gelijktijdige resectie van de lobus quadra-
tus of linker leverhelft, maar stijgt tot 35% wanneer een 
rechter hemihepatectomie of lobectomie wordt uitgevoerd. De 
gebruikelijke doodsoorzaak is galwegobstructie door recidive-
rende tumorgroei, onafhankelijk van de omvang van de resectie. 
De verschillende typen paratumorale bypasses en transtumorale 
drainages worden vervolgens besproken. De gemiddelde operatie 
mortaliteit van respectievelijk 349 en 190 patiënten afkomstig 
uit series met tenminste 5 patiënten is 25 en 16% en de post-
operatieve overleving van beide is 11 maanden. Een duidelijk 
verschil in resultaat tussen de verschillende bypass procedu-
res is niet aantoonbaar. Een overtuigend effect van radio- of 
chemotherapie is niet te vinden. Ook na levertransplantatie 
sterven de patiënten aan tumorrecidief. Externe drainage kan 
alleen geïndiceerd zijn als terminale palliatie. De vergelij-
king van de verschillende vormen van therapie wordt echter 
belemmerd door de betrekkelijke onvergelijkbaarheid van de 
patiënten. 
In Hoofdstuk 3 worden de verschillende tumoreigenschappen en 
vormen van therapie vergeleken in een retrospectief onderzoek 
van 51 Nederlandse patiënten. 84% Van de tumoren was nodulair 
skleroserend, 16% papillair. Bij 71% van de patiënten was de 
tumor diameter kleiner dan 5 cm en bij 33% zelfs niet groter 
dan 2 cm. Bij de helft van de patiënten met een tumor door-
snede van hoogstens 5 cm waren geen metastasen aanwezig ten 
tijde van de operatie. Er bestond geen relatie tussen type of 
differentiatiegraad van de tumor enerzijds en het optreden van 
metastasen of lokale uitbreiding anderzijds. De doodsoorzaak 
was meestal het gevolg van recidiverende biliaire obstructie, 
namelijk cholangitis en liverinsufficientie. 
Bij vier patiënten werd de tumor gereseceerd en ondanks het 
feit dat tenminste bij twee patiënten de resectie incompleet 
was, werd een gemiddelde postoperatieve overlevingsduur van 
22 maanden bereikt. Er bestonden geen duidelijke verschillen 
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tussen de resultaten van paratumorale (9 patiënten) en trans-
tumorale (20 patiënten) drainage, de operatiemortaliteit was 
20 tot 22% en de gemiddelde overlevingsduur 6 tot 9 maanden. 
Van radiotherapie was geen duidelijk effect aantoonbaar. 
Negen patiënten leefden langer dan êên jaar, zonder aantoon-
bare relatie met leeftijd, duur van de voorafgaande icterus, 
tumortype, aard van de operatie, toediening van radiotherapie 
en doodsoorzaak. Acht jaar na paratumorale bypass en radio-
therapie is één patiënt in leven. Geconcludeerd kan worden dat 
resectie, desnoods incompleet, de beste behandeling vormt. 
Hoofdstuk 4 bevat de resultaten van een prospectief onderzoek 
in een gespecialiseerde kliniek in Engeland naar de eigen-
schappen en resectiemogelijkheden van 24 patiënten met conflu-
entietumoren die de v. portae hadden aangetast. Angiografisch 
aantoonbare aantasting van het bifurcatiegebied van de v.por-
tae bestond bij 45% van de patiënten met een nodulaire skìero-
serende tumor en bij bijna de helft van deze 45% bestond even-
eens aantasting van de a. hepática, lobus caudatus of lobus 
quadratus. De vasculaire aantasting was niet gerelateerd aan 
grootte of differentiatiegraad van de tumor of aan het vóór-
komen van metastasen. Deze aantasting bestond niet uit intra-
luminale tumorinvasie maar uit verdrukking van de vaten door 
peritumoraal sklerotisch weefsel. Vaataantasting vormt daarom 
geen contra-indicatie voor resectie. 
Een paratumorale bypass of transtumorale drainage werd gecon-
strueerd bij 12 patiënten en gaf een operatiemortaliteit van 
17% en een gemiddelde postoperatieve overlevingsduur van zeven 
maanden. Resectie van de tumor, samen met rechter lobectomie 
of linker hemihepatectomie, werd verricht bij acht patiënten; 
in drie gevallen werd daarbij een lateraal segment van de v. 
portae bifurcatie verwijderd en tweemaal werd de volledige 
bifurcatie gereseceerd, gevolgd door end-to-end reconstructie. 
De ziektegeschiedenis en operatie van zes patiënten worden 
nader besproken. Drie van de acht patiënten overleden in de 
postoperatieve periode, de gemiddelde overlevingsduur van de 
overigen is 11 maanden. Tenslotte worden de methoden voor 
v. portae reconstructie aangegeven en de literatuur over hepa-
tectomie en gelijktijdige v. portae resectie besproken. 
Hoofdstuk 5 geeft een analyse van de slechte resultaten. Hoewel 
bij de helft van de patiënten geen metastasering wordt aange-
troffen, moet op grond van de submuceuze en periductale groei-
kenmerken van de tumoren toch worden aangenomen dat ten tijde 
van de behandeling reeds tumorweefsel in de weefsels om de 
hepaticus confluentie aanwezig is. Bij alle bestaande vormen 
van resectie worden deze weefsels slechts partieel verwijderd. 
Het gebruikelijke optreden van een lokaal tumorrecidief is 
daarom dan ook niet verwonderlijk. 
In Hoofdstuk б worden de vereisten en mogelijkheden van een 
radicale resectie besproken. Blokresectie van de rechter lever­
kwab, hilus en ligamentum hepatoduodenale, waarna de linker-
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kwab met een arteriale en volledige portale vascularisatie 
overblijft, vormt de beste mogelijkheid. Revascularisatie-
methoden van de resterende linkerkwab worden besproken en 
een operatieve procedure wordt voorgesteld waarbij de recon­
structie van de vascularisatie van de linkerkwab wordt uitge­
voerd ббг de eigenlijke blokresectie. 
Door de v.umbilicalis, die bij de mens in gecollabeerde vorm 
aanwezig blijft, te openen wordt toegang tot het linker hepa­
tische ν. portae stelsel verkregen. Door de heropende v. um­
bilicalis te anastomoseren met de v. lienalis ontstaat een 
verbinding tussen het splanchnische en het hepatische portale 
systeem, die de v. portae kan vervangen. Na constructie van 
een dergelijke umbilicale paraportale bypass kan de v.portae 
worden gereseceerd. Door de arterietak die de linkerkwab ver­
zorgt te klieven vlak voor intrede in het parenchym en te 
re-anastomoseren met een andere bovenbuiksarterie, krijgt de 
linkerkwab een afzonderlijke arteriele circulatie. Wanneer 
deze portale en arteriele reconstructies goed blijken te func­
tioneren, kan de gewenste blokresectie van de rechter lever­
kwab en het ligamentum hepatoduodenale veilig worden uitge­
voerd. 
De ervaringen die in het verleden met het gebruik van de 
v.umbilicalis zijn opgedaan worden besproken. Op grond van 
deze ervaringen is de effectiviteit van de voorgestelde toe­
passing waarschijnlijk. Tenslotte wordt de wenselijkheid van 
retrohepatische vasculaire isolatie belicht. 
Hoofdstuk 7 bevat het verslag van een anatomisch postmortem 
onderzoek van 40 levers naar de uitvoerbaarheid van de voor­
gesteld blokresectie. Bij 91% van de dissecties kon de v. 
umbilicalis worden heropend.tot een lumen dat vrijwel even 
wijd was als dat van de linker v. portae tak.Na omsingeling 
en klieving van de linker v. portae tak in de fissura umbili­
calis kan het ν. portae stelsel van de linker leverkwab worden 
bereikt via de heropende v. umbilicalis. De arterietak van de 
linker kwab gaat het parenchym binnen dorsaal van de v.portae 
tak, de linker ductus hepaticus ligt op dat niveau craniaal 
van de v. portae tak. 
Het transsectievlak langs de scissura umbilicalis blijft 
ruim 4 cm van de hepaticus confluentie verwijderd. Na paren­
chym transsectie blijft aan de linkerzijde de linkerkwab over 
met v. umbilicalis, arteriestomp en galwegstomp. Portale en 
arteriele revascularisatie van de linker kwab OD deze wijze, 
voorafgaande aan transsectie van de lever, bleken in het ob­
ductiepreparaat goed uitvoerbaar. Het eindresultaat na radi­
cale blokresectie zal haemodynamisch vergelijkbaar zijn met 
een standaard rechter lobectomie en biliodigestieve recon­
structie . 
In Hoofdstuk 8 wordt een experimenteel onderzoek gepresenteerd 
naar de functionele effectiviteit van paraportale bypasses, 
arteriele revascularisatie en leverresectie in 23 honden. 
Omdat er bij proefdieren geen bruikbare v. umbilicalis bleek 
te bestaan, werd de v. lienalis gemobiliseerd, distaal doorge-
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knipt en end-to-end geanastomoseerd met een stomp van een v. 
portae tak die gespaard was tijdens een linker hemihepatecto-
mie. De overblijvende rechter leverhelft had OD die wijze een 
dubbel instroomkanaal voor het portale bloed. De v. portae 
werd veilig doorgeknipt wanneer duidelijk was dat de parapor-
tale bypass goed functioneerde. De a. hepática en de a.liena-
lis werden in dezelfde zitting of zes weken later doorgeknipt, 
gevolgd door een end-in-end sleeve-anastomosis van het centra-
le deel van de a. lienalis in het perifere deel van de a.hepá-
tica. Er werden 46 operaties uitgevoerd. 
Linker hemihepatectomie met vervanging van de v. portae 
door de paraportale bypass werd goed door de honden doorstaan. 
Door het aanvankelijke nauwe lumen van de bypass steeg de 
portale druk van 6 tot 13 mm Hg maar bij re-operaties één tot 
drie maanden later bleek dat de bypasses zich hadden verwijd 
tot vaten die bijna even wijd waren als de oorspronkelijke 
v. portae, terwijl de portale druk was genormaliseerd. 
Arteriele verplaatsing als een afzonderlijke procedure of 
samen met linker hemihepatectomie leverde een open doch nauwe 
anastomose op in zeven van de 11 honden. Hemiheoatectomie met 
gelijktijdige portale èn arteriele verplaatsing bij zes honden 
was dodelijk binnen 24 uur ten gevolge van shock, waarschijn-
lijk door een hepatische afvloedobstructie op basis van lever-
ischaemie. 
Geconcludeerd wordt dat de splenische paraportale bypass, 
vergelijkbaar met de menselijke umbilicale bypass, goed kan 
functioneren. Wanneer bij de mens geen bruikbare v.umbilicalis 
voor handen is, kan een splenische paraportale bypass dezelfde 
functie vervullen. Voor een gelijktijdige arteriele verplaat-
sing moet de grootst beschikbare arterie of veneus interpo-
sitie transplantaat worden gebruikt met de wijdste anastomose. 
In Hoofdstuk 9 tenslotte wordt de voorgestelde radicale blok-
resectie stap voor stap besproken. 
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APPENDIX I 
Results of resection of primary tumours of the hepatic duct confluence 
Authors patients operative mean survival 
TtortalitY (months) 
alive after (vrs) 
1 1* 2 3 
Akwari and Kelly (7) 4 
Alexandre et al.(9) 3 
Altemeier (15) 1 
Andersson et al. (17) 3 
Bërard et al. (39) 4 
Bertrand et al.(43) 1 
Bird et al. (46) 1 
Bismuth et al.(56) 1 
Blumgart (68,70) 17 
Braasch et al.(77, 80) 2 
Brown and Myers (87) 2 
Cameron et al. (109) 10 
Camprodon et al.(110) 1 
Chitwood et al. (131) 5 
Crismer et al.(145) 1 
Crozetti (146) 1 
Engler et al.(109) 1 
Evander et al.(178) 16 
Finney (184) 1 
Fortner et al.(195) 6 
Foster et al. (199) 1 
George et al. (208) 3 
Hart and White (243) 3 
Haynes et al. (246) 1 
Heully et al. (263) 1 
Hoevels and Ihee (270) 3 
Hellender et al.(273) 2 
Ingis and Farmer (290) 1 
Innocenti et al.(291) 1 
Iwasaki et al.(294) <a' (9) 
Kajitani (300) 2 
Karakousis (303) 2 
Kelly (304) 1 
Kozaka et al.(315) 2 
Launois (330,332,333) 11 
Longmire et al.(357) 2 
Mann (373) 1 
McDermott and Peinert084)7 
McDermott (385,386) 3 
Mistilis and Schiff (402)1 
Nicoli et al.(418) 2 
Nishimura et al.(420) 2 
Ong and Lee (432) 2 
den Otter (435) 3 
Philippakis et al.(446) 1 
Quattlebaum (458) 3 
Rodgers et al.(471) 1 
Rohner (476) 4 
Roux (461) 1 
Salembier (487,489) 5 
Saubier et al. (491) 3 
Skoog and Thorén (512,558) 8 
Todoroki et al. (561)(a)23 
Tompkins et al. (S64) 22 
Tsuchiya (570,571) 9 
Tsuzuki et al.(572,574) 11 
Van Vroonhoven (589) 1 
Warren et al.(596) 9 
Whelton et al.(606) 2 
White (609) 1 
0 
0 
0 
1 
0 
0 
0 
0 
3 
0 
1 
0 
0 
0 
1 
0 
0 
2 
0 
3 
1 
0 
0 
0 
0 
1 
0 
0 
0 
(1) 
0 
0 
0 
0 
2 
1 
0 
0 
0 
0 
0 
0 
2 
1 
0 
1 
0 
2 
0 
1 
0 
2 
1 
5 
2 
0 
1 
0 
1 
0 
33 
14 
42 
36 
13 
16 
12 
78 
15 
60 
8 
21 
16 
17 
60 
10 
? 
16 
20 
12 
11 
9 
28 
8 
24 
? 
(12) 
12 
15 
19 
20 
28 
12 
13 
10 
·> 
30 
9 
17 
13 
13 
+ 12 
28 
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15 
16 
? 
23 
+ 16 
7 
17 
15 
26 
20 
23 
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2 
2 
1 
2 
9 
1 
1 
4 
1 
1 
2 
2 
1 
2 
1 
2 
1 
3 
5 
? 
1 
0 
(4 
14 
1 
0 
0 
1 
1 
0 
0 
1 
0 
1 
2 
0 
1 
1 
2 
6 
0 
0 
0 
1 
0 
1 
1 
0 
0 
1 
1 
0 
1 
7 
9 
1 
0 
0 
1 
0 
0 
0 
1 
0 
1 
1 
0 
0 
0 
0 
5 
0 
0 
0 
1 
0 
0 
0 
0 
0 
1 
1 
0 
1 
3 
9 
1 
0 
0 
0 
0 
0 
0 
1 
0 
0 
0) 
0 
0 
0 
0 
3 
0 
0 
0 
1 
0 
0 
0 
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0 
0 
0 
1 
0 
1 
1 
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(a) 
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the series of Iwasaki has been worked into the series of Todoroki 
except for the 's year survival 
APPENDIX Ц 
Results of paraturooral blllo-enteric bypass for primary tumour of the 
hepatic duct confluence 
Authors patients operative mean survival 
mortality (months) 
alive afte (yrs) 
Alvarez (16) 2 
Andersson et al.(17) β 
Arianoff et al.(19) 10 
Bertrand et al.(43) 11 
Bismuth (48) 4 5 
Bodner (69) 4 
Cahow (101) 9 
Chapuis (124) 32 
Chigot et al. (128) 20 
Corlette (137) 1 
Couinaud (14 3) 
Crismer et al. (145) 
Cukier et al. (147) 
Dalmas et al. (148) 
Gautier et al. (207) 
Hepp et al. (253<а' 
Hepp et al. (258)(a) 38 
Hellender et al.(273) 3 
Huguet (277) <b> ... 24 
Huguet et al.(286),D'l3 
Launois et al.(330) 14 
LeNeel et al. (348) 3 
Levasseur et al.(349) 1 
Longmire (355,357,359) (c)ll 
Malt et al.(371) 4 
Mercadier (394) 16 
Moreno Gonzalez (407)12 
Mourgue Molines (409) 3 
Osborne et al.(434) 1 
Patel et al. (438) 
Pelissier (441) 
Perissat et al.(443) 
Prioton et al. (457) 
Ragins et al. (460) 
Saegesser et al. (484) 6 
Salembier (487,489) 16 
Schamaun (498) 
Schutt (500) 
Seigert et al.(503) 
Seiro (504) 
Sullivan (539) 
Tsuzuki (572) 
Wagenaar (591) 
White (609) 
Wong (618) 
32 
2 
12 
3 
5 
1 
1 
4 
6 
2 
1 
3 
10 
7 
о 
4 
1 
0 
0 
о 
о 
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4 
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2 
0 
2 
0 
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1 
2 
0 
11 
о 
5 
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2 
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0 
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2 
0 
0 
0 
0 
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8 
11 
20 
13 
8 
15 
? 
9 
18 
5 
12 
10 
12 
5 
9 
15 
3 
? 
17 
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15 
7 
12 
8 
? 
16 
15 
•у 
3 
5 
19 
14 
io 
4 
5 
26 
20 
•7 
29 
б 
7 
16 
12 
and there may be an overlap in these series 
1 
1 
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2 
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11 
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2 
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0 
0 
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0 
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0 
2 
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0 
0 
0 
0 
0 
1 
0 
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(с) the survival of one patient (more than 4I¡ years) is not included in the 
total mean survival 
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ftPPENDIX III 
Results of operative transturooral drainage for primary tumour of the 
hepatic duct confluence (numbers in brackets indicate the number of patients 
who survived the operation. In these series no total number of patients is 
reported) 
Authors patients operative mean survival alive after (yrs) 
mortality (months) 
H 1 1\ 2 3 
Akwari and Kelly (7) 
Altemeier et al. (13) 
Black et al. (59) 
Blumgart (63) 
Cameron et al.(107) 
Eriksson (176( 
Everson (180) 
Green et al. (226) 
Grill (228) 
?(26) 
?(18) 
2 
5 
14 
5 
1 
2 
30 
Huguet et al.(285,286)21 
Launois et al.(330) 
Lees et al. (343) 
Longmire (359) 
Marais (374) 
Mercadier (394) 
Reynolds (465) 
2 
31 
2 
2 
1 
1 
Ritchie and McLean(469)3 
Sako et al. (485) 
Salembier(487,489) 
Schamaun (498) 
Shidler (508) 
Smoron (518) 
Stoppa et al (535) 
Terblanche (545, 548) 
Thorbjarnarson (555) 
Tompkins et al. (564) 
Tsuzuki (572) 
VanderVelde (581) 
Whelton et al.(606) 
White (609) 
1 
6 
1 
1 
?(12) 
4 
9 
3 
24 
12 
6 
20 
7 
? 
? 
0 
0 
2 
1 
0 
0 
2 
2 
0 
1 
0 
0 
0 
0 
0 
0 
1 
0 
0 
3 
1 
0 
4 
6 
3 
7 
0 
10 
? 
13 
+ 12 
12 
8 
18 
10 
? 
13 
7 
10* 
8 
5 
5 
19 
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1 
7 
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15 
10 
4 
15 
20 
? 
17 
8 
16 
7 
? 
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3 
1 
2 
19 
1 
19 
1 
1 
0 
1 
2 
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4 
0 
1 
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3 
6 
1 
7 
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1 
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14 
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STELLINGEN 
1 
Een hilair galwegcarcinoom is reseceerbaar tot het tegendeel 
is bewezen. 
2 
Wanneer bij een grote leverresectie ook de afferente vascula-
risatie van de lever verwijderd moet worden verdient het aan-
beveling om voorafgaand aan de resectie de reconstructie van 
de vaten uit te voeren. 
3 
Klieven van het ligamentum teres mag alleen op stricte indi-
catie worden uitgevoerd, aangezien daarmee een autoloog veneus 
transplantaat verloren gaat. 
4 
Sparende miltchirurgie is zeker geïndiceerd in gebieden waar 
malaria endemisch is. 
5 
De behandeling van een tropisch ulcus met een split skin graft 
is eerst zinvol als de oppervlakte van het ulcus groter is dan 
2x2 cm. 
6 
Levermetastasen van colorectale carcinomen dienen vaker gere-
seceerd te worden. 
7 
Medische miskenning van het obligate karakter waarmee vocht 
zich in een ontstekingsgebied sequestreert heeft menigeen zijn 
nieren gekost. 
8 
Tussen geneeskunst en geneeskunde bestaat geen relatie. 
9 
Diagnostische wildgroei is gebaseerd op angst. 
10 
De beste reggae en rum komen nog steeds uit Jamaica, maar de 
Jamaicaanse bush thee blijkt niet beter dan chemotherapeutica 
in het veroorzaken van veno-occlusive disease van de lever. 
E . J . Boerma NIJMEGEN, 6 mei 1983 



